ABML American Battery Technology Company (QX)

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 10-Q

 

☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the quarterly period ended March 31, 2024

 

☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE EXCHANGE ACT OF 1934

 

Commission File number: 000-55088

 

 

AMERICAN BATTERY TECHNOLOGY COMPANY

(Exact name of registrant as specified in its charter)

 

Nevada		33-1227980
(State or other jurisdiction of incorporation or organization)		(I.R.S. Employer Identification No.)

 

100 Washington Street, Suite 100, Reno, NV 89503

(Address of principal executive offices, including zip code)

 

(775) 473-4744

(Registrant’s telephone number, including area code)

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of Each Class		Trading Symbol(s)		Name of Each Exchange on Which Registered
Common stock, $0.001 par value		ABAT		The Nasdaq Stock Market LLC

 

Indicate by check mark whether the registrant (1) filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the past 12 months (or for such shorter quarter that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

 

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter quarter that the registrant was required to submit such files). Yes ☒ No ☐

 

Indicate by check mark whether the registrant is a large, accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 

	Large accelerated filer	☐	Accelerated filer	☐
	Non-accelerated filer	☒	Smaller reporting company	☒
	Emerging growth company	☐

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition quarter for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act) Yes ☐ No ☒

 

As of May 13, 2024, 58,598,133 shares of common stock, $0.001 par value per share were outstanding.

 

 

 

CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS

 

This quarterly report on Form 10-Q (this “Report”) contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended (“Securities Act”), and Section 21E of the Securities Exchange Act of 1934, as amended (“Exchange Act”). All statements included in this Report, other than statements of historical facts, that address activities, conditions, events, or developments with respect to our financial condition, results of operations, business prospects or economic performance that we expect, believe, or anticipate will or may occur in the future, or that address plans and objectives of management for future operations, are forward-looking statements. The forward-looking statements are contained principally in the “Business” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations” sections of this Report. These statements involve known and unknown risks, uncertainties and other factors that may cause our actual results, performance or achievements to be materially different from any future results, performances or achievements expressed or implied by the forward-looking statements. In some cases, you can identify forward-looking statements by terms such as “anticipates”, “believes”, “seeks”, “could”, “estimates”, “expects”, “intends”, “may”, “plans”, “potential”, “predicts”, “projects”, “should”, “would” and similar expressions intended to identify forward-looking statements.

 

Forward-looking statements appear throughout this report, and include statements about such matters as: anticipated operating results; relationships with our customers; consumer demand; financial resources and condition; changes in revenues; changes in profitability; changes in accounting treatment; cost of sales; selling, general and administrative expenses; interest expense; the ability to produce the liquidity or enter into agreements to acquire the capital necessary to continue our operations and take advantage of opportunities; legal proceedings and claims.

 

Forward-looking statements reflect our current views with respect to future events and are based on assumptions and analyses made by us in light of our experience and our perception of historical trends, current conditions, expected future developments, and other factors that we believe are appropriate under the circumstances. We caution you that forward-looking statements are not guarantees of future performance and these statements are subject to known and unknown risks and uncertainties, which may cause our actual results or performance to be materially different from any future results or performance expressed or implied by the forward-looking statements.

 

Also, forward-looking statements represent our estimates and assumptions only as of the date of this Report. You should read this Report and the documents that we reference and file as exhibits to this Report completely and with the understanding that our actual future results may be materially different from what we expect. The forward-looking statements in this report speak only as of the filing of this Report. Except as required by applicable securities laws, we assume no obligation to update any prior forward-looking statements.

 

PRESENTATION OF INFORMATION

 

Except as otherwise indicated by the context, references in this Report to “we”, “us”, “our” and the “Company” are to the combined business of American Battery Technology Company and its consolidated subsidiaries.

 

This Report includes our unaudited consolidated financial statements as of and for the period ended March 31, 2024, and 2023. These financial statements have been prepared in accordance with generally accepted accounting principles in the United States (“US GAAP”). All financial information in this Report is presented in US dollars, unless otherwise indicated, and should be read in conjunction with our unaudited consolidated financial statements and the notes included in this Report.

 

 

TABLE OF CONTENTS

 

PART I
ITEM 1	Financial Statements (unaudited)	4
ITEM 2	Management’s Discussion and Analysis of Financial Condition and Results of Operations	30
ITEM 3	Quantitative and Qualitative Disclosures about Market Risk	35
ITEM 4	Controls and Procedures	35
PART II. OTHER INFORMATION
ITEM 1	Legal Proceedings	36
ITEM 1A	Risk Factors	36
ITEM 2.	Unregistered Sales of Equity Securities and Use of Proceeds	36
ITEM 3.	Defaults Upon Senior Securities	36
ITEM 4.	Mine Safety Disclosure	36
ITEM 5.	Other Information	36
ITEM 6.	Exhibits	37

 

 

ITEM 1. FINANCIAL STATEMENTS

 

The accompanying condensed consolidated financial statements (unaudited) have been prepared by the Company’s management in conformity with accounting principles generally accepted in the United States of America. In the opinion of management, all adjustments considered necessary for a fair presentation of the results of operations and financial position have been included and all such adjustments are of a normal recurring nature.

 

Operating results for the nine months ended March 31, 2024, are not necessarily indicative of the results that can be expected for the fiscal year ending June 30, 2024.

 

Condensed Consolidated Balance Sheets (unaudited)	5
Condensed Consolidated Statements of Operations (unaudited)	6
Condensed Consolidated Statements of Stockholders’ Equity (unaudited)	7
Condensed Consolidated Statements of Cash Flows (unaudited)	9
Notes to the Condensed Consolidated Financial Statements (unaudited)	10

 

 

AMERICAN BATTERY TECHNOLOGY COMPANY

Condensed Consolidated Balance Sheets (unaudited)

 

		March 31, 2024 (Unaudited)				June 30, 2023
ASSETS
Current assets
Cash		$	5,995,134			$	2,320,149
Investments			60,165				11,250
Inventory (Note 3)			622,545				125,204
Grants receivable (Note 4)			527,723				320,457
Prepaid expenses and deposits			450,784				1,625,980
Subscription receivable (Note 12)			2,446,353				350,550
Other current assets			242,850				–
Total current assets			10,345,554				4,753,590
Other deposits (Note 5)			279,878				27,740,587
Property, plant and equipment, net (Note 6)			65,586,651				29,946,099
Mining properties (Note 7)			8,392,978				8,223,323
Intangible assets (Note 8)			4,584,831				3,851,899
Right-of-use asset (Note 11)			67,366				143,154
Total assets		$	89,257,258			$	74,658,652
LIABILITIES & STOCKHOLDERS’ EQUITY
Current liabilities
Accounts payable and accrued liabilities (Note 9)		$	6,260,691			$	7,734,864
Notes payable, current (Note 10)			10,748,506				6,000,000
Total current liabilities			17,009,197				13,734,864
Equity compensation liability (Note 14)			2,179,498				833,427
Notes payable, non-current (Note 10)			–				54,304
Total liabilities			19,188,695				14,622,595
Commitments and contingencies (Note 16)			–				–
STOCKHOLDERS’ EQUITY
Series A Preferred Stock Authorized: 33,334 preferred shares, par value of $0.001 per share; Issued and outstanding: nil preferred shares as of March 31, 2024 and June 30, 2023.			–				–
Series B Preferred Stock Authorized: 133,334 preferred shares, par value of $10.00 per share; Issued and outstanding: nil preferred shares as of March 31, 2024 and June 30, 2023.			–				–
Series C Preferred Stock Authorized: 66,667 preferred shares, par value of $10.00 per share; Issued and outstanding: nil preferred shares as of March 31, 2024 and June 30, 2023.			–				–
Preferred Stock value			–				–
Common Stock Authorized: 80,000,000 common shares, par value of $0.001 per share; Issued and outstanding: 55,058,411 and 45,888,131 common shares as of March 31, 2024, and June 30, 2023, respectively			55,059				45,887
Additional paid-in capital			259,405,304				222,301,371
Common stock issuable (receivable)			499,681				(1,484,693	)
Accumulated deficit			(189,891,481	)			(160,826,508	)
Total stockholders’ equity			70,068,563				60,036,057
Total liabilities and stockholders’ equity		$	89,257,258			$	74,658,652

 

(The accompanying notes are an integral part of these condensed consolidated unaudited financial statements)

 

 

AMERICAN BATTERY TECHNOLOGY COMPANY

Condensed Consolidated Statements of Operations (unaudited)

 

		Three months ended March 31, 2024				Three months ended March 31, 2023				Nine months ended March 31, 2024				Nine months ended March 31, 2023
Operating expenses
General and administrative		$	3,229,202			$	3,538,541			$	10,699,915			$	9,445,776
Research and development			3,954,744				1,509,085				11,137,762				3,464,372
Exploration costs			1,422,758				584,344				3,596,103				1,479,507
Total operating expenses			8,606,704				5,631,970				25,433,780				14,389,655
Net loss before other income (expense)			(8,606,704	)			(5,631,970	)			(25,433,780	)			(14,389,655	)
Other income (expense)
Interest expense			(2,452	)			-				(145,089	)			-
Amortization and accretion of financing costs			(1,150,127	)			-				(3,015,280	)			-
Gain on sale of mining claims			-				-				-				98,919
Unrealized gain (loss) on investment			(19,089	)			2,949				(24,586	)			(11,709	)
Change in fair value of derivative liability			(216,765	)			-				(446,238	)			-
Other income			-				21,000				-				63,000
Total other income (expense)			(1,388,433	)			23,949				(3,631,193	)			150,210
Net loss		$	(9,995,137	)		$	(5,608,021	)		$	(29,064,973	)		$	(14,239,445	)
Net loss per share, basic and diluted		$	(0.19	)		$	(0.13	)		$	(0.59	)		$	(0.33	)
Weighted average shares outstanding			51,993,863				43,466,522				49,092,325				43,201,865

 

(The accompanying notes are an integral part of these condensed consolidated unaudited financial statements)

 

 

AMERICAN BATTERY TECHNOLOGY COMPANY

Condensed Consolidated Statements of Stockholders’ Equity (unaudited)

 

Three months ended March 31, 2024:

 

		Common Shares								Additional Paid-In				Common Stock				Accumulated
		Number				Amount				Capital				Issuable				Deficit				Total
Balance, December 31, 2023			49,343,225			$	49,345			$	243,823,714				-			$	(179,896,345	)		$	63,976,714
Vesting of share-based awards			597,019				597				(597	)			-				-				-
Stock-based compensation expense			-				-				4,089,033				-				-				4,089,033
Shares issued pursuant to share purchase agreement, net of issuance costs			5,103,037				5,102				11,493,171				499,681				-				11,997,954
Shares issued pursuant to warrant exercises			15,130				15				(15	)			-				-				-
Net loss for the period			-				-				-				-				(9,995,137	)			(9,995,137	)
Balance, March 31, 2024			55,058,411			$	55,059			$	259,405,304			$	499,681			$	(189,891,481	)		$	70,068,563

 

Three months ended March 31, 2023:

 

		Common Shares								Additional Paid-In				Common Stock Issuable				Accumulated
		Number				Amount				Capital				(receivable)				Deficit				Total
Balance, December 31, 2022			43,341,065			$	43,342			$	193,785,953			$	(646,177	)		$	(147,266,792	)		$	45,916,326
Shares issued for professional services			-				-				-				10,596				-				10,596
Vesting of share-based awards			172,095				172				(172	)			-				-				-
Stock-based compensation expense			-				-				2,555,584				-				-				2,555,584
Shares issued from purchase agreements			133,333				133				1,550,266				654,267								2,204,666
Shares issued from private placement, net of issuance costs			952,381				952				8,856,399				-				-				8,857,351
Net loss for the period			-				-				-				-				(5,608,021	)			(5,608,021	)
Balance, March 31, 2023			44,598,874			$	44,599			$	206,748,030			$	18,686			$	(152,874,813	)		$	53,936,502

 

(The accompanying notes are an integral part of these condensed consolidated unaudited financial statements)

 

 

AMERICAN BATTERY TECHNOLOGY COMPANY

Condensed Consolidated Statements of Stockholders’ Equity (unaudited)

 

Nine months ended March 31, 2024:

 

		Common Shares								Additional Paid-In				Common Stock Issuable				Accumulated
		Number				Amount				Capital				(receivable)				Deficit				Total
Balance, June 30, 2023			45,888,131			$	45,887			$	222,301,371			$	(1,484,693	)		$	(160,826,508	)		$	60,036,057
Shares issued for professional services			1,326				1				15,172				(15,307	)			-				(134	)
Vesting of share-based awards			909,972				913				(913	)			-				-				-
Stock-based compensation expense			-				-				10,975,214				-				-				10,975,214
Shares issued pursuant to rounding of share reverse split			59,164				59				(59	)			-				-				-
Shares reclaimed pursuant to asset acquisition			(128,206	)			(128	)			(1,255,650	)			1,500,000				-				244,222
Shares issued pursuant to share purchase agreement			8,209,262				8,208				27,332,791				499,681				-				27,840,680
Shares issued pursuant to share private agreement, net of issuance costs			-				-				-				-				-				-
Shares issued pursuant to warrant exercises			118,762				119				37,379				-				-				37,498
Net loss for the period			-				-				-				-				(29,064,973	)			(29,064,973	)
Balance, March 31, 2024			55,058,411			$	55,059			$	259,405,304			$	499,681			$	(189,891,481	)		$	70,068,563

 

Nine months ended March 31, 2023:

 

		Common Shares								Additional Paid-In				Common Stock Issuable				Accumulated
		Number				Amount				Capital				(receivable)				Deficit				Total
Balance, June 30, 2022			42,942,576			$	42,943			$	188,151,484			$	75,000			$	(138,635,368	)		$	49,634,059
Balance			42,942,576			$	42,943			$	188,151,484			$	75,000			$	(138,635,368	)		$	49,634,059
Shares issued for professional services			10,009				10				103,579				(56,314	)			-				47,275
Vesting of share-based awards			293,908				294				(294	)			-				-				-
Stock-based compensation expense			-				-				6,078,889				-				-				6,078,889
Shares issued from purchase agreement			400,000				400				3,557,973				-				-				3,558,373
Shares issued from private placement, net of issuance costs			952,381				952				8,856,399				-				-				8,857,351
Net loss for the period			-				-				-				-				(14,239,445	)			(14,239,445	)
Balance, March 31, 2023			44,598,874			$	44,599			$	206,748,030			$	18,686			$	(152,874,813	)		$	53,936,502
Balance			44,598,874			$	44,599			$	206,748,030			$	18,686			$	(152,874,813	)		$	53,936,502

 

(The accompanying notes are an integral part of these condensed consolidated unaudited financial statements)

 

 

AMERICAN BATTERY TECHNOLOGY COMPANY

Condensed Consolidated Statements of Cash Flows (unaudited)

 

		Nine months ended. March 31, 2024				Nine months ended. March 31, 2023
Operating Activities
Net loss attributable to stockholders		$	(29,064,973	)		$	(14,239,445	)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation expense			121,075				66,436
Accretion of financing costs			3,014,414				-
Amortization of right-of-use asset			75,788				75,787
Unrealized loss on investment			24,586				11,709
Stock-based compensation			12,322,198				6,078,889
Shares issued for professional services			(1,047	)			47,275
Change in fair value of derivative liability			419,739				-
Changes in operating assets and liabilities:
Inventory			(497,341	)			-
Grants receivable			(207,266	)			(276,231	)
Prepaid expenses and deposits			799,596				(837,180	)
Other current assets			(316,351	)
Accounts payable and accrued liabilities			969,487				(1,653,541	)
Net change in operating lease liability			(90,427	)			(89,759	)
Net Cash Used in Operating Activities			(12,430,522	)			(10,816,060	)
Investing Activities
Other acquisition deposits			(279,878	)			(6,081,591	)
Acquisition of property, equipment, and water rights			(11,586,857	)			(3,918,863	)
Acquisition cost reimbursements from government grants			672,404				-
Purchase of mining properties			(169,714	)			(8,007,362	)
Net Cash Used in Investing Activities			(11,364,045	)			(18,007,816	)
Financing Activities
Proceeds from issuance of common shares, net of issuance costs			-				8,857,351
Proceeds from exercise of share purchase warrants			37,498				-
Principal paid on notes payable			(18,600,000	)			-
Proceeds from notes payable, net of issuance costs			20,287,118				-
Proceeds from share purchase agreements, net of issuance costs			25,744,936				3,558,373
Net Cash Provided by Financing Activities			27,469,552				12,415,724
Increase (decrease) in Cash			3,674,986				(16,408,152	)
Cash – Beginning of Period			2,320,149				28,989,166
Cash – End of Period		$	5,995,134			$	12,581,014
Supplemental disclosures (Note 15)

 

(The accompanying notes are an integral part of these condensed consolidated unaudited financial statements)

 

 

AMERICAN BATTERY TECHNOLOGY COMPANY

Notes to the Condensed Consolidated Financial Statements

For the period ended March 31, 2024

(unaudited)

 

1. Organization and Nature of Operations

 

American Battery Technology Company (“the Company” or “ABTC”) is a new entrant in the lithium-ion battery industry that is working to increase the domestic U.S. production of battery materials, such as lithium, nickel, cobalt, and manganese through its engagement in the exploration of new primary resources of battery metals, in the development and commercialization of new technologies for the extraction of these battery metals from primary resources, and in the commercialization of an internally developed integrated process for the recycling of lithium-ion batteries. Through this three-pronged approach the Company is working to both increase the domestic production of these battery materials, and to ensure that as these materials reach their end of lives that the constituent elemental battery metals are returned to the domestic manufacturing supply chain in a closed-loop fashion.

 

The Company was incorporated under the laws of the State of Nevada on October 6, 2011, for the purpose of acquiring rights to mineral properties with the objective of being a producing mineral company. ABTC began operations of its first lithium-ion battery recycling facility in October 2023 and has a limited operating history, and as of March 31, 2024 had not generated or realized revenues from its activities. The principal executive offices are located at 100 Washington Ave., Suite 100, Reno, NV 89503.

 

Liquidity and Capital Resources

 

During the nine months ended March 31, 2024, the Company incurred a net loss of $29.1 million and used cash of $12.4 million for operating activities. At March 31, 2024, the Company has a cash balance of $6.0 million and an accumulated deficit of $189.9 million.

 

The continuation of the Company as a going concern is dependent upon generating profit from its operations and its ability to obtain debt or equity financing. There is no assurance that the Company will be able to generate sufficient profits, obtain such financings, or obtain them on favorable terms, which could limit its operations. Any such financing activities are subject to market conditions. These uncertainties cause substantial doubt to exist as to the Company’s ability to continue as a going concern for 12 months from issuance of these financial statements. These condensed consolidated financial statements do not include any adjustments to the recoverability and classification of recorded asset amounts and classification of liabilities that might be necessary should the Company be unable to continue as a going concern. These adjustments could be material.

 

The going concern assessment excludes the Company’s undrawn amounts from the common stock purchase agreements with Tysadco (Note 12) and the Company’s at-the-market (“ATM”) offering (Note 17), which could provide sources of liquidity.

 

Based on our current operating plan, unless we generate income from the operations of our facilities and Government Grant Awards, or raise additional capital (debt or equity), it is possible that we will be unable to maintain our financial covenants under our existing Note agreement (Note 10). If such covenant violations are not waived by the Note holder, it would result in an event of default, causing an acceleration of the outstanding balances. If we do raise additional capital through public or private equity offerings, as opposed to debt or additional Note issuances, the ownership interest of our existing stockholders may be diluted.

 

2. Summary of Significant Accounting Policies

 

a) Basis of Presentation and Principles of Consolidation

 

The condensed consolidated financial statements of the Company have been prepared in accordance with accounting principles generally accepted in the United States (“US GAAP”) and are expressed in U.S. dollars. The Company’s fiscal year end is June 30.

 

These condensed consolidated financial statements include the accounts of the Company and its wholly owned subsidiaries, Oroplata Exploraciones E Ingenieria SRL (dissolved), LithiumOre Corporation (formerly Lithortech Resources Inc), ABMC AG, LLC (dissolved) and Aqua Metals Transfer LLC. All inter-company accounts and transactions have been eliminated upon consolidation.

 

On September 11, 2023, the Company effected a one-for-fifteen reverse-stock-split with respect to the authorized, issued, and outstanding shares of common stock and preferred stock. All share and per-share amounts included in this Form 10-Q are presented as if the stock split had been effective from the beginning of the earliest period presented.

 

10

 

AMERICAN BATTERY TECHNOLOGY COMPANY

Notes to the Condensed Consolidated Financial Statements

For the period ended March 31, 2024

(unaudited)

 

Immaterial Correction of Previously Issued Consolidated Financial Statements

 

Subsequent to the issuance of the Company’s December 31, 2023 condensed consolidated financial statements, the Company identified errors in the application of Accounting Standards Codification (“ASC”) 710, “Compensation-General,” and ASC 718, “Compensation-Stock Compensation,” related to expense recognition for cash and equity awards that are subject to both service and performance conditions. ASC 710 and ASC 718 require recognition of compensation cost once achievement of the performance condition becomes probable as the requisite service is provided. Historically, the Company did not recognize compensation cost for certain cash and equity awards until the performance conditions in the form of milestones were achieved, and for the Company’s common share warrant performance-based awards, no compensation cost had previously been recognized when the performance conditions either became probable of achievement or were achieved. As the common share warrant and RSU performance-based awards to executive officers and key employees are granted with a fixed dollar value and settled in a variable number of common share warrants or RSUs, these awards are liability-classified and the corresponding compensation cost should be recorded to current or long-term liabilities, depending on expected timing of settlement of the award, once the performance conditions become probable of achievement.

 

The correction of this error resulted in an increase in compensation cost of $0.9 million as of and for the fiscal year ended June 30, 2023, and an increase in compensation cost of $1.6 million and $0.6 million for the quarters ended September 30, 2023 and December 31, 2023, respectively. For the six-month period ended December 31, 2023, the errors resulted in an increase in compensation cost of $2.2 million. As certain of these awards are liability-classified, the correction of this error resulted in an increase of $0.3 million in accounts payable and accrued liabilities for the current portion of the awards and an increase of $0.8 million in equity compensation liability for the noncurrent portion of the awards as of June 30, 2023.

 

The Company also identified an error in application of ASC 815, “Derivatives and Hedging,” related to the initial and subsequent recognition of a conversion option in the Company’s convertible notes that does not qualify for equity classification. ASC 815 requires bifurcation of the conversion option with subsequent changes in the fair value of the bifurcated derivative to be recorded in earnings. At issuance of the convertible notes, the Company should have recognized a derivative liability and a corresponding discount on the convertible notes resulting from bifurcation of the derivative, with subsequent changes in the fair value of the derivative liability and accretion of the discount recorded in earnings.

 

The correction of this error resulted in an increase in interest and other expense of less than $0.1 million for the quarter ended September 30, 2023 and $0.3 million for the quarter ended December 31, 2023. For the six-month period ended December 31, 2023, the error resulted in an increase in interest and other expenses of $0.4 million.

 

The Company has evaluated the effects of the corrections detailed in the tables below on the previously issued consolidated financial statements, individually and in the aggregate, in accordance with the guidance in ASC 250, “Accounting Changes and Error Corrections.” The Company has concluded such corrections to be immaterial to its previously issued consolidated financial statements. While management believes the effect of the errors is immaterial to the Company’s previously issued consolidated financial statements as of and for the year ended June 30, 2023, and the condensed consolidated financial statements as of and for the three months ended September 30, 2023 and as of and for the three and six months ended December 31, 2023, the financial statement line items impacted by these errors have been corrected. In addition, the immaterial error is being corrected prospectively in the Company’s subsequent quarterly and annual filings.

 

The tables below reflect the sections of the Company’s condensed consolidated financial statements that were impacted by the error.

 Schedule of Consolidated Financial Statements

CONSOLIDATED BALANCE SHEET

 

		As Reported				Adjustments				As Corrected
		June 30, 2023
		As Reported				Adjustments				As Corrected
Liabilities and Stockholders’ Equity
Current liabilities:
Accounts payable and accrued liabilities		$	7,389,864			$	345,000			$	7,734,864
Total current liabilities			13,389,864				345,000				13,734,864
Equity compensation liability			-				833,427				833,427
Total liabilities			13,444,168				1,178,427				14,622,595
Stockholders’ equity
Additional paid in capital		$	222,626,865			$	(325,494	)		$	222,301,371
Accumulated deficit			(159,973,575	)			(852,933	)			(160,826,508	)
Total stockholders’ equity			61,214,484				(1,178,427	)			60,036,057

 

11

 

AMERICAN BATTERY TECHNOLOGY COMPANY

Notes to the Condensed Consolidated Financial Statements

For the period ended March 31, 2024

(unaudited)

 

CONSOLIDATED STATEMENT OF OPERATIONS

 

		Fiscal year ended June 30, 2023
		As Reported				Adjustments				As Corrected
Operating expenses
General and administrative		$	11,960,831			$	887,300			$	12,848,131
Research and development			7,703,895				(138,160	)			7,565,735
Exploration			1,910,548				103,793				2,014,341
Total operating expenses			21,575,274				852,933				22,428,207
Net loss before other income (expense)		$	(21,575,274	)		$	(852,933	)		$	(22,428,207	)
Net loss attributable to common stockholders		$	(21,338,207	)		$	(852,933	)		$	(22,191,140	)
Net loss per share, basic and diluted		$	(0.49	)		$	(0.02	)		$	(0.51	)

 

CONSOLIDATED STATEMENT OF STOCKHOLDERS’ EQUITY

 

		Fiscal year ended June 30, 2023
		As Reported				Adjustments				As Corrected
Stockholders’ Equity
Additional Paid-In Capital:
Stock-based compensation expense		$	9,249,462			$	(325,494	)		$	8,923,968
Balance, June 30, 2023		$	222,626,865			$	(325,494	)		$	222,301,371
Accumulated Deficit
Net loss for period		$	(21,338,207	)		$	(852,933	)		$	(22,191,140	)
Balance, June 30, 2023			(159,973,575	)		$	(852,933	)		$	(160,826,508	)

 

CONSOLIDATED STATEMENTS OF CASH FLOWS

 

		As Reported				Adjustments				As Corrected
		Fiscal year ended June 30, 2023
		As Reported				Adjustments				As Corrected
Operating Activities
Net loss attributable to stockholders		$	(21,338,207	)		$	(852,933	)		$	(22,191,140	)
Adjustments to reconcile net loss to net cash used in operating activities:
Stock-based compensation			9,249,462				507,933				9,757,395
Changes in operating assets and liabilities:
Accounts payable and accrued liabilities		$	(187,796	)		$	345,000			$	157,204
Net Cash Used in Operating Activities		$	(13,367,980	)		$	-			$	(13,367,980	)

 

12

 

CONDENSED CONSOLIDATED STATEMENT OF OPERATIONS

 

		As Reported				Adjustments				As Corrected
		Three months ended September 30, 2023
		As Reported				Adjustments				As Corrected
Operating expenses
General and administrative		$	2,948,846			$	105,152			$	3,053,998
Research and development			2,155,314				1,458,538				3,613,852
Exploration			1,279,782				70,138				1,349,920
Total operating expenses			6,383,942				1,633,827				8,017,769
Net loss before other income (expense)		$	(6,383,942	)		$	(1,633,827	)		$	(8,017,769	)
Other income (expense)
Amortization of financing costs		$	(706,731	)		$	(26,165	)		$	(732,896	)
Total other income (expense)			(848,043	)			(26,165	)			(874,208	)
Net loss attributable to common stockholders		$	(7,231,985	)		$	(1,659,992	)		$	(8,891,977	)
Net loss per share, basic and diluted		$	(0.16	)		$	(0.03	)		$	(0.19	)

 

CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY

 

		As Reported				Adjustments				As Corrected
		Three months ended September 30, 2023
		As Reported				Adjustments				As Corrected
Stockholders’ Equity
Additional Paid-In Capital:
Balance, June 30, 2023		$	222,626,865			$	(325,494	)		$	222,301,371
Stock-based compensation expense			1,921,442				981,396				2,902,838
Balance, September 30, 2023		$	226,317,285			$	655,903			$	226,973,188
Accumulated Deficit
Balance, June 30, 2023		$	(159,973,575	)		$	(852,933	)		$	(160,826,508	)
Net loss for period			(7,231,985	)			(1,659,992	)			(8,891,977	)
Balance, September 30, 2023		$	(167,205,560	)		$	(2,512,926	)		$	(169,718,486	)

 

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

 

			As Reported				Adjustments				As Corrected
			Three months ended September 30, 2023
			As Reported				Adjustments				As Corrected
Operating Activities
Net loss attributable to stockholders		$	(7,231,985	)		$	(1,659,992	)		$	(8,891,977	)
Adjustments to reconcile net loss to net cash used in operating activities:
Accretion expense		$	256,459			$	26,165			$	282,624
Stock-based compensation			1,921,442				1,447,827				3,369,269
Changes in operating assets and liabilities:
Accounts payable and accrued liabilities		$	228,071			$	186,000			$	414,071
Net Cash Used in Operating Activities		$	(4,758,984	)		$	-			$	(4,758,984	)

 

13

 

AMERICAN BATTERY TECHNOLOGY COMPANY

Notes to the Condensed Consolidated Financial Statements

For the period ended March 31, 2024

(unaudited)

 

CONDENSED CONSOLIDATED STATEMENT OF OPERATIONS

 

		As Reported				Adjustments				As Corrected
		Three months ended December 31, 2023
		As Reported				Adjustments				As Corrected
Operating expenses
General and administrative		$	4,310,452			$	106,264			$	4,416,716
Research and development			3,148,873				420,294				3,569,167
Exploration costs			771,523				51,902				823,425
Total operating expenses			8,230,848				578,459				8,809,307
Net loss before other income (expense)		$	(8,230,848	)		$	(578,459	)		$	(8,809,307	)
Other income (expense)
Amortization and accretion of financing costs		$	(1,053,766	)		$	(78,492	)		$	(1,132,258	)
Change in fair value of derivative liability			-				(229,473	)			(229,473	)
Total other income (expense)			(1,060,587	)			(307,965	)			(1,368,552	)
Net loss		$	(9,291,435	)		$	(886,424	)		$	(10,177,859	)
Net loss per share, basic and diluted		$	(0.19	)		$	(0.02	)		$	(0.21	)

 

CONDENSED CONSOLIDATED STATEMENT OF OPERATIONS

 

		As Reported				Adjustments				As Corrected
		Six months ended December 31, 2023
		As Reported				Adjustments				As Corrected
Operating expenses
General and administrative		$	7,259,298			$	211,415			$	7,470,713
Research and development			5,304,187				1,878,831				7,183,018
Exploration costs			2,051,305				122,040				2,173,345
Total operating expenses			14,614,790				2,212,286				16,827,076
Net loss before other income (expense)		$	(14,614,790	)		$	(2,212,286	)		$	(16,827,076	)
Other income (expense)
Amortization and accretion of financing costs		$	(1,760,497	)		$	(104,657	)		$	(1,865,154	)
Change in fair value of derivative liability			-				(229,473	)			(229,473	)
Total other income (expense)			(1,908,630	)			(334,130	)			(2,242,760	)
Net loss		$	(16,523,420	)		$	(2,546,416	)		$	(19,069,836	)
Net loss per share, basic and diluted		$	(0.35	)		$	(0.05	)		$	(0.40	)

 

14

 

AMERICAN BATTERY TECHNOLOGY COMPANY

Notes to the Condensed Consolidated Financial Statements

For the period ended March 31, 2024

(unaudited)

 

CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY

 

			As Reported				Adjustments				As Corrected
		Three months ended December 31, 2023
			As Reported				Adjustments				As Corrected
Stockholders’ Equity
Additional Paid-In Capital:
Balance, September 30, 2023		$	226,317,285			$	655,903			$	226,973,188
Stock-based compensation expense			3,836,466				146,877				3,983,343
Balance, December 31, 2023		$	243,020,935			$	802,779			$	243,823,714
Accumulated Deficit
Balance, September 30, 2023		$	(167,205,560	)		$	(2,512,926	)		$	(169,718,486
Net loss for period			(9,291,435	)			(886,424	)			(10,177,859	)
Balance, December 31, 2023		$	(176,496,995	)		$	(3,399,350	)		$	(179,896,345	)

 

CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY

 

		As Reported				Adjustments				As Corrected
		Six months ended December 31, 2023
		As Reported				Adjustments				As Corrected
Stockholders’ Equity
Additional Paid-In Capital:
Balance, June 30, 2023		$	222,626,865			$	(325,494	)		$	222,301,371
Stock-based compensation expense			5,757,908				1,128,273				6,886,181
Balance, December 31, 2023		$	243,020,935			$	802,779			$	243,823,714
Accumulated Deficit
Balance, June 30, 2023		$	(159,973,575	)		$	(852,933	)		$	(160,826,508	)
Net loss for period			(16,523,420	)			(2,546,416	)			(19,069,836	)
Balance, December 31, 2023		$	(176,496,995	)		$	(3,399,350	)		$	(179,896,345	)

 

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

 

		Six months ended December 31, 2023
		As Reported				Adjustments				As Corrected
Operating Activities
Net loss attributable to stockholders		$	(16,523,420	)		$	(2,546,416	)		$	(19,069,836	)
Adjustments to reconcile net loss to net cash used in operating activities:
Accretion of financing costs		$	1,760,497			$	104,657			$	1,865,154
Stock-based compensation			5,757,908				1,933,603				7,691,511
Shares issued for professional services			(132)				(316	)			(448	)
Change in fair value of derivative liability			-				229,473				229,473
Changes in operating assets and liabilities:
Accounts payable and accrued liabilities		$	2,223,865			$	279,000			$	2,502,865
Net Cash Used in Operating Activities		$	(7,418,700	)		$	-			$	(7,418,700	)

 

b) Use of Estimates

 

The preparation of these consolidated financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting periods. The Company regularly evaluates estimates and assumptions related to the fair value of stock-based compensation, valuation and recoverability of long-lived assets and intangible assets subject to impairment testing, and deferred income tax asset valuation allowances.

 

The Company bases its estimates and assumptions on current facts, historical experience, and various other factors that it believes to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities and the accrual of costs and expenses that are not readily apparent from other sources. The actual results experienced by the Company may differ materially and adversely from the Company’s estimates. To the extent there are material differences between the estimates and the actual results, future results of operations may be affected.

 

15

 

AMERICAN BATTERY TECHNOLOGY COMPANY

Notes to the Condensed Consolidated Financial Statements

For the period ended March 31, 2024

(unaudited)

 

2. Summary of Significant Accounting Policies (continued)

 

c) Long-Lived Assets

 

Long-lived assets, such as property and equipment, mineral properties, and purchased intangibles, are evaluated for impairment whenever events or changes in circumstances indicate that the carrying amount of the asset may not be recoverable in accordance with ASC 360, “Property, Plant, and Equipment.” Circumstances which could trigger a review include, but are not limited to: significant decreases in the market price of the asset; significant adverse changes in the business climate or legal factors; accumulation of costs significantly in excess of the amount originally expected for the acquisition or construction of the asset; current period cash flow or operating losses combined with a history of losses or a forecast of continuing losses associated with the use of the asset; and current expectation that the asset will more likely than not be sold or disposed significantly before the end of its estimated useful life. The Company’s long-lived assets consist of buildings, vehicles, equipment, and land. Buildings, vehicles, and equipment are depreciated on a straight-line basis over their estimated value lives ranging between three and thirty years.

 

The recoverability of assets is measured by a comparison of the carrying amount of an asset to estimated undiscounted future cash flows expected to be generated by an asset. If the carrying amount of an asset exceeds its estimated future cash flows, an impairment charge is recognized as the amount by which the carrying amount exceeds the estimated fair value of the asset. Any impairment in value is recognized as an expense in the period when the impairment occurs. No impairment charges were recorded in the three or nine months ended March 31, 2024.

 

Expenses for major repairs and maintenance which extend the useful lives of property and equipment are capitalized. All other maintenance expenses, including planned major maintenance activities, are expensed as incurred. Gains or losses from property disposals are included in income or loss from operations.

 

d) Mining Properties

 

Costs of lease, exploration, carrying and retaining unproven mineral properties are expensed as incurred. The Company expenses all mineral exploration costs as incurred as it is still in the exploration stage. If the Company identifies proven and probable reserves in its investigation of its properties and upon development of a plan for operating a mine, it will enter the development stage and capitalize future costs until production is established. When a property reaches the production stage, the related capitalized costs are amortized on a units-of-production basis over the proven and probable reserves following the commencement of production. Interest expense allocable to the cost of developing mining properties and to construct new facilities is capitalized until assets are ready for their intended use.

 

To date, the Company has not established the commercial feasibility of any exploration prospects; therefore, all exploration costs are being expensed.

 

ASC 930-805, “Extractive Activities-Mining: Business Combinations,” states that mineral rights consist of the legal right to explore, extract, and retain at least a portion of the benefits from mineral deposits. Mining assets include mineral rights which are considered tangible assets under ASC 930-805. ASC 930-805 requires that mineral rights be recognized at fair value as of the acquisition date. As a result, the direct costs to acquire mineral rights are initially capitalized as tangible assets. Mineral rights include costs associated with acquiring patented and unpatented mining claims.

 

e) Intangible Assets

 

Intangible assets consist of water rights that have indefinite useful lives are tested annually for impairment, or more frequently if events and circumstances indicate that the asset might be impaired. An impairment loss is recognized to the extent that the carrying amount of the asset group exceeds its fair value. Annually, or when there is a triggering event, the Company first performs a qualitative assessment by evaluating all relevant events and circumstances to determine if it is more likely than not that the indefinite-lived intangible assets are impaired; this includes considering any potential effect on significant inputs to determining the fair value of the indefinite-lived intangible assets. When it is more likely than not that an indefinite-lived intangible asset is impaired, then the Company calculates the fair value of the intangible asset and performs a quantitative impairment test. No impairment charges were recorded in the three or nine months ended March 31, 2024.

 

16

 

AMERICAN BATTERY TECHNOLOGY COMPANY

Notes to the Condensed Consolidated Financial Statements

For the period ended March 31, 2024

(unaudited)

 

2. Summary of Significant Accounting Policies (continued)

 

f) Loss per Share

 

The Company computes net income (loss) per share in accordance with ASC 260, “Earnings per Share.” ASC 260 requires presentation of both basic and diluted earnings per share (“EPS”) on the face of the income statement. Basic EPS is computed by dividing net income (loss) attributable to common stockholders (numerator) by the weighted average number of shares outstanding (denominator) during the period. Diluted EPS gives effect to all dilutive potential common shares outstanding during the period using the treasury stock method and convertible preferred stock using the if-converted method. In computing diluted EPS, the average stock price for the period is used in determining the number of shares assumed to be purchased from the exercise of stock options, warrants and awards. At March 31, 2024, the Company had 10,581,138 potentially dilutive shares outstanding, consisting of 1,355,853 from convertible notes, 5,757,894 from warrants and 3,467,391 from share awards outstanding. As the Company has reported losses for all periods presented, all potentially dilutive securities are anti-dilutive, and accordingly, basic net loss per share equaled diluted net loss per share.

 

g) Stock-based Compensation

 

The Company records stock-based compensation in accordance with ASC 718, “Stock Compensation,” using the fair value method. All transactions in which goods or services are the consideration received for the issuance of equity instruments are accounted for based on the fair value of the consideration received or the fair value of the equity instrument issued, whichever is more reliably measurable. Equity instruments issued to employees and the cost of the services received as consideration are measured and recognized based on the fair value of the equity instruments issued. The Company utilizes the Black Scholes method when calculating stock-based compensation expense relating to stock option awards and warrants.

 

The Company records the stock-based compensation expense attributed to share awards in accordance with US GAAP using the graded-vesting method. The Company amortizes the grant date fair value over the respective vesting period, beginning with recognition on the date of grant. Compensation in the form of warrants is limited to executives, and recorded as a liability until the warrant is exercised or expires. Executives may also receive compensation in the form of RSUs that are recorded as a liability until the award is settled in shares of common stock. The liability classification of these awards is based on the total value of the award granted at a fixed value but settled in a variable number of warrants or RSUs until the milestones are achieved and the warrants or RSUs are issued.

 

h) Exploration Costs

 

Mineral property acquisition costs are capitalized as incurred. Exploration and evaluation costs are expensed as incurred until proven and probable reserves are established. The Company assesses the carrying costs for impairment under ASC 360, “Property, Plant, and Equipment,” at each period end. When it has been determined that a mineral property can be economically developed as a result of establishing proven and probable reserves, the costs then incurred to develop such property are capitalized on a prospective basis. Such costs will be amortized using the units-of-production method over the estimated life of the probable reserve. If mineral properties are subsequently abandoned or impaired, any capitalized costs will be charged to operations. As of March 31, 2024 and 2023, the Company has not capitalized any such mineral property costs.

 

i) Research and Development Costs

 

Research and development (“R&D”) costs are accounted for in accordance with ASC 730, “Research and Development.” ASC 730-10-25 requires that all R&D costs be recognized as an expense as incurred. However, some costs associated with R&D activities that have an alternative future use (e.g., materials, equipment, facilities) may be capitalizable.

 

The Company has been awarded federal grant awards for specific R&D programs. Under Accounting Standards Update (“ASU”) No. 2021-10 “Government Assistance,” the Company recognizes invoiced government funds as an offset to R&D costs in the period the qualifying costs are incurred. As the federal grants receivable are not deemed to have any significant realization risk, the Company believes this best reflects the expected net expenditures associated with these programs.

 

17

 

AMERICAN BATTERY TECHNOLOGY COMPANY

Notes to the Condensed Consolidated Financial Statements

For the period ended March 31, 2024

(unaudited)

 

2. Summary of Significant Accounting Policies (continued)

 

j) Leases

 

The Company follows the guidance of ASC 842, “Leases,” which requires an entity to recognize a right-of-use (“ROU”) asset and a lease liability for virtually all leases. Operating lease ROU assets and liabilities are recognized at commencement date based on the present value of lease payments over the lease term. ROU assets represent the Company’s right to use an underlying asset for the lease term and lease liabilities represent the Company’s obligation to make lease payments arising from the lease. The Company determines the present value of lease payments utilizing its incremental borrowing rate, as the implicit rate of interest in the respective leases is not readily determinable. The Company’s incremental borrowing rate is a hypothetical rate based on its understanding of what its credit rating would be.

 

The Company has elected not to recognize ROU assets and lease liabilities for short-term leases that have a lease term of 12 months or less. The Company recognizes the lease payments associated with its short-term office space leases as an expense on a straight-line basis over the lease term. Variable lease payments associated with these leases are recognized and presented in the same manner as for all other Company leases.

 

k) Income Taxes

 

The Company accounts for income taxes using the asset and liability method in accordance with ASC 740, “Income Taxes.” The asset and liability method provides that deferred tax assets and liabilities are recognized for the expected future tax consequences of temporary differences between the financial reporting and tax bases of assets and liabilities, and for operating loss and tax credit carry-forwards.

 

Deferred tax assets and liabilities are measured using the currently enacted tax rates and laws that will be in effect when the differences are expected to reverse. The Company records a valuation allowance to reduce deferred tax assets to the amount that is believed more likely than not to be realized.

 

Any uncertain tax position liabilities have been applied against the deferred tax balance given that there is a sufficient net operating loss to cover any penalties and fees associated with the uncertain tax position. The Company assesses each of its identified uncertain positions and determines whether any potential penalties and interest liability should be accrued at the balance sheet dates.

 

Due to the Company’s cumulative loss position since inception, the likelihood of deferred tax assets being realized does not meet the more likely than not assessment guidelines. Accordingly, a valuation allowance equal to the deferred tax asset has been recorded at March 31, 2024 and June 30, 2023.

 

l) Accounting Pronouncements

 

In November 2023, the FASB issued ASU 2023-07, “Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures.” The amendment in this update expands segment disclosures by requiring disclosures about significant segment expenses that are regularly provided to the chief operating decision maker and included within each reported measure of segment profit or loss, an amount and description of its composition for other segment items, and interim disclosures of a reportable segment’s profit or loss and assets. This update is effective for our annual report for fiscal year 2025, for interim period reporting beginning in fiscal year 2026, with early adoption permitted, and will be applied retrospectively to all prior periods presented in the financial statements. We are currently evaluating the timing of adoption and the impact of this ASU on our Consolidated Financial Statements and related disclosures.

 

18

 

AMERICAN BATTERY TECHNOLOGY COMPANY

Notes to the Condensed Consolidated Financial Statements

For the period ended March 31, 2024

(unaudited)

 

In December 2023, the FASB issued ASU 2023-09, “Income Taxes (Topic 740): Improvement to Income Tax Disclosures.” The amendments further enhance income tax disclosures, primarily through standardization and disaggregation of rate reconciliation categories and income taxes paid by jurisdiction. This ASU is effective for our annual report for fiscal year 2026, with early adoption permitted, and should be applied either prospectively or retrospectively. We are currently evaluating the timing of adoption and impact of this ASU on our Consolidated Financial Statements and related disclosures.

 

m) Derivative Financial Instruments

 

The Company evaluates its financial instruments to determine if such instruments are derivatives or contain features that qualify as embedded derivatives in accordance with ASC 815, “Derivatives and Hedging”. For derivative financial instruments that are accounted for as liabilities, the derivative instrument is initially recorded at its fair value on the issuance date and is then re-valued at each reporting date, with changes in the fair value reported in earnings in the condensed consolidated statements of operations.

 

n) Convertible Notes

 

The Company evaluates all conversion, repurchase and redemption features contained in a debt instrument to determine if there are any embedded features that require bifurcation as a derivative. The Company accounts for its convertible notes as a long-term liability, with the current portion reclassified to a short-term liability, equal to the proceeds received from issuance, including any embedded conversion features, net of the unamortized debt discount and offering costs in the accompanying unaudited condensed consolidated balance sheets. The debt discount, debt issuance and offering costs are amortized over the term of the convertible notes, using the effective interest method, as interest expense in the accompanying unaudited condensed consolidated statements of operations.

 

o) Inventory

 

Inventory is stated at the lower of cost or market (net realizable value). The Company performs an assessment of the recoverability of capitalized inventory during each reporting period and writes down any excess and obsolete inventories to their net realizable value in the period in which the impairment is first identified.

 

p) Cash and Cash Equivalents

 

The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company did not have any cash equivalents as of March 31, 2024 and June 30, 2023.

 

q) Fair Value of Financial Instruments

 

The fair value of the Company’s assets and liabilities, which qualify as financial instruments under the ASC 820, “Fair Value Measurements,” equals or approximates the carrying amounts represented in the condensed consolidated balance sheets.

 

r) Other Current Assets

 

Other Current Assets are comprised of payroll tax credits related to research and development activities per IRS form 6765.

 

s) Accrued Claims and Contingencies

 

The Company is subject to various claims and contingencies related to lawsuits. A liability is recorded for claims, legal costs or other contingencies when the risk of loss is probable and reasonable estimable. The required reserves may change due to new developments in each period.

 

19

 

AMERICAN BATTERY TECHNOLOGY COMPANY

Notes to the Condensed Consolidated Financial Statements

For the period ended March 31, 2024

(unaudited)

 

3. Inventories

 

The Company’s inventory for its lithium-ion battery recycling operation is comprised of raw materials, in the form of battery feedstock, and finished goods, in the form of black mass and other metals. Inventory is valued at the lower of average cost or net realizable value. The carrying value of inventory includes those costs to acquire battery feedstock and any related carrying and processing costs incurred by the Company. 

 Schedule of Inventories

		March 31, 2024				June 30, 2023
Raw materials		$	436,968			$	125,204
Finished goods			185,577				-
Total		$	622,545			$	125,204

 

4. Government Grant and Tax Credit Awards

 

Grants receivable represent qualifying costs incurred where there is reasonable assurance that the conditions of the grant have been met but the corresponding funds have not been received as of the reporting date. As collections from the federal government have been and are expected to continue to be timely, no allowance for doubtful accounts has been established. If amounts become uncollectible, they will be charged to operations. Grants receivable was $527,723 and $320,457 as of March 31, 2024 and June 30, 2023, respectively. The Company recognizes invoiced government funds as an offset to R&D costs in the period the qualifying costs are incurred.

 

On January 20, 2021, the U.S. Department of Energy (“DOE”) announced that the Company had been selected for award negotiation for a three-year project with a total budget of $4.5 million for the field demonstration of its selective leaching, targeted purification, and electro-chemical production of battery grade lithium hydroxide from domestic claystone resources technology. Through this grant award the Company is eligible to receive reimbursement of up to 50% of eligible expenditures, or up to $2.3 million. The prime agreement contract for this grant (the “AMMTO grant”) was issued with a project start date of October 1, 2021. The Company began receiving funds related to this award during the fiscal year ending June 30, 2022. As of March 31, 2024, the cumulative funds invoiced for this grant totaled $1,560,962, which represents 68% of the total eligible reimbursements.

 

On August 16, 2021, the Company received a contract award for a 30-month project with a total budget of $2.0 million from the United States Advanced Battery Consortium (the “USABC grant”) as part of a competitively bid project, through which the Company will receive reimbursement for up to $500,000 of eligible expenditures. The objective of the contract award is for the commercial-scale development and demonstration of an integrated lithium-ion battery recycling system, the production of battery cathode grade metal products, the synthesis of high energy density active cathode material from these recycled battery metals, and the fabrication of large format automotive battery cells from these recycled materials and the testing of these cells against otherwise identical cells made from virgin sourced metals. The Company began receiving funds related to this award during the fiscal year ending June 30, 2023. As of March 31, 2024, the cumulative funds invoiced for this grant totaled $479,939, which represents 96% of the total eligible reimbursements.

 

20

 

AMERICAN BATTERY TECHNOLOGY COMPANY

Notes to the Condensed Consolidated Financial Statements

For the period ended March 31, 2024

(unaudited

 

On October 21, 2022, the U.S. DOE announced that the Company had been selected for award negotiation for a five-year project with a total budget of $115.5 million to design, construct, and commission a first-of-kind lithium hydroxide refinery using Nevada-based claystone as the feedstock to expand domestic manufacturing of battery grade lithium hydroxide for lithium-ion batteries for electric vehicles, with a focus on domestic processing of materials and components that are currently imported from foreign countries. Through this grant award the Company is eligible to receive reimbursement of up to 50% of eligible expenditures, up to $57.7 million. The prime agreement contract for this grant was issued with a project start date of September 1, 2023. The Company began receiving funds related to this award during the period ending December 31, 2023. As of March 31, 2024, the cumulative funds invoiced for this grant totaled $1,457,877, which represents 3% of the total eligible reimbursements.

 

On November 17, 2022, the U.S. DOE announced that the Company had been selected for award negotiation for a three-year project with a total budget of $20.0 million to demonstrate and commercialize next generation techniques for its lithium-ion battery recycling processes to produce low-cost and low-environmental impact domestic battery materials. Through this grant award the Company is eligible to receive reimbursement of up to 50% of eligible expenditures, up to $10.0 million. The prime agreement contract for this grant was issued with a project start date of October 1, 2023. The Company began receiving funds related to this award during the period ending December 31, 2023. As of March 31, 2024, the cumulative funds invoiced for this grant totaled $421,735, which represents 4% of the total eligible reimbursements.

 

On March 28, 2024, ABTC was selected for a tax credit for up to $19.5 million through the Qualifying Advanced Energy Project Credits program (48C). This tax credit was granted by the U.S. Department of Treasury Internal Revenue Service following a highly competitive technical and economic review process performed by the U.S.DOE, which evaluated the feasibility of applicant facilities to advance America’s buildout of globally competitive critical material recycling, processing, and refining infrastructure. This tax credit may be utilized both for the reimbursement of capital expenditures spent to date at ABTC’s battery recycling facility in the Tahoe-Reno Industrial Center (TRIC) in Storey County, Nevada.

 

Also on March 28, 2024, ABTC was selected for an additional tax credit of up to $40.5 million through the 48C program, which may be used in support of the design and construction of a new commercial battery recycling facility to be located in the United States.

 

5. Other Deposits

 

On March 1, 2023, the Company and Linico Corporation (“Linico”) entered into an Asset Purchase Agreement (“APA”) whereby the Company acquired specific tangible equipment and personal property for an aggregate purchase price of $6.0 million. Contemporaneously with the signing of the APA, the Company and Linico entered into another agreement, the Membership Interest Purchase Agreement (“MIPA”), whereby the Company would acquire 100% of the membership interests in Aqua Metals Transfer, LLC, principally real property consisting of land and a building in the Tahoe-Reno Industrial Center (TRIC) at 2500 Peru Drive, McCarran, Nevada, for an aggregate purchase price of $21.6 million. The purchase was finalized on August 11, 2023 at which time the aggregate total of $27.6 million worth of deposits was bifurcated into both real and personal property assets, inclusive of both agreements (See Note 6).

 

On June 30, 2023, the Company and Linico entered into an amendment to the MIPA. Pursuant to the terms of the amended agreement, the parties agreed to (i) remove the requirement that $1.5 million of the purchase price be held in escrow for the settlement of indemnification claims, (ii) transfer back to the Company 128,206 common shares, previously issued by the Company, in exchange for the elimination of such indemnification escrow, (iii) add a purchase price adjustment to the extent that, as of four months after the registration statement on Form S-3 filed by the Company is declared effective by the SEC, the value of the portion of the purchase price comprised of shares does not equal at least $6.0 million, (iv) provide for an interim water rights agreement through the final purchase price payment date, (iv) advance the closing date to as soon as practicable after the declaration of effectiveness of the resale registration statement on Form S-3, and (v) remove the deadline to close the acquisition by June 30, 2023.

 

21

 

AMERICAN BATTERY TECHNOLOGY COMPANY

Notes to the Condensed Consolidated Financial Statements

For the period ended March 31, 2024

(unaudited)

 

6. Property, Plant and Equipment

 

The table below presents the property, plant and equipment as of March 31, 2024 and June 30, 2023:

 Schedule of Property and Equipment

		Land				Building				Equipment				Total
Cost:
Balance, June 30, 2023		$	6,728,838			$	17,508,486			$	5,870,496			$	30,107,820
Additions			4,126,833				22,406,792				9,213,570				35,747,196
Balance, March 31, 2024		$	10,855,671			$	39,915,278			$	15,084,066			$	65,855,016
Accumulated Depreciation:
Balance, June 30, 2023		$	-			$	-			$	161,721			$	161,721
Additions											106,644				106,644
Balance, March 31, 2024		$	-			$	-			$	268,365			$	268,365
Carrying Amounts:
Balance, June 30, 2023		$	6,728,838			$	17,508,486			$	5,708,775			$	29,946,099
Balance, March 31, 2024		$	10,855,671			$	39,915,278			$	14,815,702			$	65,586,651

 

On August 11, 2023, the Company finalized the purchase of its commercial-scale battery recycling facility located in the TRIC, as indicated in Note 5. At that time, the aggregate total of $27.6 million in deposits was reclassified to Property, Plant and Equipment. The Company has installed additional equipment on site to accelerate the first commercial scale implementation of its internally developed lithium-ion battery recycling technologies.

 

7. Mining Properties

 

On July 21, 2022, the Company exercised the option to purchase the rights to unpatented lode claims in Tonopah, Nevada. Since that time, the Company has worked with third parties to conduct drill programs and analysis to verify the grade and continuity of the mining claims. Over 50% of the inferred mineral resources have been upgraded to measured and indicated classifications. The Company is still in the exploration stage and expenses all mineral exploration costs. If the Company identifies proven and probable reserves and develops an economic plan for operating a mine, it will enter the development stage and capitalize future costs until production is established.

 

8. Intangible Assets

 

On September 12, 2023, the Company acquired approximately 40.52-acre feet of water rights from the Thomas C. Woodward Living Trust, valued at $0.1 million. The water rights are treated in accordance with ASC 350, “Intangible Assets,” and have an unlimited useful life subject to beneficial use.

 

The Company’s acquisition of the commercial-scale battery recycling facility at the TRIC included water rights valued at $0.6 million and are described as an eighteen and forty-five one-hundredths (18.45) acre-foot/annually portion of the Truckee-Carson Irrigation District, Serial Number 1081-A-1. These are appurtenant to a certain real property located in Storey County, Nevada, described as Storey County Assessor Parcel Number 021-37-104 and have an unlimited useful life upon assignment to a property through use of a will-serve, which has no expiration date.

 

The table below presents total intangible assets at:

 Schedule of Intangible Assets

		March 31, 2024				June 30, 2023
Water rights		$	4,584,831			$	3,851,899

 

22

 

AMERICAN BATTERY TECHNOLOGY COMPANY

Notes to the Condensed Consolidated Financial Statements

For the period ended March 31, 2024

(unaudited)

 

9. Accounts Payable and Accrued Liabilities

 

The table below presents total accounts payable and accrued liabilities at:

 Schedule of Accounts Payable and Accrued Liabilities

		March 31, 2024				June 30, 2023
Trade payables		$	2,949,290			$	1,831,686
Accrued fixed assets			1,999,331				4,404,034
Accrued expenses			1,226,040				1,377,660
Right-of-use liability, current			86,030				121,484
Total accounts payable and accrued liabilities		$	6,260,691			$	7,734,864

 

10. Notes Payable

 

On May 17, 2023, the Company entered into a Credit Agreement (the “Credit Agreement”) with Mercuria Investments US, Inc. for pre-payment on the purchase of the Company’s recycled battery metal products. As such, inventory serves as collateral for outstanding balances. The Credit Agreement provides for an aggregate loan amount of up to $20 million, comprised of (i) an initial term loan in the aggregate principal amount of $6 million and (ii) delayed draw term loan commitments in an aggregate amount equal to $14 million. Borrowings under the Credit Agreement carry interest calculated as the secured overnight financing rate published on the Federal Reserve Bank of New York’s website, plus the applicable credit spread adjustment, based on the elected interest period, plus an applicable margin rate of 6%. The agreement contains provisions that allow the Company to remit principal and interest payments via future delivery of its initial recycling byproduct, black mass.

 

On August 30, 2023, the Company caused the repayment in full of all indebtedness, liabilities and other obligations under, and terminated, its former credit agreement, dated as of May 17, 2023 by and among the Company, as Borrower, and Mercuria Investments US, Inc., as Agent. The Company did not incur any material early termination penalties because of such termination of the credit agreement. The Company remains engaged with Mercuria Investments US, Inc. in a marketing and presale capacity.

 

On August 29, 2023, the Company and High Trail (the “Buyers”) entered into a Securities Purchase Agreement (the “Purchase Agreement”), pursuant to which the Company sold to the Buyers up to $51.0 million of a new series of senior secured convertible notes (the “Notes”). To date, $25.0 million has been received and $12.6 million has been repaid. The remaining $26 million under the facility includes $13.5 million with the condition that the Company started trading on the Nasdaq Capital Market, had $250,000 in sales, and establish an ATM or ELOC, and another $12.5 million at the discretion of the Buyers. Buyers may request partial redemptions of up to an aggregate of $1.8 million on the 15^th of each month or may convert the Notes into shares of common stock of the Company (“Conversion Shares”) at a conversion rate of 110% of the last reported sales price on the date of the agreement to acquire such Notes. The Notes bear zero coupon, mature on September 1, 2025, require a minimum of $5.0 million maintained in cash and cash equivalents, and are secured by certain real property and cash and investment accounts of the Company.

 

The Company analyzed the conversion features of the Notes for derivative accounting considerations under ASC 815-15, “Derivatives and Hedging,” and determined a conversion option should be bifurcated and separately accounted for as a derivative liability. Accordingly, the derivative liability is carried at fair value at each reporting date with the corresponding gain or loss reflected in earnings in the condensed consolidated statements of operations. See Correction of Previously Issued Consolidated Financial Statements in Note 2. The Company determined the derivative liability to have a fair value of $0.4 million at issuance of the Notes. For the three and nine months ended March 31, 2024, the Company recorded a loss on the change in fair value of the derivative liability of $0.2 million and $0.4 million, respectively. As of March 31, 2024, the fair value of the derivative liability was $0.8 million. The fair value of the derivative liability is classified within Level 3 of the fair value hierarchy and was determined using the Black-Scholes option pricing model with assumptions as of March 31, 2024 including a volatility of 81.1% and a risk-free-rate of 4.79%.

 

Note discount and issuance costs totaled $4.7 million and reduced the carrying value of the Notes as a debt discount. The carrying value, net of debt discount and issuance costs, is being accreted over the term of the Notes from date of issuance to date of full repayment, expected to be in October 2024 based on partial redemption payments, using the effective interest rate method. For the nine months ended March 31, 2024, amortization of debt discount and issuance costs totaled $2.8 million.

 

The table below presents the net carrying amounts of the Notes as of:

 Schedule of Net Carrying Amounts of the Notes

		March 31, 2024				June 30, 2023
Principal outstanding		$	12,483,333			$	-
Unamortized debt discount and issuance costs			(2,520,864	)			-
Derivative liability associated with convertible notes			366,298				-
Changes in fair market value of derivative liability			419,739				-
Net carrying value		$	10,748,506			$	-

 

The table below presents the maturities of notes payable as of March 31, 2024:

 Schedule of Maturities of Notes Payable

March 31, 2025		$	12,483,333
March 31, 2026			-
Total note payments			12,483,333
Less: unamortized debt discount and issuance costs			(2,520,864	)
Derivative liability, at fair value, less amortization			786,037
Total notes payable		$	10,748,506
Notes payable, current		$	10,748,506
Notes payable, non-current		$	-

 

23

 

AMERICAN BATTERY TECHNOLOGY COMPANY

Notes to the Condensed Consolidated Financial Statements

For the period ended March 31, 2024

(unaudited)

 

11. Leases

 

A lease provides the lessee the right to control the use of an identified asset for a period in exchange for consideration. Operating lease right-of-use assets (“RoU assets”) are presented within the asset section of the Company’s consolidated balance sheets, while lease liabilities are included within the liability section of the Company’s consolidated balance sheets at March 31, 2024 and June 30, 2023.

 

RoU assets represent the Company’s right to use an underlying asset for the lease term and operating lease liabilities represent the Company’s obligation to make lease payments arising from the lease. The Company determines if an arrangement is a lease at inception. RoU assets and liabilities are recognized at the lease commencement date based on the present value of lease payments over the lease term. Most operating leases contain renewal options that provide for rent increases based on prevailing market conditions. The terms used to calculate the RoU assets for certain properties include the renewal options that the Company is reasonably certain to exercise.

 

The discount rate used to determine the commencement date present value of lease payments is the interest rate implicit in the lease, or when that is not readily determinable, the Company estimates a rate of 8.0% for the nine months ending March 31, 2024 and 2023, based primarily on historical lending agreements. RoU assets include lease payments required to be made prior to commencement and exclude lease incentives. Both RoU assets and the related lease liability exclude variable payments not based on an index or rate, which are treated as period costs. The Company’s lease agreements do not contain significant residual value guarantees, restrictions, or covenants.

 

The Company occupies office facilities under lease agreements that expire at various dates, many of which do not exceed a year in length. Total operating lease costs for the nine months ended March 31, 2024 and 2023, were each approximately $0.1 million. The Company does not have any finance leases as of March 31, 2024 and 2023.

 

As of March 31, 2024, current lease liabilities of $0.1 million are included in “Accounts payable and accrued liabilities” on the consolidated balance sheets. The table below presents total operating lease RoU assets and lease liabilities at March 31, 2024 and June 30, 2023:

 Schedule of Operating Lease ROU Assets and Lease Liabilities

		March 31, 2024				June 30, 2023
Operating lease right-of-use asset		$	67,366			$	143,154
Operating lease liabilities		$	86,030			$	175,788

 

The table below presents the maturities of operating lease liabilities as of March 31, 2024:

 Schedule of Maturity of Operating Lease Liabilities 

March 31, 2025		$	88,632
March 31, 2026			-
Total lease payments			88,632
Less: discount			(2,601	)
Total operating lease liabilities		$	86,030
Operating lease liabilities, current		$	86,030
Operating lease liabilities, non-current		$	-

 

The table below presents the weighted average remaining lease term for operating leases and weighted average discount rate used in calculating operating lease right-of-use asset as of March 31, 2024.

 Schedule of Weighted Average Remaining Lease Term for Operating Leases and Weighted Average Discount Rate

Weighted average lease term (years)			0.67
Weighted average discount rate			8.00	%

 

24

 

AMERICAN BATTERY TECHNOLOGY COMPANY

Notes to the Condensed Consolidated Financial Statements

For the period ended March 31, 2024

(unaudited)

 

12. Stockholders’ Equity

 

On September 21, 2023, the Company’s common stock began trading on the Nasdaq Capital Market under the symbol “ABAT.” The Company was previously traded on the OTCQX Markets under the symbol “ABML.”

 

Preferred Stock

 

Our amended and restated articles of incorporation authorize shares of preferred stock and provide that shares of preferred stock may be issued from time to time in one or more series. Our board of directors will be authorized to fix the voting rights, if any, designations, powers, preferences, the relative, participating, optional or other special rights and any qualifications, limitations and restrictions thereof, applicable to the shares of each series. Our board of directors will be able to, without stockholder approval, issue shares of preferred stock with voting and other rights that could adversely affect the voting power and other rights of the holders of the common stock and could have anti-takeover effects. The ability of our board of directors to issue shares of preferred stock without stockholder approval could have the effect of delaying, deferring or preventing a change of control of us or the removal of existing management.

 

To date, the Company has authorized a total of 1,666,667 shares of preferred stock. Of this amount the Company has designated a total of 233,334 shares to three classes of preferred stock, Series A Preferred Stock, Series B Preferred Stock and Series C Preferred Stock. As of June 30, 2023 and March 31, 2024, no shares of any of these classes are issued and outstanding. A description of each class of preferred stock is listed below.

 

Series A Preferred Stock

 

The Company has 33,334 shares of Series A Preferred Stock authorized with a par value of $0.001 per share. The Company had nil shares of Series A Preferred Stock issued and outstanding on March 31, 2024, and June 30, 2023.

 

Series B Preferred Stock

 

The Company has 133,334 shares of Series B Preferred Stock authorized with a par value of $10.00 per share. The Company had nil shares of Series B Preferred Stock issued and outstanding on March 31, 2024, and June 30, 2023.

 

Series C Preferred Stock

 

The Company has 66,667 shares of Series C Preferred Stock authorized with a par value of $10.00 per share. The Company had nil shares of Series C Preferred Stock issued and outstanding on March 31, 2024, and June 30, 2023.

 

Common Stock

 

The Company has 80.0 million shares of common stock authorized, with a par value of $0.001 per share.

 

On September 11, 2023, in preparation for listing on the Nasdaq Capital Market, the Company implemented a one-for-fifteen (1-for-15) reverse split of our common stock. Prior to the reverse stock split the Company had 692,068,218 shares of common stock issued and outstanding, and after the reverse stock split, the Company had approximately 46,137,882 shares of common stock issued and outstanding. Immediately after the reverse stock split, each stockholder’s percentage ownership interest in the Company and proportional voting power remained unchanged aside from rounding fractional shares into whole shares, resulting in an additional 59,164 common shares issued. The reverse stock split did not change the par value of the common stock or preferred stock.

 

25

 

AMERICAN BATTERY TECHNOLOGY COMPANY

Notes to the Condensed Consolidated Financial Statements

For the period ended March 31, 2024

(unaudited)

 

12. Stockholders’ Equity (continued)

 

Common Stock (continued)

 

Nine months ended March 31, 2024:

 

During the period the Company issued 1,326 common shares that were previously listed as issuable as of June 30, 2023. These shares for professional services relate to previously earned board compensation.

 

During the period, the Company issued 909,972 common shares with an issuance date fair value of $4.6 million to executives, directors and employees pursuant to share award service and performance achievements. This included 171,500 RSUs granted upon election by officers of the Company to receive warrants and RSUs in lieu of cash bonuses.

 

On July 28, 2023, the Company recorded an increase of $0.2 million to stockholders’ equity for the change in fair value between the balance sheet date of June 30, 2023 and the fair value on the date the shares were returned. These shares were pursuant to the Company modifying its building purchase agreement to nullify a $1.5 million indemnification requirement and reclaim 128,205 shares that it had previously issued to the Selling Stockholder (See Note 5).

 

During the period, the Company filed prospectus supplements related to the offer and sale from time to time of up to 8,666,667 common shares directly by the Company at market prices, to Tysadco Partners, LLC, a Delaware limited liability company, pursuant to the terms of written sales agreement(s) (“Tysadco Agreement”). Pursuant to the Tysadco Agreement, the Company may offer and sell up to 8,666,667 common shares of the Company at a purchase price of 95% of the weighted-average price, with a minimum request of 33,333 shares. During the period, the Company sold 8,209,262 common shares for total proceeds of $27.8 million, of which $2.4 million is recorded as a subscription receivable on the condensed consolidated balance sheet at March 31, 2024.

 

During the period, the Company issued 45,545 common shares pursuant to cashless exercise of 50,000 share purchase warrants exercised as of June 30, 2023. During the period, the Company received cash proceeds of $37,500 pursuant to 33,334 share purchase warrants. Also during the period, the Company issued 39,883 common shares pursuant to cashless exercise of 66,667 share purchase warrants.

 

During the period, the Company recognized stock-based compensation expense of approximately $12.3 million, which was an increase to additional paid-in capital, a component of stockholders’ equity. Of the amount, approximately $4.4 million was recognized for officers and directors of the Company. See Correction of Previously Issued Consolidated Financial Statements in Note 2.

 

Nine months ended March 31, 2023:

 

During the period, the Company issued 293,908 common shares pursuant the vesting of restricted share units issued to employees and directors of the Company. Of the vested shares, 166,574 common shares with a fair value of approximately $1.7 million were issued to officers of the Company.

 

During the period, the Company sold 8,209,262 common shares pursuant the Share Purchase Agreement, effective April 2, 2021. The proceeds totaled $3.6 million, all of which were received prior to March 31, 2023.

 

During the period the Company issued 10,009 common shares for professional services, with a fair value of approximately $104,000.

 

During the period, the Company recognized stock-based compensation expense of approximately $6.1 million, which was an increase to additional paid-in capital, a component of stockholders’ equity. Of the amount, approximately $2.7 million was recognized for officers and directors of the Company.

 

26

 

AMERICAN BATTERY TECHNOLOGY COMPANY

Notes to the Condensed Consolidated Financial Statements

For the period ended March 31, 2024

(unaudited)

 

13. Share Purchase Warrants

 

During the nine months ended March 31, 2024, there were 73,217 common shares issued related to warrants exercised, of which 39,883 were issued pursuant to a cashless exercise of 66,667 share purchase warrants. In addition, there were 249,119 warrants vested related to previously granted stock-based compensation to officers of the Company, and 171,500 warrants granted upon election by officers of the Company to receive warrants and RSUs in lieu of cash bonuses.

 Schedule of Share Purchase Warrants Activity

		Number of Warrants				Weighted Average Exercise Price
Balance, June 30, 2023			5,729,360			$	14.53
Granted			236,271				3.59
Exercised			(100,002	)			(1.13	)
Expired			(107,735	)			(3.75	)
Balance, March 31, 2024			5,757,894			$	14.55

 

Additional information regarding share purchase warrants as of March 31, 2024, is as follows:

 Schedule of Additional Information Regarding Share Purchase Warrants

		Outstanding and Exercisable
Range of Exercise Prices		Number of Warrants				Weighted Average Remaining Contractual Life (years)
$1.13 - $4.33			919,214				0.33
$6.53 - $13.13			3,015,705				1.24
$23.10 - $26.25			1,822,975				0.74
			5,757,894				2.31

 

14. Equity Compensation Awards

 

The Company has established the 2021 Retention Plan (“the Retention Plan”) to issue shares in the effort to retain key executives, directors, and employees. The Retention Plan allows for several different types of awards to be granted, including but not limited to, restricted share units and restricted share awards, collectively referred to as “share awards”. Share awards generally have the same expense characteristics under US GAAP and generally vest over a four-year period at a rate of 25% per annum.

 

Under the Retention Plan, the Company is authorized to issue shares of common stock to employees and non-employees up to ten percent (10%) of the total number of shares of common stock outstanding as of December 31, 2022, on a fully diluted basis. The Company adjusts the authorized shares under the plan each December 31, while the Retention Plan remains in effect. During the nine months ended March 31, 2024 and 2023, the Company granted 1.8 million and 2.6 million share awards, respectively.

 

27

 

AMERICAN BATTERY TECHNOLOGY COMPANY

Notes to the Condensed Consolidated Financial Statements

For the period ended March 31, 2024

(unaudited)

 

14. Equity Compensation Awards (continued)

 

The table below reflects the share award activity for the period ended March 31, 2024:

 Schedule of Restricted Shares and Restricted Share Units Non-vested

		Units				Weighted- Average Grant Date Fair Value per Unit
Unvested share awards at June 30, 2023			1,736,376			$	8.35
Granted			2,634,678				4.03
Vested			(1,092,155	)			5.54
Other			–				–
Forfeitures			–			$	–
Unvested awards at March 31, 2024			3,278,899			$	5.71

 

As awards are granted, stock-based compensation equivalent to the fair market value on the date of grant is expensed over the requisite service period, using the graded vesting attribution method as acceptable under ASC 718, “Stock-Based Compensation.”

 

The Company recognized stock-based compensation expense of $12.3 million and $ 6.1 million for the nine months ended March 31, 2024 and 2023, respectively. Of these amounts, $5.0 million and $2.7 million, respectively, were related to officers and directors of the Company. For the nine months ended March 31, 2024 and 2023, total stock-based compensation expense included $1.3 million and nil related to warrants awarded to officers of the Company. As of March 31, 2024 and June 30, 2023, the equity compensation liability totaled $2.1 million and $0.8 million related to warrants awarded to officers of the Company. See Correction of Previously Issued Consolidated Financial Statements in Note 2. As of March 31, 2023 several grant performance targets for the fiscal year ended June 30, 2024 have been defined via employee and retention agreements. These performance targets have not yet been achieved by employees and officers thus, the Company has deferred any stock-based compensation recognition until such achievements are probable of achievement and approval by the board of directors has occurred.

 

As of March 31, 2024 and June 30, 2023, there were approximately $10.3 million and $8.7 million of unamortized expenses relating to outstanding share awards to be recognized over a remaining weighted-average period of 3.0 years and 3.2 years, respectively.

 

The table below presents the stock-based compensation expense per respective line item on the consolidated statements of operations for the nine months ended March 31:

 Schedule of Stock-Based Compensation Expense

		2024				2023
General and administrative		$	6,143,765			$	3,588,076
Research and development			5,197,699				1,985,491
Exploration			952,592				505,322
Stock-based compensation expense		$	12,294,056			$	6,078,889

 

Executive officers and selected other key employees are eligible to receive common share performance-based awards, as determined by the board of directors. The payouts, in the form of share awards, vary based on the degree to which corporate operating objectives are met. These performance-based awards typically include a service-based requirement, which is generally four-years.

 

28

 

AMERICAN BATTERY TECHNOLOGY COMPANY

Notes to the Condensed Consolidated Financial Statements

For the period ended March 31, 2024

(unaudited)

 

15. Supplemental Statement of Cash Flow Disclosures

 

For the nine months ended March 31:

 Schedule of Statement of Cash Flow Disclosures

		2024				2023
Supplemental disclosures:
Interest paid		$	16,017			$	-
Non-cash investing and financing activities:
Current liabilities associated with investing activities			1,999,331				1,938,564
Deposits capitalized as investing activities			27,103,351				150,000

 

16. Commitments and Contingencies

 

From time to time, the Company may become involved in various lawsuits and legal proceedings, which arise in the ordinary course of business. Litigation is subject to inherent uncertainties, and an adverse result in these or other matters may arise from time to time that may harm business. Except as otherwise identified herein, management is currently not aware of any such legal proceedings or claims that could have, individually or in aggregate, a material adverse effect on our business, financial condition, or operating results.

 

Operating Leases

 

The Company leases its principal office location in Reno, Nevada. It also leases lab space at the University of Nevada, Reno on short term leases. The principal office location lease expires on November 30, 2024 and the Lab leases expire on November 30, 2024. Consistent with the guidance in ASC 842, The Company has recorded the principal office lease in its consolidated balance sheet as an operating lease. For further information on operating lease commitments, see Note 11 – Leases.

 

Financial Assurance:

 

Nevada and other states, as well as federal regulations governing mine operations on federal land, require financial assurance to be provided for the estimated costs of mine reclamation and closure, including groundwater quality protection programs. The Company has satisfied financial assurance requirements using a combination of cash bonds and surety bonds. The amount of financial assurance The Company is required to provide will vary with changes in laws, regulations, reclamation and closure requirements, and cost estimates. At March 31, 2024, The Company’s financial assurance obligations associated with U.S. mine closure and reclamation/restoration cost estimate totaled $59,646, for which the Company is legally required to satisfy its financial assurance obligations for its mining properties in Tonopah, Nevada. The Company was previously released of all of its liability in the Railroad Valley region of Nevada.

 

17. Subsequent Events

 

On April 3, 2024, the Company entered into an ATM Sales Agreement (the “Sales Agreement”) with Virtu Americas LLC (the “Sales Agent”), pursuant to which the Company may offer and sell, from time to time through the Sales Agent, shares (the “Shares”) of the Company’s common stock, par value $0.001 per share (the “Common Stock”), having an aggregate offering price of up to $50,000,000, subject to the terms and conditions of the Sales Agreement. The Company has filed a prospectus supplement to its registration statement on Form S-3 (File No. 333-252492) offering the Shares.

 

On April 24, 2024, the Company announced the completion of the “Amended Resource Estimate and Initial Assessment with Project Economics for the Tonopah Flats Lithium Project, Esmeralda and Nye Counties, Nevada, USA” (“Amended IA”) and the publication of the S-K 1300 Technical Report Summary (“TRS”) disclosing mineral resources, including an initial economic assessment, for the Tonopah Flats Lithium Project. The TRS was completed by RESPEC Company LLC, a qualified person, in compliance with Item 1300 of Regulation S-K and with an effective date of April 5, 2024.

 

 

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

 

Forward-Looking Statements

 

The following discussion of the Company’s financial condition and results of operations should be read in conjunction with the consolidated financial statements and the notes thereto included elsewhere in this Form 10-Q and the Form 10-K for the fiscal year ended June 30, 2023. The information in this discussion contains forward-looking statements and information within the meaning of Section 27A of the Securities Act and Section 21E of the Exchange Act. These forward-looking statements include, but are not limited to, statements concerning our strategy, future operations, future financial position, future revenues, projected costs, prospects and plans and objectives of management. The words “anticipates,” “believes,” “estimates,” “expects,” “intends,” “may,” “plans,” “projects,” “will,” “would” and similar expressions are intended to identify forward-looking statements, although not all forward-looking statements contain these identifying words. The Company may not actually achieve the plans, intentions, or expectations disclosed in our forward-looking statements and undue reliance should not be placed on the Company’s forward-looking statements. Actual results or events could differ materially from the plans, intentions and expectations disclosed in the forward-looking statements that we make. These forward-looking statements involve risks and uncertainties that could cause our actual results to differ materially from those in the forward-looking statements, including, without limitation, the risks set forth in our filings with the SEC. The forward-looking statements are applicable only as of the date on which they are made, and we do not assume any obligation to update any forward-looking statements except as required by applicable securities laws.

 

Overview

 

American Battery Technology Company (the “Company”) is a new entrant in the lithium–ion battery industry that is working to increase the domestic U.S. production of battery materials, such as lithium, nickel, cobalt, and manganese through its exploration of new domestic-US primary resources of battery metals, development and commercialization of new technologies for the extraction of these battery metals from primary resources, and commercialization of an internally developed integrated process for the recycling of lithium–ion batteries. Through this three–pronged approach the Company is working to both increase the domestic production of these battery materials, and to ensure spent batteries have their elemental battery metals returned to the domestic manufacturing supply chain in an economical, environmentally-conscious, closed–loop fashion.

 

To implement this business strategy, the Company has constructed its first integrated lithium–ion battery recycling facility, which takes in waste and end–of–life battery materials from the electric vehicle, stationary storage, and consumer electronics industries. The ramp-up and operations of this facility are of the highest priority to the Company, and as such it has significantly increased the resources devoted to its execution including the further internal hiring of technical staff, expansion of laboratory facilities, and purchasing of equipment. The Company has been awarded a competitively bid grant from the U.S. Advanced Battery Consortium to support a $2 million project to accelerate the development and demonstration of the technologies within this integrated lithium–ion battery recycling facility. The Company has also been awarded an additional grant from the U.S. Department of Energy to support a $20 million project under the Bipartisan Infrastructure Law to validate, test, and deploy three next-generation disruptive advanced separation and processing recycling technologies.

 

Additionally, the Company is accelerating the demonstration and commercialization of its internally developed low–cost and low–environmental impact processing train for the manufacturing of battery grade lithium hydroxide from Nevada–based sedimentary claystone resources. The Company has been awarded a grant cooperative agreement from the U.S. Department of Energy’s Advanced Manufacturing and Materials Technologies Office through the Critical Materials Innovation program to support a $4.5 million project for the construction and operation of a multi–ton per day integrated continuous demonstration system to support the scale–up and commercialization of these technologies. The Company has also been awarded an additional grant award under the Bipartisan Infrastructure Law to support a $115 million project to design, construct, and commission a first-of-kind commercial-scale refinery to produce 30,000 MT of battery-grade lithium hydroxide per year from this resource.

 

 

ABTC has completed the construction and commissioning of its lithium hydroxide (LiOH) pilot plant, marking a significant milestone in the commercialization of its internally-developed processes to access an unrealized domestic primary lithium resource. The construction and commissioning of this pilot plant enables ABTC to demonstrate its technologies for accessing the lithium housed in its unconventional resource, Tonopah Lithium Flats Project, in an integrated and continuous system, and to generate large amounts of battery grade lithium hydroxide for delivery to customers for qualifications and evaluation. The construction and operation of this pilot demonstration plant are supported by a competitively awarded grant from the U.S. Department of Energy (DOE) for this $4.5 million effort. Product from the pilot plant is being sent to xxx for confirmation and validation...

 

ABTC has filed an amended Initial Assessment for its Tonopah Flats Lithium Project (TFLP). The TFLP is one of the largest identified lithium resources in the U.S., and while initial pit designs and economic analyses in previous assessments evaluated the full resource, this updated Initial Assessment utilizes a commercialization pathway with a more rigorous mine plan that contemplates utilization of only Measured and Indicated Mineral Resources, and excludes Inferred Mineral Resources, to supply the planned commercial-scale lithium hydroxide monohydrate (LHM) refinery. This commercialization pathway allows for an engineered phased development, with improved access to the higher quality portions of the resource, and at improved project economics.

 

On March 28, 2024, ABTC was selected for an approximately $19.5 million tax credit through the Qualifying Advanced Energy Project Credits program (48C). This tax credit was granted by the U.S. Department of Treasury Internal Revenue Service following a highly competitive technical and economic review process performed by the U.S. Department of Energy (DOE), which evaluated the feasibility of applicant facilities to advance America’s buildout of globally competitive critical material recycling, processing, and refining infrastructure. This $19.5 million tax credit can be utilized both for the reimbursement of capital expenditures spent to date, and also for equipment and infrastructure for additional value-add operations at ABTC’s battery recycling facility in the Tahoe-Reno Industrial Center (TRIC) in Storey County, Nevada.

 

Also on March 28, 2024, ABTC has been selected for an additional $40.5 million tax credit through the Qualifying Advanced Energy Project Credits program (48C) to support the design and construction of a new, next-generation, commercial battery recycling facility to be located in the United States. As with ABTC’s initial $19.5 million tax credit under the 48C program supporting the construction and buildout of its battery recycling facility in Nevada, this additional award was granted by the U.S. Department of Treasury Internal Revenue Service following a highly competitive technical and economic review process performed by the U.S. Department of Energy (DOE), which evaluated the feasibility of applicant facilities to advance America’s buildout of globally competitive critical material recycling, processing, and refining infrastructure.

 

Financial Highlights:

 

	●	In October 2023, the Company completed construction and began ramping up its first integrated lithium-ion battery recycling facility near Reno, NV. Once fully ramped, this facility has the capacity to process approximately 20,000 MT/year of battery materials and to produce multiple streams of battery grade metals and other byproducts.
	●	The prime agreement contract for the Company’s grant to support its $115 million project for its commercial-scale lithium hydroxide refinery was issued with a project start date of September 1, 2023. The Company began receiving funds related to this award during the period ended December 31, 2023.
	●	The prime agreement contract for the Company’s grant to support its $20 million project for its next-generation advanced battery recycling technologies was issued with a project start date of October 1, 2023. The Company began receiving funds related to this award during the period ended December 31, 2023.
	●	Government grant funding increased to $3.0 million for the nine months ended March 31, 2024 compared to $0.7 million during the same period of the prior year. Out of the current period’s $3.0 million in grant funding, $0.8 million was recorded as an offset to fixed assets, as reimbursements related to equipment purchases, and $2.2 million was recorded as an offset to research and development costs within the condensed consolidated statement of operations.
	●	As of March 31, 2024, the Company had total cash on hand of $6.0 million.
	●	Cash used for the acquisition of property, construction, equipment, mineral rights and water rights for the nine months ended March 31, 2024 was $11.4 million. Cash used in the same period of the prior year totaled $18.0 million primarily for water rights and equipment.
	●	Cash used in operations for the nine months ended March 31, 2024 was $12.4 million, compared to $10.8 million use of cash during the nine months ended March 31, 2023.
	●	On August 29, 2023, the Company entered into a Securities Purchase Agreement for up to $51.0 million of a new series of senior secured convertible notes. To date, $25.0 million of these notes have been issued, and the remaining notes may be issued to expand operations in the future.
	●	On April 3, 2024, the Company entered into an ATM Sales Agreement with Virtu Americas LLC having an aggregate offering price of up to $50.0 million which may be used to fund operations.

 

 

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (CONTINUED)

 

Components of Statements of Operations

 

Operating Expenses

 

During the nine months ended March 31, 2024, the Company incurred $29.1 million of operating expenses compared to $14.2 million during the nine months ended March 31, 2023.

 

General and administrative expenses consist of stock-based compensation, office expenses, legal, recruitment, business development, public relations, and general facility expenses. For the nine months ended March 31, 2024, general and administrative expenses were $10.7 million, an increase of $1.3 million over the same period in the prior year primarily related to increases in stock-based compensation, audit and insurance costs.

 

Research and development expenses consist primarily of laboratory leases, supplies, salaries, stock-based compensation, and employee benefits. Research and development expenses for the nine months ended March 31, 2024 and 2023 were $11.1 million and $3.5 million, respectively. The increase is primarily due to increased employee headcount. These costs are partially offset by federal grant funds for awards that it has contracted with various federal agencies. The Company recognized an offset to its research and development costs of $2.2 million and $0.7 million related to these awards for the nine months ended March 31, 2024 and 2023 respectively.

 

Exploration costs consist primarily of drilling, assay, claim fees, personnel, stock-based compensation, office and warehouse costs, travel, and other costs related to exploration of claims in central Nevada. Exploration expenses totaled $3.6 million for the nine months ended March 31, 2024 compared to $1.5 million during the same period in the prior year. The increase year-over-year resulted principally from increased drilling, assaying and engineering costs to further define and potentially upgrade the geological classification of the mineral rights.

 

Other Income (Expense)

 

During the nine months ended March 31, 2024, the Company recorded other expense of $3.6 million, including $3.0 million for amortization of debt financing costs, $0.1 million for interest expense and $0.4 million for changes in fair value of the derivative liability. During the nine months ended March 31, 2023, the Company recorded other income of $0.2 million largely related to the sale of mining claims it previously held in Railroad Valley, Nevada.

 

Net Loss

 

During the nine months ended March 31, 2024, the Company incurred a net loss of $29.1 million or $0.59 loss per share compared to a net loss of $14.2 million, or $0.33 loss per share, during the nine months ended March 31, 2023.

 

Liquidity and Capital Resources

 

At March 31, 2024, the Company had cash of $6.0 million and total assets of $89.3 million compared to cash of $2.3 million and total assets of $74.7 million at June 30, 2023. The increase in cash is due to utilization of the common stock purchase agreements with Tysadco.

 

The Company had total current liabilities of $17.0 million at March 31, 2024, compared to $13.7 million at June 30, 2023. The increase related to new convertible debt, offset by full repayment of the Mercuria debt and principal payments on the new convertible debt.

 

As of March 31, 2024 the Company had a working capital deficiency of $6.7 million compared to a working capital deficiency of $9.0 million at June 30, 2023. The working capital deficiency in both periods is largely attributed to the current classification of all or nearly all of the convertible notes, as well as acquisitions of property and equipment and cash used in operating activities, partially offset by an increase in cash generated from financing activities during the nine months ended March 31, 2024.

 

 

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (CONTINUED)

 

Cash Flows

 

For the nine months ended March 31:

 

		2024				2023
Cash used in operating activities		$	(12,430,522	)		$	(10,816,060	)
Cash used in investing activities			(11,364,045	)			(18,007,816	)
Cash provided by financing activities			27,469,552				12,415,724
Net increase (decrease) in cash during the period			3,674,985				(16,408,152	)

 

Cash from Operating Activities.

 

During the nine months ended March 31, 2024, the Company used $12.4 million of cash for operating activities, compared to $10.8 million cash used during the nine months ended March 31, 2024. The increase included cash costs for engineering, research and development as well as increased exploration expenses. Increased research and development costs were to support the development of the Company’s process for the recycling of lithium-ion batteries and for the extraction of lithium from the Company’s lithium claystone mining claims. The Company has also seen a steady increase in exploration activity expenses as it works to continue upgrading the geological category of its claims in the Tonopah, Nevada region.

 

Cash from Investing Activities

 

During the nine months ended March 31, 2024, the Company used cash in investing activities of $11.4 million, consisting primarily of $10.2 million related to property and equipment for its recycling facilities. This is in comparison to cash used in investing activities of $18.0 million for the nine months ended March 31, 2023, consisting primarily of $8.0 million for mineral rights and $6.0 million for plant equipment.

 

Cash from Financing Activities

 

During the nine months ended March 31, 2024, the Company had net cash provided by financing activities of $27.5 million. This represents the need for capital while the Company ramps up the recycling plant, develops its lithium ore pilot plant, and upgrades the geological category of its Tonopah claims through additional studies and assessments.

 

During the nine months ended March 31, 2024, the Company issued 8.2 million shares of common stock pursuant to purchase agreements for net proceeds of $25.7 million and the Company issued convertible notes for net proceeds of $20.3 million. These were partially offset by repayment of notes payable during the period totaling $16.8 million.

 

Working Capital

 

		March 31, 2024				June 30, 2023
Current assets		$	10,345,554			$	4,753,588
Current liabilities			17,009,197				13,734,864
Working capital			(6,663,643	)			(8,981,274	)

 

Future Financing

 

We will continue to rely on sales of our common shares, debt, or other financing to fund our business operations as needed beyond any revenue generated from internal operations and the government tax credits and grants that offset research & development expenses, and capital expenditures. Issuances of additional shares will result in dilution to existing stockholders. There is no assurance that we will achieve any additional sales of the securities or arrange for debt or other financing to fund planned operating activities, acquisitions and exploration activities.

 

 

Critical Accounting Estimates

 

Our condensed consolidated financial statements have been prepared in accordance with GAAP. The preparation of the condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities and disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements and the reported amounts of revenue and expenses during the reporting periods. We evaluate our estimates and assumptions on an ongoing basis using historical experience and other factors and adjust those estimates and assumptions when facts and circumstances dictate. Actual results could differ materially from those estimates and assumptions.

 

While our significant accounting policies are more fully described in Note 2, “Summary of Significant Accounting Policies” in the notes to our condensed consolidated financial statements included elsewhere in this Quarterly Report on Form 10-Q, the following accounting policies involve a greater degree of judgment and complexity. Accordingly, these are the accounting policies we believe are the most critical to aid in fully understanding and evaluating our financial condition and results of operations.

 

Derivative Financial Instruments

 

The Company evaluates its financial instruments to determine if such instruments are derivatives or contain features that qualify as embedded derivatives in accordance with ASC 815, “Derivatives and Hedging”. For derivative financial instruments that are accounted for as liabilities, the derivative instrument is initially recorded at its fair value on the issuance date and is then re-valued at each reporting date, with changes in the fair value reported in the statements of operations.

 

Fair Value of Financial Instruments

 

The fair value of the Company’s assets and liabilities, which qualify as financial instruments under the ASC 820, “Fair Value Measurements”, equals or approximates the carrying amounts represented in the balance sheets.

 

Convertible Notes

 

The Company evaluates all conversion, repurchase and redemption features contained in a debt instrument to determine if there are any embedded features that require bifurcation as a derivative. The Company accounts for its convertible notes as a long-term liability, with the current portion reclassified to a short-term liability, equal to the proceeds received from issuance, including any embedded conversion features, net of the unamortized debt discount and offering costs in the accompanying unaudited consolidated balance sheets. The debt issuance and offering costs are amortized over the term of the convertible notes, using the effective interest method, as interest expense in the accompanying unaudited consolidated statements of operations.

 

Long-Lived Assets

 

Long-lived assets, such as property, plant and equipment, mineral properties, and purchased intangibles, are evaluated for impairment whenever events or changes in circumstances indicate that the carrying amount of the asset may not be recoverable in accordance with Accounting Standards Codification (“ASC”) topic 360, Property, Plant, and Equipment. Circumstances which could trigger a review include, but are not limited to: significant decreases in the market price of the asset; significant adverse changes in the business climate or legal factors; accumulation of costs significantly in excess of the amount originally expected for the acquisition or construction of the asset; current period cash flow or operating losses combined with a history of losses or a forecast of continuing losses associated with the use of the asset; and current expectation that the asset will more likely than not be sold or disposed significantly before the end of its estimated useful life. The Company’s long-lived assets consist of buildings, vehicles, equipment, and land. Buildings, vehicles and equipment are depreciated on a straight-line basis over their estimated value lives ranging between three and thirty years.

 

 

The recoverability of assets is measured by a comparison of the carrying amount of an asset to estimated undiscounted future cash flows expected to be generated by an asset. If the carrying amount of an asset exceeds its estimated future cash flows, an impairment charge is recognized as the amount by which the carrying amount exceeds the estimated fair value of the asset. Any impairment in value is recognized as an expense in the period when the impairment occurs.

 

Expenses for major repairs and maintenance which extend the useful lives of property, plant and equipment are capitalized. All other maintenance expenses, including planned major maintenance activities, are expensed as incurred. Gains or losses from property disposals are included in income or loss from operations.

 

Off-Balance Sheet Arrangements

 

As of March 31, 2024, we had no significant off-balance sheet arrangements that have or are reasonably likely to have a current or future effect on our financial condition, changes in financial condition, revenues or expenses, results of operations, liquidity, capital expenses or capital resources that are material to stockholders.

 

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

 

Not Applicable.

 

ITEM 4. CONTROLS AND PROCEDURES

 

Controls and Procedures

 

Evaluation of Disclosure Controls and Procedures

 

We maintain disclosure controls and procedures, as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act of 1934, as amended (the “Exchange Act”). Disclosure controls and procedures are controls and other procedures designed to ensure that the information required to be disclosed by us in the reports that we file or submit under the Exchange Act (15 U.S.C. 78a et seq.) is recorded, processed, summarized, and reported within the time periods specified in the SEC’s rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed by us in the reports that we file or submit under the Exchange Act is accumulated and communicated to our management, including our principal executive officer and our principal financial officer, as appropriate, to allow timely decisions regarding required disclosure. In designing and evaluating the disclosure controls and procedures, management recognizes that any controls and procedures, no matter how well designed and operated, can provide only reasonable and not absolute assurance of achieving the desired control objectives, and management necessarily applies its judgment in evaluating the cost-benefit relationship of possible controls and procedures.

 

The Company’s management, with the participation of the Chief Executive Officer and Chief Financial Officer of the Company, carried out an evaluation of the effectiveness of the design and operation of the Company’s disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) of the Exchange Act as of March 31, 2024, the end of the period covered by this report. Based on such evaluation, the Company’s Chief Executive Officer and Chief Financial Officer have concluded that, as of March 31, 2024, the Company’s disclosure controls and procedures are not effective, based on the material weaknesses described below.

 

Material Weakness in Internal Control over Financial Reporting

 

Our management is responsible for establishing and maintaining adequate internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) of the Exchange Act). Management, with the participation of the principal executive officer and principal financial officer, under the oversight of our Board of Directors, assessed the effectiveness of our internal control over financial reporting as of March 31, 2024 based on the criteria set forth by the Committee of Sponsoring Organizations of the Treadway Commission in Internal Control-Integrated Framework (2013 Framework). Based on this assessment, management concluded that, as of March 31, 2024, our internal control over financial reporting was not effective, due to the material weaknesses in internal control over financial reporting, described below.

 

Internal control over financial reporting is a process designed under the supervision and with the participation of our management, including the individuals serving as our principal executive officer and principal financial officer, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with accounting principles generally accepted in the United States of America.

 

A material weakness is a deficiency, or combination of deficiencies, in internal control over financial reporting, such that there is a reasonable possibility that a material misstatement of annual or interim financial statements will not be prevented or detected on a timely basis.

 

The Company did not have a sufficient complement of personnel with appropriate technical expertise to perform an effective risk assessment. In addition, the Company did not maintain proper segregation of duties related to accounting processes. As a consequence, internal control deficiencies related to the design and operation of process-level controls were determined to be pervasive throughout the Company’s financial reporting processes. While these material weaknesses did result in an immaterial misstatements of the Company’s consolidated financial statements, these material weaknesses create a reasonable possibility that a material misstatement of account balances or disclosures in the consolidated financial statements may not be prevented or detected in a timely manner. Therefore, we concluded that the deficiencies represent material weaknesses in the Company’s internal control over financial reporting and our internal control over financial reporting was not effective as of March 31, 2024.

 

 

ITEM 4. CONTROLS AND PROCEDURES (CONTINUED)

 

Remediation Plan

 

During the year ended June 30, 2023, we enhanced our internal control over financial reporting and remediated material weaknesses including controls over IT systems and lack of adequate documentation evidencing operating effectiveness of internal controls. However, due to the small size of the organization and accounting resources available, controls relating to segregation of duties, as well as supervision and review of complex accounting matters, remain material weaknesses as previously presented in our financial statements for the fiscal years ended June 30, 2023, 2022 and 2021. See Immaterial Correction of Previously Issued Consolidated Financial Statements in Note 2.

 

During the period ended March 31, 2024, additional remediation efforts included removing accounting personnel access to both create and post a journal entry, moving the systems administration tasks to personnel outside of the accounting department, and adding review procedures by qualified personnel over complex accounting matters by way of engaging third-party professionals with whom to consult regarding complex accounting applications and valuations. However, there is no guarantee that these measures will remediate the material weaknesses described above.

 

We are committed to ensuring that our internal control over financial reporting is designed and operating effectively. While we believe procedures are in place as of March 31, 2024 to address the material weaknesses, remediation steps are required to be in place and effective for an adequate period of time. We cannot provide assurance that such material weaknesses will be remediated, and we may discover additional material weaknesses that may require additional time and resources to remediate.

 

Changes in Internal Control over Financial Reporting

 

Except as noted above with respect to the completion of certain steps in the remediation plan, there was no change in our internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) that occurred during the fiscal quarter covered by this Interim Report on Form 10–Q that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

 

PART II – OTHER INFORMATION

 

ITEM 1. LEGAL PROCEEDINGS

 

Please refer to “Item 1. Legal Proceedings” in our 2023 Form 10-Q for the six months ended December 21, 2023, for information regarding material pending legal proceedings. In addition to those material legal proceedings, on January 21, 2024, our former Chief Financial Officer, Kimberly Eckert filed a Charge of Discrimination with the Nevada Equal Rights Commission, alleging that that the Company discriminated against her due to her sex (female) in violation of Title VII of the Civil Rights Act of 1964, as amended. There have been no additional material legal proceedings and no other material developments in the legal proceedings previously disclosed.

 

Other than these proceedings, to the best of our knowledge, we are not currently a party to any legal proceedings that, individually or in aggregate, are deemed to be material to our financial condition or results of operations.

 

ITEM 1A. RISK FACTORS

 

There were no material changes from the risk factors set forth under Part I, Business; Item 1A, Risk Factors in our Annual Report on Form 10-K for the fiscal year ended June 30, 2023, as filed with the SEC on September 28, 2023.

 

ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

 

None.

 

ITEM 3. DEFAULTS UPON SENIOR SECURITIES

 

None.

 

ITEM 4. MINE SAFETY DISCLOSURE

 

Not Applicable

 

ITEM 5. OTHER INFORMATION

 

None.

 

 

ITEM 6. EXHIBITS

 

The following exhibits are either provided with this Annual Report or are incorporated herein by reference:

 

Exhibit		Description		Filed Herein		Incorporated Date		By Form		Reference Exhibit
10.1		Amendment to Offer Letter between American Battery Technology Company and Scott Jolcover dated, March 15, 2024				03/18/2024		8-K		10.1
10.2		Amendment to Offer Letter between American Battery Technology Company and Ryan Melsert dated, March 15, 2024				03/18/2024		8-K		10.2
10.3		Amendment to Offer Letter between American Battery Technology Company and Andrés Meza dated, March 15, 2024				03/18/2024		8-K		10.3
31.1		Rule 13a-14(a)/ 15d-14(a) Certification of Chief Executive Officer		x
31.2		Rule 13a-14(a)/ 15d-14(a) Certification of Chief Financial Officer		x
32.1		Section 1350 Certification of Chief Executive Officer*
32.2		Section 1350 Certification of Chief Financial Officer*
101		INS Inline XBRL Instant Document.		x
101		SCH Inline XBRL Taxonomy Extension Schema Document		x
101		CAL Inline XBRL Taxonomy Extension Calculation Linkbase Document		x
101		LAB Inline XRBL Taxonomy Label Linkbase Document		x
101		PRE Inline XBRL Taxonomy Extension Presentation Linkbase Document		x
101		DEF Inline XBRL Taxonomy Extension Definition Linkbase Document		x
104		Cover Page Interactive Data File (embedded within the Inline XBRL document)		x

 

*Furnished herewith.

 

 

 

EXHIBIT 31.1

 

The certification required by Rule 13a–14a (17 CFR 240.13a–14(a)) or Rule 15d–14(a) (17CFR 240. 15d–14(a))

 

I, Ryan Melsert, certify that:

 

1.	I have reviewed this Form 10–Q of American Battery Technology Company (the “Registrant”);
2.	Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3.	Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the Registrant as of, and for, the periods presented in this report;
4.	The Registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act 13a–15(e) and 15d – 15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a–15(f) and 15d–15(f) for the Registrant and have:

 

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the Registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

(b) Designed such internal control over financing reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

(c) Evaluated the effectiveness of the Registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end to the period covered by this report based on such evaluation; and

 

(d) Disclosed in this report any change in the Registrant’s internal control over financial reporting that occurred during the Registrant’s most recent fiscal period (the Registrant’s fourth fiscal period in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the Registrant’s internal control over financial reporting; and

 

5.	The Registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the Registrant’s auditors and the audit committee of the Registrant’s board of directors (or persons performing the equivalent functions):

 

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the Registrant’s ability to record, process, summarize and report financial information; and

 

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the Registrant’s internal control over financial reporting.

 

Date: May 15, 2024	By:	/s/ Ryan Melsert
		Ryan Melsert
		Chief Executive Officer,
		Director

 

 

 

EXHIBIT 31.2

 

The certification required by Rule 13a–14a (17 CFR 240.13a–14(a)) or Rule 15d–14(a) (17CFR 240. 15d–14(a))

 

I, Jesse Deutsch, certify that:

 

1.	I have reviewed this Form 10–Q of American Battery Technology Company (the “Registrant”);
2.	Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3.	Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the Registrant as of, and for, the periods presented in this report;
4.	The Registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act 13a–15(e) and 15d – 15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a–15(f) and 15d–15(f) for the Registrant and have:

 

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the Registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

(b) Designed such internal control over financing reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

(c) Evaluated the effectiveness of the Registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end to the period covered by this report based on such evaluation; and

 

(d) Disclosed in this report any change in the Registrant’s internal control over financial reporting that occurred during the Registrant’s most recent fiscal period (the Registrant’s fourth fiscal period in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the Registrant’s internal control over financial reporting; and

 

5.	The Registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the Registrant’s auditors and the audit committee of the Registrant’s board of directors (or persons performing the equivalent functions):

 

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the Registrant’s ability to record, process, summarize and report financial information; and

 

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the Registrant’s internal control over financial reporting.

 

Date: May 15, 2024	By:	/s/ Jesse Deutsch
		Jesse Deutsch
		Chief Financial Officer

 

 

 

EXHIBIT 32.1

 

CERTIFICATE PURSUANT TO

18 U.S.C. SECTION 1350

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES–OXLEY ACT OF 2002

 

In connection with the Quarterly Report (the “Report”) on Form 10–Q of American Battery Technology Company. (the “Company”) for the period ended March 31, 2024, as filed with the Securities and Exchange Commission on the date hereof, I, Ryan Melsert, Chief Executive Officer, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes–Oxley Act of 2002, that, to the best of my knowledge and belief:

 

1.	The Report fully complies with the requirements of Section 13 (a) or 15 (d) of the Securities and Exchange Act of 1934, as amended; and
2.	The information contained in this Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

Date: May 15, 2024	By:	/s/ Ryan Melsert
		Ryan Melsert
		Chief Executive Officer,
		Director

 

 

 

EXHIBIT 32.2

 

CERTIFICATE PURSUANT TO

18 U.S.C. SECTION 1350

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES–OXLEY ACT OF 2002

 

In connection with the Quarterly Report (the “Report”) on Form 10–Q of American Battery Technology Company. (the “Company”) for the period ended March 31, 2024, as filed with the Securities and Exchange Commission on the date hereof, I, Jesse Deutsch, Chief Financial Officer, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes–Oxley Act of 2002, that, to the best of my knowledge and belief:

 

1.	The Report fully complies with the requirements of Section 13 (a) or 15 (d) of the Securities and Exchange Act of 1934, as amended; and
2.	The information contained in this Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

Date: May 15, 2024	By:	/s/ Jesse Deutsch
		Jesse Deutsch
		Chief Financial Officer

 

 

v3.24.1.1.u2

Cover - shares	9 Months Ended
	Mar. 31, 2024	May 13, 2024
Cover [Abstract]
Document Type	10-Q
Amendment Flag	false
Document Quarterly Report	true
Document Transition Report	false
Document Period End Date	Mar. 31, 2024
Document Fiscal Period Focus	Q3
Document Fiscal Year Focus	2024
Current Fiscal Year End Date	--06-30
Entity File Number	000-55088
Entity Registrant Name	AMERICAN BATTERY TECHNOLOGY COMPANY
Entity Central Index Key	0001576873
Entity Tax Identification Number	33-1227980
Entity Incorporation, State or Country Code	NV
Entity Address, Address Line One	100 Washington Street
Entity Address, Address Line Two	Suite 100
Entity Address, City or Town	Reno
Entity Address, State or Province	NV
Entity Address, Postal Zip Code	89503
City Area Code	(775)
Local Phone Number	473-4744
Title of 12(b) Security	Common stock, $0.001 par value
Trading Symbol	ABAT
Security Exchange Name	NASDAQ
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		58,598,133

v3.24.1.1.u2

Condensed Consolidated Balance Sheets (Unaudited) - USD ($)	Mar. 31, 2024	Jun. 30, 2023
Current assets
Cash	$ 5,995,134	$ 2,320,149
Investments	60,165	11,250
Inventory (Note 3)	622,545	125,204
Grants receivable (Note 4)	527,723	320,457
Prepaid expenses and deposits	450,784	1,625,980
Subscription receivable (Note 12)	2,446,353	350,550
Other current assets	242,850
Total current assets	10,345,554	4,753,590
Other deposits (Note 5)	279,878	27,740,587
Property, plant and equipment, net (Note 6)	65,586,651	29,946,099
Mining properties (Note 7)	8,392,978	8,223,323
Intangible assets (Note 8)	4,584,831	3,851,899
Right-of-use asset (Note 11)	67,366	143,154
Total assets	89,257,258	74,658,652
Current liabilities
Accounts payable and accrued liabilities (Note 9)	6,260,691	7,734,864
Notes payable, current (Note 10)	10,748,506	6,000,000
Total current liabilities	17,009,197	13,734,864
Equity compensation liability (Note 14)	2,179,498	833,427
Notes payable, non-current (Note 10)		54,304
Total liabilities	19,188,695	14,622,595
Commitments and contingencies (Note 16)
STOCKHOLDERS’ EQUITY
Common Stock Authorized: 80,000,000 common shares, par value of $0.001 per share; Issued and outstanding: 55,058,411 and 45,888,131 common shares as of March 31, 2024, and June 30, 2023, respectively	55,059	45,887
Additional paid-in capital	259,405,304	222,301,371
Common stock issuable (receivable)	499,681	(1,484,693)
Accumulated deficit	(189,891,481)	(160,826,508)
Total stockholders’ equity	70,068,563	60,036,057
Total liabilities and stockholders’ equity	89,257,258	74,658,652
Series A Preferred Stock [Member]
STOCKHOLDERS’ EQUITY
Preferred Stock value
Series B Preferred Stock [Member]
STOCKHOLDERS’ EQUITY
Preferred Stock value
Series C Preferred Stock [Member]
STOCKHOLDERS’ EQUITY
Preferred Stock value

v3.24.1.1.u2

Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical) - $ / shares	Mar. 31, 2024	Jun. 30, 2023
Common stock, shares authorized	80,000,000	80,000,000
Common stock, par value	$ 0.001	$ 0.001
Common stock, shares issued	55,058,411	45,888,131
Common stock, shares outstanding	55,058,411	45,888,131
Series A Preferred Stock [Member]
Preferred stock, shares authorized	33,334	33,334
Preferred stock, par value	$ 0.001	$ 0.001
Preferred stock, shares issued
Preferred stock, shares outstanding
Series B Preferred Stock [Member]
Preferred stock, shares authorized	133,334	133,334
Preferred stock, par value	$ 10.00	$ 10.00
Preferred stock, shares issued
Preferred stock, shares outstanding
Series C Preferred Stock [Member]
Preferred stock, shares authorized	66,667	66,667
Preferred stock, par value	$ 10.00	$ 10.00
Preferred stock, shares issued
Preferred stock, shares outstanding

v3.24.1.1.u2

Condensed Consolidated Statements of Operations (Unaudited) - USD ($)	3 Months Ended		9 Months Ended
	Mar. 31, 2024	Mar. 31, 2023	Mar. 31, 2024	Mar. 31, 2023
Operating expenses
General and administrative	$ 3,229,202	$ 3,538,541	$ 10,699,915	$ 9,445,776
Research and development	3,954,744	1,509,085	11,137,762	3,464,372
Exploration costs	1,422,758	584,344	3,596,103	1,479,507
Total operating expenses	8,606,704	5,631,970	25,433,780	14,389,655
Net loss before other income (expense)	(8,606,704)	(5,631,970)	(25,433,780)	(14,389,655)
Other income (expense)
Interest expense	(2,452)		(145,089)
Amortization and accretion of financing costs	(1,150,127)		(3,015,280)
Gain on sale of mining claims				98,919
Unrealized gain (loss) on investment	(19,089)	2,949	(24,586)	(11,709)
Change in fair value of derivative liability	(216,765)		(446,238)
Other income		21,000		63,000
Total other income (expense)	(1,388,433)	23,949	(3,631,193)	150,210
Net loss	$ (9,995,137)	$ (5,608,021)	$ (29,064,973)	$ (14,239,445)
Net loss per share, basic	$ (0.19)	$ (0.13)	$ (0.59)	$ (0.33)
Net loss per share, diluted	$ (0.19)	$ (0.13)	$ (0.59)	$ (0.33)
Weighted average shares outstanding basic	51,993,863	43,466,522	49,092,325	43,201,865
Weighted average shares outstanding diluted	51,993,863	43,466,522	49,092,325	43,201,865

v3.24.1.1.u2

Condensed Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($)	Common Stock [Member]	Additional Paid-in Capital [Member]	Common Stock Issuable [Member]	Retained Earnings [Member]	Total
Balance at Jun. 30, 2022	$ 42,943	$ 188,151,484	$ 75,000	$ (138,635,368)	$ 49,634,059
Balance, shares at Jun. 30, 2022	42,942,576
Vesting of share-based awards	$ 294	(294)
Vesting of share-based awards, shares	293,908
Stock-based compensation expense		6,078,889			6,078,889
Net loss for the period				(14,239,445)	(14,239,445)
Shares issued for professional services	10	103,579	(56,314)		47,275
Shares issued from purchase agreement	$ 400	3,557,973			3,558,373
Shares issued from purchase agreements, net of issuance costs, shares	400,000
Shares issued from private placement, net of issuance costs	$ 952	8,856,399			8,857,351
Shares issued from private placement, net of issuance costs, shares	952,381
Shares issued for professional services, shares	10,009
Balance at Mar. 31, 2023	$ 44,599	206,748,030	18,686	(152,874,813)	53,936,502
Balance, shares at Mar. 31, 2023	44,598,874
Balance at Jun. 30, 2022	$ 42,943	188,151,484	75,000	(138,635,368)	49,634,059
Balance, shares at Jun. 30, 2022	42,942,576
Net loss for the period				(22,191,140)
Balance at Jun. 30, 2023	$ 45,887	222,301,371	(1,484,693)	(160,826,508)	60,036,057
Balance, shares at Jun. 30, 2023	45,888,131
Balance at Dec. 31, 2022	$ 43,342	193,785,953	(646,177)	(147,266,792)	45,916,326
Balance, shares at Dec. 31, 2022	43,341,065
Vesting of share-based awards	$ 172	(172)
Vesting of share-based awards, shares	172,095
Stock-based compensation expense		2,555,584			2,555,584
Net loss for the period				(5,608,021)	(5,608,021)
Shares issued for professional services			10,596		10,596
Shares issued from purchase agreement	$ 133	1,550,266	654,267		2,204,666
Shares issued from purchase agreements, net of issuance costs, shares	133,333
Shares issued from private placement, net of issuance costs	$ 952	8,856,399			8,857,351
Shares issued from private placement, net of issuance costs, shares	952,381
Balance at Mar. 31, 2023	$ 44,599	206,748,030	18,686	(152,874,813)	53,936,502
Balance, shares at Mar. 31, 2023	44,598,874
Balance at Jun. 30, 2023	$ 45,887	222,301,371	(1,484,693)	(160,826,508)	60,036,057
Balance, shares at Jun. 30, 2023	45,888,131
Net loss for the period				(8,891,977)
Balance at Sep. 30, 2023		226,973,188		(169,718,486)
Balance at Jun. 30, 2023	$ 45,887	222,301,371	(1,484,693)	(160,826,508)	60,036,057
Balance, shares at Jun. 30, 2023	45,888,131
Net loss for the period				(19,069,836)	(19,069,836)
Balance at Dec. 31, 2023	$ 49,345	243,823,714		(179,896,345)	63,976,714
Balance, shares at Dec. 31, 2023	49,343,225
Balance at Jun. 30, 2023	$ 45,887	222,301,371	(1,484,693)	(160,826,508)	60,036,057
Balance, shares at Jun. 30, 2023	45,888,131
Vesting of share-based awards	$ 913	(913)
Vesting of share-based awards, shares	909,972
Stock-based compensation expense		10,975,214			10,975,214
Shares issued pursuant to share purchase agreement	$ 8,208	27,332,791	499,681		27,840,680
Shares issued pursuant to share purchase agreement, net of issuance costs, shares	8,209,262
Shares issued pursuant to warrant exercises	$ 119	37,379			37,498
Shares issued pursuant to warrant exercises, shares	118,762
Net loss for the period				(29,064,973)	(29,064,973)
Shares issued for professional services	$ 1	15,172	(15,307)		(134)
Shares issued from purchase agreements, net of issuance costs, shares	39,883
Shares issued from private placement, net of issuance costs
Shares issued for professional services, shares	1,326
Shares issued pursuant to rounding of share reverse split	$ 59	(59)
Shares issued pursuant to rounding of share split, shares	59,164
Shares reclaimed pursuant to asset acquisition	$ (128)	(1,255,650)	1,500,000		244,222
Shares reclaimed pursuant to asset acquisition, shares	(128,206)
Balance at Mar. 31, 2024	$ 55,059	259,405,304	499,681	(189,891,481)	70,068,563
Balance, shares at Mar. 31, 2024	55,058,411
Balance at Sep. 30, 2023		226,973,188		(169,718,486)
Net loss for the period				(10,177,859)	(10,177,859)
Balance at Dec. 31, 2023	$ 49,345	243,823,714		(179,896,345)	63,976,714
Balance, shares at Dec. 31, 2023	49,343,225
Vesting of share-based awards	$ 597	(597)
Vesting of share-based awards, shares	597,019
Stock-based compensation expense		4,089,033			4,089,033
Shares issued pursuant to share purchase agreement	$ 5,102	11,493,171	499,681		11,997,954
Shares issued pursuant to share purchase agreement, net of issuance costs, shares	5,103,037
Shares issued pursuant to warrant exercises	$ 15	(15)
Shares issued pursuant to warrant exercises, shares	15,130
Net loss for the period				(9,995,137)	(9,995,137)
Balance at Mar. 31, 2024	$ 55,059	$ 259,405,304	$ 499,681	$ (189,891,481)	$ 70,068,563
Balance, shares at Mar. 31, 2024	55,058,411

v3.24.1.1.u2

Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)	3 Months Ended			6 Months Ended	9 Months Ended		12 Months Ended
	Mar. 31, 2024	Sep. 30, 2023	Mar. 31, 2023	Dec. 31, 2023	Mar. 31, 2024	Mar. 31, 2023	Jun. 30, 2023
Operating Activities
Net loss attributable to stockholders	$ (9,995,137)		$ (5,608,021)	$ (19,069,836)	$ (29,064,973)	$ (14,239,445)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation expense					121,075	66,436
Accretion of financing costs		$ 282,624		1,865,154	3,014,414
Amortization of right-of-use asset					75,788	75,787
Unrealized loss on investment	19,089		(2,949)		24,586	11,709
Stock-based compensation		3,369,269		7,691,511	12,322,198	6,078,889	$ 9,757,395
Shares issued for professional services				(448)	(1,047)	47,275
Change in fair value of derivative liability					419,739
Changes in operating assets and liabilities:
Inventory					(497,341)
Grants receivable					(207,266)	(276,231)
Prepaid expenses and deposits					799,596	(837,180)
Other current assets					(316,351)
Accounts payable and accrued liabilities		414,071		2,502,865	969,487	(1,653,541)	157,204
Net change in operating lease liability					(90,427)	(89,759)
Net Cash Used in Operating Activities		(4,758,984)		(7,418,700)	(12,430,522)	(10,816,060)	(13,367,980)
Investing Activities
Other acquisition deposits					(279,878)	(6,081,591)
Acquisition of property, equipment, and water rights					(11,586,857)	(3,918,863)
Acquisition cost reimbursements from government grants					672,404
Purchase of mining properties					(169,714)	(8,007,362)
Net Cash Used in Investing Activities					(11,364,045)	(18,007,816)
Financing Activities
Proceeds from issuance of common shares, net of issuance costs						8,857,351
Proceeds from exercise of share purchase warrants					37,498
Principal paid on notes payable					(18,600,000)
Proceeds from notes payable, net of issuance costs					20,287,118
Proceeds from share purchase agreements, net of issuance costs					25,744,936	3,558,373
Net Cash Provided by Financing Activities					27,469,552	12,415,724
Increase (decrease) in Cash					3,674,986	(16,408,152)
Cash – Beginning of Period		$ 2,320,149		$ 2,320,149	2,320,149	28,989,166	28,989,166
Cash – End of Period	$ 5,995,134		$ 12,581,014		$ 5,995,134	$ 12,581,014	$ 2,320,149

v3.24.1.1.u2

Organization and Nature of Operations	9 Months Ended
	Mar. 31, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Organization and Nature of Operations	1. Organization and Nature of Operations   American Battery Technology Company (“the Company” or “ABTC”) is a new entrant in the lithium-ion battery industry that is working to increase the domestic U.S. production of battery materials, such as lithium, nickel, cobalt, and manganese through its engagement in the exploration of new primary resources of battery metals, in the development and commercialization of new technologies for the extraction of these battery metals from primary resources, and in the commercialization of an internally developed integrated process for the recycling of lithium-ion batteries. Through this three-pronged approach the Company is working to both increase the domestic production of these battery materials, and to ensure that as these materials reach their end of lives that the constituent elemental battery metals are returned to the domestic manufacturing supply chain in a closed-loop fashion.   The Company was incorporated under the laws of the State of Nevada on October 6, 2011, for the purpose of acquiring rights to mineral properties with the objective of being a producing mineral company. ABTC began operations of its first lithium-ion battery recycling facility in October 2023 and has a limited operating history, and as of March 31, 2024 had not generated or realized revenues from its activities. The principal executive offices are located at 100 Washington Ave., Suite 100, Reno, NV 89503.   Liquidity and Capital Resources   During the nine months ended March 31, 2024, the Company incurred a net loss of $29.1 million and used cash of $12.4 million for operating activities. At March 31, 2024, the Company has a cash balance of $6.0 million and an accumulated deficit of $189.9 million.   The continuation of the Company as a going concern is dependent upon generating profit from its operations and its ability to obtain debt or equity financing. There is no assurance that the Company will be able to generate sufficient profits, obtain such financings, or obtain them on favorable terms, which could limit its operations. Any such financing activities are subject to market conditions. These uncertainties cause substantial doubt to exist as to the Company’s ability to continue as a going concern for 12 months from issuance of these financial statements. These condensed consolidated financial statements do not include any adjustments to the recoverability and classification of recorded asset amounts and classification of liabilities that might be necessary should the Company be unable to continue as a going concern. These adjustments could be material.   The going concern assessment excludes the Company’s undrawn amounts from the common stock purchase agreements with Tysadco (Note 12) and the Company’s at-the-market (“ATM”) offering (Note 17), which could provide sources of liquidity.   Based on our current operating plan, unless we generate income from the operations of our facilities and Government Grant Awards, or raise additional capital (debt or equity), it is possible that we will be unable to maintain our financial covenants under our existing Note agreement (Note 10). If such covenant violations are not waived by the Note holder, it would result in an event of default, causing an acceleration of the outstanding balances. If we do raise additional capital through public or private equity offerings, as opposed to debt or additional Note issuances, the ownership interest of our existing stockholders may be diluted.

v3.24.1.1.u2

Summary of Significant Accounting Policies	9 Months Ended
	Mar. 31, 2024
Accounting Policies [Abstract]
Summary of Significant Accounting Policies	2. Summary of Significant Accounting Policies   a) Basis of Presentation and Principles of Consolidation   The condensed consolidated financial statements of the Company have been prepared in accordance with accounting principles generally accepted in the United States (“US GAAP”) and are expressed in U.S. dollars. The Company’s fiscal year end is June 30.   These condensed consolidated financial statements include the accounts of the Company and its wholly owned subsidiaries, Oroplata Exploraciones E Ingenieria SRL (dissolved), LithiumOre Corporation (formerly Lithortech Resources Inc), ABMC AG, LLC (dissolved) and Aqua Metals Transfer LLC. All inter-company accounts and transactions have been eliminated upon consolidation.   On September 11, 2023, the Company effected a one-for-fifteen reverse-stock-split with respect to the authorized, issued, and outstanding shares of common stock and preferred stock. All share and per-share amounts included in this Form 10-Q are presented as if the stock split had been effective from the beginning of the earliest period presented.     AMERICAN BATTERY TECHNOLOGY COMPANY Notes to the Condensed Consolidated Financial Statements For the period ended March 31, 2024 (unaudited)   Immaterial Correction of Previously Issued Consolidated Financial Statements   Subsequent to the issuance of the Company’s December 31, 2023 condensed consolidated financial statements, the Company identified errors in the application of Accounting Standards Codification (“ASC”) 710, “Compensation-General,” and ASC 718, “Compensation-Stock Compensation,” related to expense recognition for cash and equity awards that are subject to both service and performance conditions. ASC 710 and ASC 718 require recognition of compensation cost once achievement of the performance condition becomes probable as the requisite service is provided. Historically, the Company did not recognize compensation cost for certain cash and equity awards until the performance conditions in the form of milestones were achieved, and for the Company’s common share warrant performance-based awards, no compensation cost had previously been recognized when the performance conditions either became probable of achievement or were achieved. As the common share warrant and RSU performance-based awards to executive officers and key employees are granted with a fixed dollar value and settled in a variable number of common share warrants or RSUs, these awards are liability-classified and the corresponding compensation cost should be recorded to current or long-term liabilities, depending on expected timing of settlement of the award, once the performance conditions become probable of achievement.   The correction of this error resulted in an increase in compensation cost of $0.9 million as of and for the fiscal year ended June 30, 2023, and an increase in compensation cost of $1.6 million and $0.6 million for the quarters ended September 30, 2023 and December 31, 2023, respectively. For the six-month period ended December 31, 2023, the errors resulted in an increase in compensation cost of $2.2 million. As certain of these awards are liability-classified, the correction of this error resulted in an increase of $0.3 million in accounts payable and accrued liabilities for the current portion of the awards and an increase of $0.8 million in equity compensation liability for the noncurrent portion of the awards as of June 30, 2023.   The Company also identified an error in application of ASC 815, “Derivatives and Hedging,” related to the initial and subsequent recognition of a conversion option in the Company’s convertible notes that does not qualify for equity classification. ASC 815 requires bifurcation of the conversion option with subsequent changes in the fair value of the bifurcated derivative to be recorded in earnings. At issuance of the convertible notes, the Company should have recognized a derivative liability and a corresponding discount on the convertible notes resulting from bifurcation of the derivative, with subsequent changes in the fair value of the derivative liability and accretion of the discount recorded in earnings.   The correction of this error resulted in an increase in interest and other expense of less than $0.1 million for the quarter ended September 30, 2023 and $0.3 million for the quarter ended December 31, 2023. For the six-month period ended December 31, 2023, the error resulted in an increase in interest and other expenses of $0.4 million.   The Company has evaluated the effects of the corrections detailed in the tables below on the previously issued consolidated financial statements, individually and in the aggregate, in accordance with the guidance in ASC 250, “Accounting Changes and Error Corrections.” The Company has concluded such corrections to be immaterial to its previously issued consolidated financial statements. While management believes the effect of the errors is immaterial to the Company’s previously issued consolidated financial statements as of and for the year ended June 30, 2023, and the condensed consolidated financial statements as of and for the three months ended September 30, 2023 and as of and for the three and six months ended December 31, 2023, the financial statement line items impacted by these errors have been corrected. In addition, the immaterial error is being corrected prospectively in the Company’s subsequent quarterly and annual filings.   The tables below reflect the sections of the Company’s condensed consolidated financial statements that were impacted by the error.  Schedule of Consolidated Financial Statements CONSOLIDATED BALANCE SHEET       As Reported     Adjustments     As Corrected       June 30, 2023       As Reported     Adjustments     As Corrected   Liabilities and Stockholders’ Equity                           Current liabilities:                         Accounts payable and accrued liabilities   $ 7,389,864     $ 345,000     $ 7,734,864   Total current liabilities     13,389,864       345,000       13,734,864   Equity compensation liability     -       833,427       833,427   Total liabilities     13,444,168       1,178,427       14,622,595                             Stockholders’ equity                         Additional paid in capital   $ 222,626,865     $ (325,494 )   $ 222,301,371   Accumulated deficit     (159,973,575 )     (852,933 )     (160,826,508 ) Total stockholders’ equity     61,214,484       (1,178,427 )     60,036,057       AMERICAN BATTERY TECHNOLOGY COMPANY Notes to the Condensed Consolidated Financial Statements For the period ended March 31, 2024 (unaudited)   CONSOLIDATED STATEMENT OF OPERATIONS                           Fiscal year ended June 30, 2023       As Reported     Adjustments     As Corrected                       Operating expenses                         General and administrative   $ 11,960,831     $ 887,300     $ 12,848,131   Research and development     7,703,895       (138,160 )     7,565,735   Exploration     1,910,548       103,793       2,014,341   Total operating expenses     21,575,274       852,933       22,428,207                             Net loss before other income (expense)   $ (21,575,274 )   $ (852,933 )   $ (22,428,207 )                           Net loss attributable to common stockholders   $ (21,338,207 )   $ (852,933 )   $ (22,191,140 ) Net loss per share, basic and diluted   $ (0.49 )   $ (0.02 )   $ (0.51 )   CONSOLIDATED STATEMENT OF STOCKHOLDERS’ EQUITY                                 Fiscal year ended June 30, 2023       As Reported     Adjustments     As Corrected   Stockholders’ Equity                                                   Additional Paid-In Capital:                         Stock-based compensation expense   $ 9,249,462     $ (325,494 )   $ 8,923,968   Balance, June 30, 2023   $ 222,626,865     $ (325,494 )   $ 222,301,371                             Accumulated Deficit                         Net loss for period   $ (21,338,207 )   $ (852,933 )   $ (22,191,140 ) Balance, June 30, 2023     (159,973,575 )   $ (852,933 )   $ (160,826,508 )   CONSOLIDATED STATEMENTS OF CASH FLOWS       As Reported     Adjustments     As Corrected       Fiscal year ended June 30, 2023       As Reported     Adjustments     As Corrected                       Operating Activities                         Net loss attributable to stockholders   $ (21,338,207 )   $ (852,933 )   $ (22,191,140 )                           Adjustments to reconcile net loss to net cash used in operating activities:                         Stock-based compensation     9,249,462       507,933       9,757,395   Changes in operating assets and liabilities:                         Accounts payable and accrued liabilities   $ (187,796 )   $ 345,000     $ 157,204                             Net Cash Used in Operating Activities   $ (13,367,980 )   $ -     $ (13,367,980 )     CONDENSED CONSOLIDATED STATEMENT OF OPERATIONS       As Reported     Adjustments     As Corrected       Three months ended September 30, 2023       As Reported     Adjustments     As Corrected                       Operating expenses                         General and administrative   $ 2,948,846     $ 105,152     $ 3,053,998   Research and development     2,155,314       1,458,538       3,613,852   Exploration     1,279,782       70,138       1,349,920   Total operating expenses     6,383,942       1,633,827       8,017,769                             Net loss before other income (expense)   $ (6,383,942 )   $ (1,633,827 )   $ (8,017,769 )                           Other income (expense)                         Amortization of financing costs   $ (706,731 )   $ (26,165 )   $ (732,896 ) Total other income (expense)     (848,043 )     (26,165 )     (874,208 )                           Net loss attributable to common stockholders   $ (7,231,985 )   $ (1,659,992 )   $ (8,891,977 ) Net loss per share, basic and diluted   $ (0.16 )   $ (0.03 )   $ (0.19 )   CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY       As Reported     Adjustments     As Corrected       Three months ended September 30, 2023       As Reported     Adjustments     As Corrected                       Stockholders’ Equity                                                   Additional Paid-In Capital:                         Balance, June 30, 2023   $ 222,626,865     $ (325,494 )   $ 222,301,371   Stock-based compensation expense     1,921,442       981,396       2,902,838   Balance, September 30, 2023   $ 226,317,285     $ 655,903     $ 226,973,188                             Accumulated Deficit                         Balance, June 30, 2023   $ (159,973,575 )   $ (852,933 )   $ (160,826,508 ) Net loss for period   (7,231,985 )   (1,659,992 )   (8,891,977 ) Balance, September 30, 2023   $ (167,205,560 )   $ (2,512,926 )   $ (169,718,486 )   CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS         As Reported       Adjustments       As Corrected         Three months ended September 30, 2023         As Reported       Adjustments       As Corrected   Operating Activities                         Net loss attributable to stockholders   $ (7,231,985 )   $ (1,659,992 )   $ (8,891,977 ) Adjustments to reconcile net loss to net cash used in operating activities:                         Accretion expense   $ 256,459     $ 26,165     $ 282,624   Stock-based compensation     1,921,442       1,447,827       3,369,269   Changes in operating assets and liabilities:                         Accounts payable and accrued liabilities   $ 228,071     $ 186,000     $ 414,071                             Net Cash Used in Operating Activities   $ (4,758,984 )   $ -     $ (4,758,984 )     AMERICAN BATTERY TECHNOLOGY COMPANY Notes to the Condensed Consolidated Financial Statements For the period ended March 31, 2024 (unaudited)   CONDENSED CONSOLIDATED STATEMENT OF OPERATIONS       As Reported     Adjustments     As Corrected       Three months ended December 31, 2023       As Reported     Adjustments     As Corrected                       Operating expenses                         General and administrative   $ 4,310,452     $ 106,264     $ 4,416,716   Research and development     3,148,873       420,294       3,569,167   Exploration costs     771,523       51,902       823,425   Total operating expenses     8,230,848       578,459       8,809,307                           Net loss before other income (expense)   $ (8,230,848 )   $ (578,459 )   $ (8,809,307 )                           Other income (expense)                         Amortization and accretion of financing costs   $ (1,053,766 )   $ (78,492 )   $ (1,132,258 ) Change in fair value of derivative liability     -       (229,473 )     (229,473 ) Total other income (expense)     (1,060,587 )     (307,965 )     (1,368,552 )                           Net loss   $ (9,291,435 )   $ (886,424 )   $ (10,177,859 ) Net loss per share, basic and diluted   $ (0.19 )   $ (0.02 )   $ (0.21 )   CONDENSED CONSOLIDATED STATEMENT OF OPERATIONS       As Reported     Adjustments     As Corrected       Six months ended December 31, 2023       As Reported     Adjustments     As Corrected                       Operating expenses                         General and administrative   $ 7,259,298     $ 211,415     $ 7,470,713   Research and development     5,304,187       1,878,831       7,183,018   Exploration costs     2,051,305       122,040       2,173,345   Total operating expenses     14,614,790       2,212,286       16,827,076                             Net loss before other income (expense)   $ (14,614,790 )   $ (2,212,286 )   $ (16,827,076 )                           Other income (expense)                         Amortization and accretion of financing costs   $ (1,760,497 )   $ (104,657 )   $ (1,865,154 ) Change in fair value of derivative liability     -       (229,473 )     (229,473 ) Total other income (expense)     (1,908,630 )     (334,130 )     (2,242,760 )                           Net loss   $ (16,523,420 )   $ (2,546,416 )   $ (19,069,836 ) Net loss per share, basic and diluted   $ (0.35 )   $ (0.05 ) $ (0.40 )     AMERICAN BATTERY TECHNOLOGY COMPANY Notes to the Condensed Consolidated Financial Statements For the period ended March 31, 2024 (unaudited)   CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY         As Reported       Adjustments       As Corrected       Three months ended December 31, 2023         As Reported       Adjustments       As Corrected   Stockholders’ Equity                                                   Additional Paid-In Capital:                         Balance, September 30, 2023   $ 226,317,285     $ 655,903     $ 226,973,188   Stock-based compensation expense     3,836,466       146,877       3,983,343   Balance, December 31, 2023   $ 243,020,935     $ 802,779     $ 243,823,714                             Accumulated Deficit                         Balance, September 30, 2023   $ (167,205,560 )   $ (2,512,926 )   $ (169,718,486   Net loss for period     (9,291,435 )     (886,424 )     (10,177,859 ) Balance, December 31, 2023   $ (176,496,995 )   $ (3,399,350 )   $ (179,896,345 )   CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY       As Reported     Adjustments     As Corrected       Six months ended December 31, 2023       As Reported     Adjustments     As Corrected                       Stockholders’ Equity                         Additional Paid-In Capital:                         Balance, June 30, 2023   $ 222,626,865     $ (325,494 )   $ 222,301,371   Stock-based compensation expense     5,757,908     1,128,273       6,886,181   Balance, December 31, 2023   $ 243,020,935     $ 802,779     $ 243,823,714   Accumulated Deficit                         Balance, June 30, 2023   $ (159,973,575 )   $ (852,933 )   $ (160,826,508 ) Net loss for period   (16,523,420 )   (2,546,416 )   (19,069,836 ) Balance, December 31, 2023   $ (176,496,995 )   $ (3,399,350 )   $ (179,896,345 )   CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS                           Six months ended December 31, 2023       As Reported     Adjustments     As Corrected                       Operating Activities                       Net loss attributable to stockholders   $ (16,523,420 )   $ (2,546,416 )   $ (19,069,836 ) Adjustments to reconcile net loss to net cash used in operating activities:                         Accretion of financing costs   $ 1,760,497     $ 104,657   $ 1,865,154   Stock-based compensation     5,757,908       1,933,603       7,691,511   Shares issued for professional services     (132)       (316 )     (448 ) Change in fair value of derivative liability     -       229,473       229,473   Changes in operating assets and liabilities:                         Accounts payable and accrued liabilities   $ 2,223,865     $ 279,000     $ 2,502,865                             Net Cash Used in Operating Activities   $ (7,418,700 )   $ -   $ (7,418,700 )   b) Use of Estimates   The preparation of these consolidated financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting periods. The Company regularly evaluates estimates and assumptions related to the fair value of stock-based compensation, valuation and recoverability of long-lived assets and intangible assets subject to impairment testing, and deferred income tax asset valuation allowances.   The Company bases its estimates and assumptions on current facts, historical experience, and various other factors that it believes to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities and the accrual of costs and expenses that are not readily apparent from other sources. The actual results experienced by the Company may differ materially and adversely from the Company’s estimates. To the extent there are material differences between the estimates and the actual results, future results of operations may be affected.     AMERICAN BATTERY TECHNOLOGY COMPANY Notes to the Condensed Consolidated Financial Statements For the period ended March 31, 2024 (unaudited)   2. Summary of Significant Accounting Policies (continued)   c) Long-Lived Assets   Long-lived assets, such as property and equipment, mineral properties, and purchased intangibles, are evaluated for impairment whenever events or changes in circumstances indicate that the carrying amount of the asset may not be recoverable in accordance with ASC 360, “Property, Plant, and Equipment.” Circumstances which could trigger a review include, but are not limited to: significant decreases in the market price of the asset; significant adverse changes in the business climate or legal factors; accumulation of costs significantly in excess of the amount originally expected for the acquisition or construction of the asset; current period cash flow or operating losses combined with a history of losses or a forecast of continuing losses associated with the use of the asset; and current expectation that the asset will more likely than not be sold or disposed significantly before the end of its estimated useful life. The Company’s long-lived assets consist of buildings, vehicles, equipment, and land. Buildings, vehicles, and equipment are depreciated on a straight-line basis over their estimated value lives ranging between three and thirty years.   The recoverability of assets is measured by a comparison of the carrying amount of an asset to estimated undiscounted future cash flows expected to be generated by an asset. If the carrying amount of an asset exceeds its estimated future cash flows, an impairment charge is recognized as the amount by which the carrying amount exceeds the estimated fair value of the asset. Any impairment in value is recognized as an expense in the period when the impairment occurs. No impairment charges were recorded in the three or nine months ended March 31, 2024.   Expenses for major repairs and maintenance which extend the useful lives of property and equipment are capitalized. All other maintenance expenses, including planned major maintenance activities, are expensed as incurred. Gains or losses from property disposals are included in income or loss from operations.   d) Mining Properties   Costs of lease, exploration, carrying and retaining unproven mineral properties are expensed as incurred. The Company expenses all mineral exploration costs as incurred as it is still in the exploration stage. If the Company identifies proven and probable reserves in its investigation of its properties and upon development of a plan for operating a mine, it will enter the development stage and capitalize future costs until production is established. When a property reaches the production stage, the related capitalized costs are amortized on a units-of-production basis over the proven and probable reserves following the commencement of production. Interest expense allocable to the cost of developing mining properties and to construct new facilities is capitalized until assets are ready for their intended use.   To date, the Company has not established the commercial feasibility of any exploration prospects; therefore, all exploration costs are being expensed.   ASC 930-805, “Extractive Activities-Mining: Business Combinations,” states that mineral rights consist of the legal right to explore, extract, and retain at least a portion of the benefits from mineral deposits. Mining assets include mineral rights which are considered tangible assets under ASC 930-805. ASC 930-805 requires that mineral rights be recognized at fair value as of the acquisition date. As a result, the direct costs to acquire mineral rights are initially capitalized as tangible assets. Mineral rights include costs associated with acquiring patented and unpatented mining claims.   e) Intangible Assets   Intangible assets consist of water rights that have indefinite useful lives are tested annually for impairment, or more frequently if events and circumstances indicate that the asset might be impaired. An impairment loss is recognized to the extent that the carrying amount of the asset group exceeds its fair value. Annually, or when there is a triggering event, the Company first performs a qualitative assessment by evaluating all relevant events and circumstances to determine if it is more likely than not that the indefinite-lived intangible assets are impaired; this includes considering any potential effect on significant inputs to determining the fair value of the indefinite-lived intangible assets. When it is more likely than not that an indefinite-lived intangible asset is impaired, then the Company calculates the fair value of the intangible asset and performs a quantitative impairment test. No impairment charges were recorded in the three or nine months ended March 31, 2024.     AMERICAN BATTERY TECHNOLOGY COMPANY Notes to the Condensed Consolidated Financial Statements For the period ended March 31, 2024 (unaudited)   2. Summary of Significant Accounting Policies (continued)   f) Loss per Share   The Company computes net income (loss) per share in accordance with ASC 260, “Earnings per Share.” ASC 260 requires presentation of both basic and diluted earnings per share (“EPS”) on the face of the income statement. Basic EPS is computed by dividing net income (loss) attributable to common stockholders (numerator) by the weighted average number of shares outstanding (denominator) during the period. Diluted EPS gives effect to all dilutive potential common shares outstanding during the period using the treasury stock method and convertible preferred stock using the if-converted method. In computing diluted EPS, the average stock price for the period is used in determining the number of shares assumed to be purchased from the exercise of stock options, warrants and awards. At March 31, 2024, the Company had 10,581,138 potentially dilutive shares outstanding, consisting of 1,355,853 from convertible notes, 5,757,894 from warrants and 3,467,391 from share awards outstanding. As the Company has reported losses for all periods presented, all potentially dilutive securities are anti-dilutive, and accordingly, basic net loss per share equaled diluted net loss per share.   g) Stock-based Compensation   The Company records stock-based compensation in accordance with ASC 718, “Stock Compensation,” using the fair value method. All transactions in which goods or services are the consideration received for the issuance of equity instruments are accounted for based on the fair value of the consideration received or the fair value of the equity instrument issued, whichever is more reliably measurable. Equity instruments issued to employees and the cost of the services received as consideration are measured and recognized based on the fair value of the equity instruments issued. The Company utilizes the Black Scholes method when calculating stock-based compensation expense relating to stock option awards and warrants.   The Company records the stock-based compensation expense attributed to share awards in accordance with US GAAP using the graded-vesting method. The Company amortizes the grant date fair value over the respective vesting period, beginning with recognition on the date of grant. Compensation in the form of warrants is limited to executives, and recorded as a liability until the warrant is exercised or expires. Executives may also receive compensation in the form of RSUs that are recorded as a liability until the award is settled in shares of common stock. The liability classification of these awards is based on the total value of the award granted at a fixed value but settled in a variable number of warrants or RSUs until the milestones are achieved and the warrants or RSUs are issued.   h) Exploration Costs   Mineral property acquisition costs are capitalized as incurred. Exploration and evaluation costs are expensed as incurred until proven and probable reserves are established. The Company assesses the carrying costs for impairment under ASC 360, “Property, Plant, and Equipment,” at each period end. When it has been determined that a mineral property can be economically developed as a result of establishing proven and probable reserves, the costs then incurred to develop such property are capitalized on a prospective basis. Such costs will be amortized using the units-of-production method over the estimated life of the probable reserve. If mineral properties are subsequently abandoned or impaired, any capitalized costs will be charged to operations. As of March 31, 2024 and 2023, the Company has not capitalized any such mineral property costs.   i) Research and Development Costs   Research and development (“R&D”) costs are accounted for in accordance with ASC 730, “Research and Development.” ASC 730-10-25 requires that all R&D costs be recognized as an expense as incurred. However, some costs associated with R&D activities that have an alternative future use (e.g., materials, equipment, facilities) may be capitalizable.   The Company has been awarded federal grant awards for specific R&D programs. Under Accounting Standards Update (“ASU”) No. 2021-10 “Government Assistance,” the Company recognizes invoiced government funds as an offset to R&D costs in the period the qualifying costs are incurred. As the federal grants receivable are not deemed to have any significant realization risk, the Company believes this best reflects the expected net expenditures associated with these programs.     AMERICAN BATTERY TECHNOLOGY COMPANY Notes to the Condensed Consolidated Financial Statements For the period ended March 31, 2024 (unaudited)   2. Summary of Significant Accounting Policies (continued)   j) Leases   The Company follows the guidance of ASC 842, “Leases,” which requires an entity to recognize a right-of-use (“ROU”) asset and a lease liability for virtually all leases. Operating lease ROU assets and liabilities are recognized at commencement date based on the present value of lease payments over the lease term. ROU assets represent the Company’s right to use an underlying asset for the lease term and lease liabilities represent the Company’s obligation to make lease payments arising from the lease. The Company determines the present value of lease payments utilizing its incremental borrowing rate, as the implicit rate of interest in the respective leases is not readily determinable. The Company’s incremental borrowing rate is a hypothetical rate based on its understanding of what its credit rating would be.   The Company has elected not to recognize ROU assets and lease liabilities for short-term leases that have a lease term of 12 months or less. The Company recognizes the lease payments associated with its short-term office space leases as an expense on a straight-line basis over the lease term. Variable lease payments associated with these leases are recognized and presented in the same manner as for all other Company leases.   k) Income Taxes   The Company accounts for income taxes using the asset and liability method in accordance with ASC 740, “Income Taxes.” The asset and liability method provides that deferred tax assets and liabilities are recognized for the expected future tax consequences of temporary differences between the financial reporting and tax bases of assets and liabilities, and for operating loss and tax credit carry-forwards.   Deferred tax assets and liabilities are measured using the currently enacted tax rates and laws that will be in effect when the differences are expected to reverse. The Company records a valuation allowance to reduce deferred tax assets to the amount that is believed more likely than not to be realized.   Any uncertain tax position liabilities have been applied against the deferred tax balance given that there is a sufficient net operating loss to cover any penalties and fees associated with the uncertain tax position. The Company assesses each of its identified uncertain positions and determines whether any potential penalties and interest liability should be accrued at the balance sheet dates.   Due to the Company’s cumulative loss position since inception, the likelihood of deferred tax assets being realized does not meet the more likely than not assessment guidelines. Accordingly, a valuation allowance equal to the deferred tax asset has been recorded at March 31, 2024 and June 30, 2023.   l) Accounting Pronouncements   In November 2023, the FASB issued ASU 2023-07, “Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures.” The amendment in this update expands segment disclosures by requiring disclosures about significant segment expenses that are regularly provided to the chief operating decision maker and included within each reported measure of segment profit or loss, an amount and description of its composition for other segment items, and interim disclosures of a reportable segment’s profit or loss and assets. This update is effective for our annual report for fiscal year 2025, for interim period reporting beginning in fiscal year 2026, with early adoption permitted, and will be applied retrospectively to all prior periods presented in the financial statements. We are currently evaluating the timing of adoption and the impact of this ASU on our Consolidated Financial Statements and related disclosures.     AMERICAN BATTERY TECHNOLOGY COMPANY Notes to the Condensed Consolidated Financial Statements For the period ended March 31, 2024 (unaudited)   In December 2023, the FASB issued ASU 2023-09, “Income Taxes (Topic 740): Improvement to Income Tax Disclosures.” The amendments further enhance income tax disclosures, primarily through standardization and disaggregation of rate reconciliation categories and income taxes paid by jurisdiction. This ASU is effective for our annual report for fiscal year 2026, with early adoption permitted, and should be applied either prospectively or retrospectively. We are currently evaluating the timing of adoption and impact of this ASU on our Consolidated Financial Statements and related disclosures.   m) Derivative Financial Instruments   The Company evaluates its financial instruments to determine if such instruments are derivatives or contain features that qualify as embedded derivatives in accordance with ASC 815, “Derivatives and Hedging”. For derivative financial instruments that are accounted for as liabilities, the derivative instrument is initially recorded at its fair value on the issuance date and is then re-valued at each reporting date, with changes in the fair value reported in earnings in the condensed consolidated statements of operations.   n) Convertible Notes   The Company evaluates all conversion, repurchase and redemption features contained in a debt instrument to determine if there are any embedded features that require bifurcation as a derivative. The Company accounts for its convertible notes as a long-term liability, with the current portion reclassified to a short-term liability, equal to the proceeds received from issuance, including any embedded conversion features, net of the unamortized debt discount and offering costs in the accompanying unaudited condensed consolidated balance sheets. The debt discount, debt issuance and offering costs are amortized over the term of the convertible notes, using the effective interest method, as interest expense in the accompanying unaudited condensed consolidated statements of operations.   o) Inventory   Inventory is stated at the lower of cost or market (net realizable value). The Company performs an assessment of the recoverability of capitalized inventory during each reporting period and writes down any excess and obsolete inventories to their net realizable value in the period in which the impairment is first identified.   p) Cash and Cash Equivalents   The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company did not have any cash equivalents as of March 31, 2024 and June 30, 2023.   q) Fair Value of Financial Instruments   The fair value of the Company’s assets and liabilities, which qualify as financial instruments under the ASC 820, “Fair Value Measurements,” equals or approximates the carrying amounts represented in the condensed consolidated balance sheets.   r) Other Current Assets   Other Current Assets are comprised of payroll tax credits related to research and development activities per IRS form 6765.   s) Accrued Claims and Contingencies   The Company is subject to various claims and contingencies related to lawsuits. A liability is recorded for claims, legal costs or other contingencies when the risk of loss is probable and reasonable estimable. The required reserves may change due to new developments in each period.     AMERICAN BATTERY TECHNOLOGY COMPANY Notes to the Condensed Consolidated Financial Statements For the period ended March 31, 2024 (unaudited)

v3.24.1.1.u2

Inventories	9 Months Ended
	Mar. 31, 2024
Inventory Disclosure [Abstract]
Inventories	3. Inventories   The Company’s inventory for its lithium-ion battery recycling operation is comprised of raw materials, in the form of battery feedstock, and finished goods, in the form of black mass and other metals. Inventory is valued at the lower of average cost or net realizable value. The carrying value of inventory includes those costs to acquire battery feedstock and any related carrying and processing costs incurred by the Company.   Schedule of Inventories     March 31, 2024     June 30, 2023   Raw materials   $ 436,968     $ 125,204   Finished goods     185,577       -   Total   $ 622,545     $ 125,204

v3.24.1.1.u2

Government Grant and Tax Credit Awards	9 Months Ended
	Mar. 31, 2024
Government Grant And Tax Credit Awards
Government Grant and Tax Credit Awards	4. Government Grant and Tax Credit Awards   Grants receivable represent qualifying costs incurred where there is reasonable assurance that the conditions of the grant have been met but the corresponding funds have not been received as of the reporting date. As collections from the federal government have been and are expected to continue to be timely, no allowance for doubtful accounts has been established. If amounts become uncollectible, they will be charged to operations. Grants receivable was $527,723 and $320,457 as of March 31, 2024 and June 30, 2023, respectively. The Company recognizes invoiced government funds as an offset to R&D costs in the period the qualifying costs are incurred.   On January 20, 2021, the U.S. Department of Energy (“DOE”) announced that the Company had been selected for award negotiation for a three-year project with a total budget of $4.5 million for the field demonstration of its selective leaching, targeted purification, and electro-chemical production of battery grade lithium hydroxide from domestic claystone resources technology. Through this grant award the Company is eligible to receive reimbursement of up to 50% of eligible expenditures, or up to $2.3 million. The prime agreement contract for this grant (the “AMMTO grant”) was issued with a project start date of October 1, 2021. The Company began receiving funds related to this award during the fiscal year ending June 30, 2022. As of March 31, 2024, the cumulative funds invoiced for this grant totaled $1,560,962, which represents 68% of the total eligible reimbursements.   On August 16, 2021, the Company received a contract award for a 30-month project with a total budget of $2.0 million from the United States Advanced Battery Consortium (the “USABC grant”) as part of a competitively bid project, through which the Company will receive reimbursement for up to $500,000 of eligible expenditures. The objective of the contract award is for the commercial-scale development and demonstration of an integrated lithium-ion battery recycling system, the production of battery cathode grade metal products, the synthesis of high energy density active cathode material from these recycled battery metals, and the fabrication of large format automotive battery cells from these recycled materials and the testing of these cells against otherwise identical cells made from virgin sourced metals. The Company began receiving funds related to this award during the fiscal year ending June 30, 2023. As of March 31, 2024, the cumulative funds invoiced for this grant totaled $479,939, which represents 96% of the total eligible reimbursements.     AMERICAN BATTERY TECHNOLOGY COMPANY Notes to the Condensed Consolidated Financial Statements For the period ended March 31, 2024 (unaudited   On October 21, 2022, the U.S. DOE announced that the Company had been selected for award negotiation for a five-year project with a total budget of $115.5 million to design, construct, and commission a first-of-kind lithium hydroxide refinery using Nevada-based claystone as the feedstock to expand domestic manufacturing of battery grade lithium hydroxide for lithium-ion batteries for electric vehicles, with a focus on domestic processing of materials and components that are currently imported from foreign countries. Through this grant award the Company is eligible to receive reimbursement of up to 50% of eligible expenditures, up to $57.7 million. The prime agreement contract for this grant was issued with a project start date of September 1, 2023. The Company began receiving funds related to this award during the period ending December 31, 2023. As of March 31, 2024, the cumulative funds invoiced for this grant totaled $1,457,877, which represents 3% of the total eligible reimbursements.   On November 17, 2022, the U.S. DOE announced that the Company had been selected for award negotiation for a three-year project with a total budget of $20.0 million to demonstrate and commercialize next generation techniques for its lithium-ion battery recycling processes to produce low-cost and low-environmental impact domestic battery materials. Through this grant award the Company is eligible to receive reimbursement of up to 50% of eligible expenditures, up to $10.0 million. The prime agreement contract for this grant was issued with a project start date of October 1, 2023. The Company began receiving funds related to this award during the period ending December 31, 2023. As of March 31, 2024, the cumulative funds invoiced for this grant totaled $421,735, which represents 4% of the total eligible reimbursements.   On March 28, 2024, ABTC was selected for a tax credit for up to $19.5 million through the Qualifying Advanced Energy Project Credits program (48C). This tax credit was granted by the U.S. Department of Treasury Internal Revenue Service following a highly competitive technical and economic review process performed by the U.S.DOE, which evaluated the feasibility of applicant facilities to advance America’s buildout of globally competitive critical material recycling, processing, and refining infrastructure. This tax credit may be utilized both for the reimbursement of capital expenditures spent to date at ABTC’s battery recycling facility in the Tahoe-Reno Industrial Center (TRIC) in Storey County, Nevada.   Also on March 28, 2024, ABTC was selected for an additional tax credit of up to $40.5 million through the 48C program, which may be used in support of the design and construction of a new commercial battery recycling facility to be located in the United States.

v3.24.1.1.u2

Other Deposits	9 Months Ended
	Mar. 31, 2024
Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]
Other Deposits	5. Other Deposits   On March 1, 2023, the Company and Linico Corporation (“Linico”) entered into an Asset Purchase Agreement (“APA”) whereby the Company acquired specific tangible equipment and personal property for an aggregate purchase price of $6.0 million. Contemporaneously with the signing of the APA, the Company and Linico entered into another agreement, the Membership Interest Purchase Agreement (“MIPA”), whereby the Company would acquire 100% of the membership interests in Aqua Metals Transfer, LLC, principally real property consisting of land and a building in the Tahoe-Reno Industrial Center (TRIC) at 2500 Peru Drive, McCarran, Nevada, for an aggregate purchase price of $21.6 million. The purchase was finalized on August 11, 2023 at which time the aggregate total of $27.6 million worth of deposits was bifurcated into both real and personal property assets, inclusive of both agreements (See Note 6).   On June 30, 2023, the Company and Linico entered into an amendment to the MIPA. Pursuant to the terms of the amended agreement, the parties agreed to (i) remove the requirement that $1.5 million of the purchase price be held in escrow for the settlement of indemnification claims, (ii) transfer back to the Company 128,206 common shares, previously issued by the Company, in exchange for the elimination of such indemnification escrow, (iii) add a purchase price adjustment to the extent that, as of four months after the registration statement on Form S-3 filed by the Company is declared effective by the SEC, the value of the portion of the purchase price comprised of shares does not equal at least $6.0 million, (iv) provide for an interim water rights agreement through the final purchase price payment date, (iv) advance the closing date to as soon as practicable after the declaration of effectiveness of the resale registration statement on Form S-3, and (v) remove the deadline to close the acquisition by June 30, 2023.     AMERICAN BATTERY TECHNOLOGY COMPANY Notes to the Condensed Consolidated Financial Statements For the period ended March 31, 2024 (unaudited)

v3.24.1.1.u2

Property, Plant and Equipment	9 Months Ended
	Mar. 31, 2024
Property, Plant and Equipment [Abstract]
Property, Plant and Equipment	6. Property, Plant and Equipment   The table below presents the property, plant and equipment as of March 31, 2024 and June 30, 2023:  Schedule of Property and Equipment     Land     Building     Equipment     Total   Cost:                                                                   Balance, June 30, 2023   $ 6,728,838     $ 17,508,486     $ 5,870,496     $ 30,107,820   Additions     4,126,833       22,406,792       9,213,570       35,747,196                                     Balance, March 31, 2024   $ 10,855,671     $ 39,915,278     $ 15,084,066     $ 65,855,016                                     Accumulated Depreciation:                                                                   Balance, June 30, 2023   $ -     $ -     $ 161,721     $ 161,721   Additions                     106,644       106,644                                     Balance, March 31, 2024   $ -     $ -     $ 268,365     $ 268,365                                     Carrying Amounts:                                 Balance, June 30, 2023   $ 6,728,838     $ 17,508,486     $ 5,708,775     $ 29,946,099   Balance, March 31, 2024   $ 10,855,671     $ 39,915,278     $ 14,815,702     $ 65,586,651     On August 11, 2023, the Company finalized the purchase of its commercial-scale battery recycling facility located in the TRIC, as indicated in Note 5. At that time, the aggregate total of $27.6 million in deposits was reclassified to Property, Plant and Equipment. The Company has installed additional equipment on site to accelerate the first commercial scale implementation of its internally developed lithium-ion battery recycling technologies.

v3.24.1.1.u2

Mining Properties	9 Months Ended
	Mar. 31, 2024
Mining Properties
Mining Properties	7. Mining Properties   On July 21, 2022, the Company exercised the option to purchase the rights to unpatented lode claims in Tonopah, Nevada. Since that time, the Company has worked with third parties to conduct drill programs and analysis to verify the grade and continuity of the mining claims. Over 50% of the inferred mineral resources have been upgraded to measured and indicated classifications. The Company is still in the exploration stage and expenses all mineral exploration costs. If the Company identifies proven and probable reserves and develops an economic plan for operating a mine, it will enter the development stage and capitalize future costs until production is established.

v3.24.1.1.u2

Intangible Assets	9 Months Ended
	Mar. 31, 2024
Goodwill and Intangible Assets Disclosure [Abstract]
Intangible Assets	8. Intangible Assets   On September 12, 2023, the Company acquired approximately 40.52-acre feet of water rights from the Thomas C. Woodward Living Trust, valued at $0.1 million. The water rights are treated in accordance with ASC 350, “Intangible Assets,” and have an unlimited useful life subject to beneficial use.   The Company’s acquisition of the commercial-scale battery recycling facility at the TRIC included water rights valued at $0.6 million and are described as an eighteen and forty-five one-hundredths (18.45) acre-foot/annually portion of the Truckee-Carson Irrigation District, Serial Number 1081-A-1. These are appurtenant to a certain real property located in Storey County, Nevada, described as Storey County Assessor Parcel Number 021-37-104 and have an unlimited useful life upon assignment to a property through use of a will-serve, which has no expiration date.   The table below presents total intangible assets at:  Schedule of Intangible Assets     March 31, 2024     June 30, 2023   Water rights   $ 4,584,831     $ 3,851,899       AMERICAN BATTERY TECHNOLOGY COMPANY Notes to the Condensed Consolidated Financial Statements For the period ended March 31, 2024 (unaudited)

v3.24.1.1.u2

Accounts Payable and Accrued Liabilities	9 Months Ended
	Mar. 31, 2024
Payables and Accruals [Abstract]
Accounts Payable and Accrued Liabilities	9. Accounts Payable and Accrued Liabilities   The table below presents total accounts payable and accrued liabilities at:  Schedule of Accounts Payable and Accrued Liabilities     March 31, 2024     June 30, 2023   Trade payables   $ 2,949,290     $ 1,831,686   Accrued fixed assets     1,999,331       4,404,034   Accrued expenses     1,226,040       1,377,660   Right-of-use liability, current     86,030       121,484   Total accounts payable and accrued liabilities   $ 6,260,691     $ 7,734,864

v3.24.1.1.u2

Notes Payable	9 Months Ended
	Mar. 31, 2024
Debt Disclosure [Abstract]
Notes Payable	10. Notes Payable   On May 17, 2023, the Company entered into a Credit Agreement (the “Credit Agreement”) with Mercuria Investments US, Inc. for pre-payment on the purchase of the Company’s recycled battery metal products. As such, inventory serves as collateral for outstanding balances. The Credit Agreement provides for an aggregate loan amount of up to $20 million, comprised of (i) an initial term loan in the aggregate principal amount of $6 million and (ii) delayed draw term loan commitments in an aggregate amount equal to $14 million. Borrowings under the Credit Agreement carry interest calculated as the secured overnight financing rate published on the Federal Reserve Bank of New York’s website, plus the applicable credit spread adjustment, based on the elected interest period, plus an applicable margin rate of 6%. The agreement contains provisions that allow the Company to remit principal and interest payments via future delivery of its initial recycling byproduct, black mass.   On August 30, 2023, the Company caused the repayment in full of all indebtedness, liabilities and other obligations under, and terminated, its former credit agreement, dated as of May 17, 2023 by and among the Company, as Borrower, and Mercuria Investments US, Inc., as Agent. The Company did not incur any material early termination penalties because of such termination of the credit agreement. The Company remains engaged with Mercuria Investments US, Inc. in a marketing and presale capacity.   On August 29, 2023, the Company and High Trail (the “Buyers”) entered into a Securities Purchase Agreement (the “Purchase Agreement”), pursuant to which the Company sold to the Buyers up to $51.0 million of a new series of senior secured convertible notes (the “Notes”). To date, $25.0 million has been received and $12.6 million has been repaid. The remaining $26 million under the facility includes $13.5 million with the condition that the Company started trading on the Nasdaq Capital Market, had $250,000 in sales, and establish an ATM or ELOC, and another $12.5 million at the discretion of the Buyers. Buyers may request partial redemptions of up to an aggregate of $1.8 million on the 15th of each month or may convert the Notes into shares of common stock of the Company (“Conversion Shares”) at a conversion rate of 110% of the last reported sales price on the date of the agreement to acquire such Notes. The Notes bear zero coupon, mature on September 1, 2025, require a minimum of $5.0 million maintained in cash and cash equivalents, and are secured by certain real property and cash and investment accounts of the Company.   The Company analyzed the conversion features of the Notes for derivative accounting considerations under ASC 815-15, “Derivatives and Hedging,” and determined a conversion option should be bifurcated and separately accounted for as a derivative liability. Accordingly, the derivative liability is carried at fair value at each reporting date with the corresponding gain or loss reflected in earnings in the condensed consolidated statements of operations. See Correction of Previously Issued Consolidated Financial Statements in Note 2. The Company determined the derivative liability to have a fair value of $0.4 million at issuance of the Notes. For the three and nine months ended March 31, 2024, the Company recorded a loss on the change in fair value of the derivative liability of $0.2 million and $0.4 million, respectively. As of March 31, 2024, the fair value of the derivative liability was $0.8 million. The fair value of the derivative liability is classified within Level 3 of the fair value hierarchy and was determined using the Black-Scholes option pricing model with assumptions as of March 31, 2024 including a volatility of 81.1% and a risk-free-rate of 4.79%.   Note discount and issuance costs totaled $4.7 million and reduced the carrying value of the Notes as a debt discount. The carrying value, net of debt discount and issuance costs, is being accreted over the term of the Notes from date of issuance to date of full repayment, expected to be in October 2024 based on partial redemption payments, using the effective interest rate method. For the nine months ended March 31, 2024, amortization of debt discount and issuance costs totaled $2.8 million.   The table below presents the net carrying amounts of the Notes as of:  Schedule of Net Carrying Amounts of the Notes     March 31, 2024     June 30, 2023   Principal outstanding   $ 12,483,333     $ -   Unamortized debt discount and issuance costs     (2,520,864 )     -   Derivative liability associated with convertible notes     366,298       -   Changes in fair market value of derivative liability     419,739       -   Net carrying value   $ 10,748,506     $ -     The table below presents the maturities of notes payable as of March 31, 2024:  Schedule of Maturities of Notes Payable         March 31, 2025   $ 12,483,333   March 31, 2026     -   Total note payments     12,483,333   Less: unamortized debt discount and issuance costs     (2,520,864 ) Derivative liability, at fair value, less amortization     786,037   Total notes payable   $ 10,748,506             Notes payable, current   $ 10,748,506   Notes payable, non-current   $ -       AMERICAN BATTERY TECHNOLOGY COMPANY Notes to the Condensed Consolidated Financial Statements For the period ended March 31, 2024 (unaudited)

v3.24.1.1.u2

Leases	9 Months Ended
	Mar. 31, 2024
Leases
Leases	11. Leases   A lease provides the lessee the right to control the use of an identified asset for a period in exchange for consideration. Operating lease right-of-use assets (“RoU assets”) are presented within the asset section of the Company’s consolidated balance sheets, while lease liabilities are included within the liability section of the Company’s consolidated balance sheets at March 31, 2024 and June 30, 2023.   RoU assets represent the Company’s right to use an underlying asset for the lease term and operating lease liabilities represent the Company’s obligation to make lease payments arising from the lease. The Company determines if an arrangement is a lease at inception. RoU assets and liabilities are recognized at the lease commencement date based on the present value of lease payments over the lease term. Most operating leases contain renewal options that provide for rent increases based on prevailing market conditions. The terms used to calculate the RoU assets for certain properties include the renewal options that the Company is reasonably certain to exercise.   The discount rate used to determine the commencement date present value of lease payments is the interest rate implicit in the lease, or when that is not readily determinable, the Company estimates a rate of 8.0% for the nine months ending March 31, 2024 and 2023, based primarily on historical lending agreements. RoU assets include lease payments required to be made prior to commencement and exclude lease incentives. Both RoU assets and the related lease liability exclude variable payments not based on an index or rate, which are treated as period costs. The Company’s lease agreements do not contain significant residual value guarantees, restrictions, or covenants.   The Company occupies office facilities under lease agreements that expire at various dates, many of which do not exceed a year in length. Total operating lease costs for the nine months ended March 31, 2024 and 2023, were each approximately $0.1 million. The Company does not have any finance leases as of March 31, 2024 and 2023.   As of March 31, 2024, current lease liabilities of $0.1 million are included in “Accounts payable and accrued liabilities” on the consolidated balance sheets. The table below presents total operating lease RoU assets and lease liabilities at March 31, 2024 and June 30, 2023:  Schedule of Operating Lease ROU Assets and Lease Liabilities     March 31, 2024     June 30, 2023   Operating lease right-of-use asset   $ 67,366     $ 143,154   Operating lease liabilities   $ 86,030     $ 175,788     The table below presents the maturities of operating lease liabilities as of March 31, 2024:  Schedule of Maturity of Operating Lease Liabilities            March 31, 2025   $ 88,632   March 31, 2026     -   Total lease payments     88,632   Less: discount     (2,601 )           Total operating lease liabilities   $ 86,030             Operating lease liabilities, current   $ 86,030   Operating lease liabilities, non-current   $ -     The table below presents the weighted average remaining lease term for operating leases and weighted average discount rate used in calculating operating lease right-of-use asset as of March 31, 2024.  Schedule of Weighted Average Remaining Lease Term for Operating Leases and Weighted Average Discount Rate Weighted average lease term (years)     0.67   Weighted average discount rate     8.00 %     AMERICAN BATTERY TECHNOLOGY COMPANY Notes to the Condensed Consolidated Financial Statements For the period ended March 31, 2024 (unaudited)

v3.24.1.1.u2

Stockholders’ Equity	9 Months Ended
	Mar. 31, 2024
Equity [Abstract]
Stockholders’ Equity	12. Stockholders’ Equity   On September 21, 2023, the Company’s common stock began trading on the Nasdaq Capital Market under the symbol “ABAT.” The Company was previously traded on the OTCQX Markets under the symbol “ABML.”   Preferred Stock   Our amended and restated articles of incorporation authorize shares of preferred stock and provide that shares of preferred stock may be issued from time to time in one or more series. Our board of directors will be authorized to fix the voting rights, if any, designations, powers, preferences, the relative, participating, optional or other special rights and any qualifications, limitations and restrictions thereof, applicable to the shares of each series. Our board of directors will be able to, without stockholder approval, issue shares of preferred stock with voting and other rights that could adversely affect the voting power and other rights of the holders of the common stock and could have anti-takeover effects. The ability of our board of directors to issue shares of preferred stock without stockholder approval could have the effect of delaying, deferring or preventing a change of control of us or the removal of existing management.   To date, the Company has authorized a total of 1,666,667 shares of preferred stock. Of this amount the Company has designated a total of 233,334 shares to three classes of preferred stock, Series A Preferred Stock, Series B Preferred Stock and Series C Preferred Stock. As of June 30, 2023 and March 31, 2024, no shares of any of these classes are issued and outstanding. A description of each class of preferred stock is listed below.   Series A Preferred Stock   The Company has 33,334 shares of Series A Preferred Stock authorized with a par value of $0.001 per share. The Company had nil shares of Series A Preferred Stock issued and outstanding on March 31, 2024, and June 30, 2023.   Series B Preferred Stock   The Company has 133,334 shares of Series B Preferred Stock authorized with a par value of $10.00 per share. The Company had nil shares of Series B Preferred Stock issued and outstanding on March 31, 2024, and June 30, 2023.   Series C Preferred Stock   The Company has 66,667 shares of Series C Preferred Stock authorized with a par value of $10.00 per share. The Company had nil shares of Series C Preferred Stock issued and outstanding on March 31, 2024, and June 30, 2023.   Common Stock   The Company has 80.0 million shares of common stock authorized, with a par value of $0.001 per share.   On September 11, 2023, in preparation for listing on the Nasdaq Capital Market, the Company implemented a one-for-fifteen (1-for-15) reverse split of our common stock. Prior to the reverse stock split the Company had 692,068,218 shares of common stock issued and outstanding, and after the reverse stock split, the Company had approximately 46,137,882 shares of common stock issued and outstanding. Immediately after the reverse stock split, each stockholder’s percentage ownership interest in the Company and proportional voting power remained unchanged aside from rounding fractional shares into whole shares, resulting in an additional 59,164 common shares issued. The reverse stock split did not change the par value of the common stock or preferred stock.     AMERICAN BATTERY TECHNOLOGY COMPANY Notes to the Condensed Consolidated Financial Statements For the period ended March 31, 2024 (unaudited)   12. Stockholders’ Equity (continued)   Common Stock (continued)   Nine months ended March 31, 2024:   During the period the Company issued 1,326 common shares that were previously listed as issuable as of June 30, 2023. These shares for professional services relate to previously earned board compensation.   During the period, the Company issued 909,972 common shares with an issuance date fair value of $4.6 million to executives, directors and employees pursuant to share award service and performance achievements. This included 171,500 RSUs granted upon election by officers of the Company to receive warrants and RSUs in lieu of cash bonuses.   On July 28, 2023, the Company recorded an increase of $0.2 million to stockholders’ equity for the change in fair value between the balance sheet date of June 30, 2023 and the fair value on the date the shares were returned. These shares were pursuant to the Company modifying its building purchase agreement to nullify a $1.5 million indemnification requirement and reclaim 128,205 shares that it had previously issued to the Selling Stockholder (See Note 5).   During the period, the Company filed prospectus supplements related to the offer and sale from time to time of up to 8,666,667 common shares directly by the Company at market prices, to Tysadco Partners, LLC, a Delaware limited liability company, pursuant to the terms of written sales agreement(s) (“Tysadco Agreement”). Pursuant to the Tysadco Agreement, the Company may offer and sell up to 8,666,667 common shares of the Company at a purchase price of 95% of the weighted-average price, with a minimum request of 33,333 shares. During the period, the Company sold 8,209,262 common shares for total proceeds of $27.8 million, of which $2.4 million is recorded as a subscription receivable on the condensed consolidated balance sheet at March 31, 2024.   During the period, the Company issued 45,545 common shares pursuant to cashless exercise of 50,000 share purchase warrants exercised as of June 30, 2023. During the period, the Company received cash proceeds of $37,500 pursuant to 33,334 share purchase warrants. Also during the period, the Company issued 39,883 common shares pursuant to cashless exercise of 66,667 share purchase warrants.   During the period, the Company recognized stock-based compensation expense of approximately $12.3 million, which was an increase to additional paid-in capital, a component of stockholders’ equity. Of the amount, approximately $4.4 million was recognized for officers and directors of the Company. See Correction of Previously Issued Consolidated Financial Statements in Note 2.   Nine months ended March 31, 2023:   During the period, the Company issued 293,908 common shares pursuant the vesting of restricted share units issued to employees and directors of the Company. Of the vested shares, 166,574 common shares with a fair value of approximately $1.7 million were issued to officers of the Company.   During the period, the Company sold 8,209,262 common shares pursuant the Share Purchase Agreement, effective April 2, 2021. The proceeds totaled $3.6 million, all of which were received prior to March 31, 2023.   During the period the Company issued 10,009 common shares for professional services, with a fair value of approximately $104,000.   During the period, the Company recognized stock-based compensation expense of approximately $6.1 million, which was an increase to additional paid-in capital, a component of stockholders’ equity. Of the amount, approximately $2.7 million was recognized for officers and directors of the Company.     AMERICAN BATTERY TECHNOLOGY COMPANY Notes to the Condensed Consolidated Financial Statements For the period ended March 31, 2024 (unaudited)

v3.24.1.1.u2

Share Purchase Warrants	9 Months Ended
	Mar. 31, 2024
Share Purchase Warrants
Share Purchase Warrants	13. Share Purchase Warrants   During the nine months ended March 31, 2024, there were 73,217 common shares issued related to warrants exercised, of which 39,883 were issued pursuant to a cashless exercise of 66,667 share purchase warrants. In addition, there were 249,119 warrants vested related to previously granted stock-based compensation to officers of the Company, and 171,500 warrants granted upon election by officers of the Company to receive warrants and RSUs in lieu of cash bonuses.  Schedule of Share Purchase Warrants Activity     Number of Warrants     Weighted Average Exercise Price                 Balance, June 30, 2023     5,729,360     $ 14.53   Granted     236,271       3.59   Exercised     (100,002 )     (1.13 ) Expired     (107,735 )     (3.75 ) Balance, March 31, 2024     5,757,894     $ 14.55     Additional information regarding share purchase warrants as of March 31, 2024, is as follows:  Schedule of Additional Information Regarding Share Purchase Warrants     Outstanding and Exercisable   Range of Exercise Prices   Number of Warrants     Weighted Average Remaining Contractual Life (years)                     $1.13 - $4.33     919,214       0.33   $6.53 - $13.13     3,015,705       1.24   $23.10 - $26.25     1,822,975       0.74         5,757,894       2.31

v3.24.1.1.u2

Equity Compensation Awards	9 Months Ended
	Mar. 31, 2024
Share-Based Payment Arrangement [Abstract]
Equity Compensation Awards	14. Equity Compensation Awards   The Company has established the 2021 Retention Plan (“the Retention Plan”) to issue shares in the effort to retain key executives, directors, and employees. The Retention Plan allows for several different types of awards to be granted, including but not limited to, restricted share units and restricted share awards, collectively referred to as “share awards”. Share awards generally have the same expense characteristics under US GAAP and generally vest over a four-year period at a rate of 25% per annum.   Under the Retention Plan, the Company is authorized to issue shares of common stock to employees and non-employees up to ten percent (10%) of the total number of shares of common stock outstanding as of December 31, 2022, on a fully diluted basis. The Company adjusts the authorized shares under the plan each December 31, while the Retention Plan remains in effect. During the nine months ended March 31, 2024 and 2023, the Company granted 1.8 million and 2.6 million share awards, respectively.     AMERICAN BATTERY TECHNOLOGY COMPANY Notes to the Condensed Consolidated Financial Statements For the period ended March 31, 2024 (unaudited)   14. Equity Compensation Awards (continued)   The table below reflects the share award activity for the period ended March 31, 2024:  Schedule of Restricted Shares and Restricted Share Units Non-vested     Units     Weighted- Average Grant Date Fair Value per Unit                 Unvested share awards at June 30, 2023     1,736,376     $ 8.35   Granted     2,634,678       4.03   Vested     (1,092,155 )     5.54   Other     –       –   Forfeitures     –     $ –   Unvested awards at March 31, 2024     3,278,899     $ 5.71     As awards are granted, stock-based compensation equivalent to the fair market value on the date of grant is expensed over the requisite service period, using the graded vesting attribution method as acceptable under ASC 718, “Stock-Based Compensation.”   The Company recognized stock-based compensation expense of $12.3 million and $ 6.1 million for the nine months ended March 31, 2024 and 2023, respectively. Of these amounts, $5.0 million and $2.7 million, respectively, were related to officers and directors of the Company. For the nine months ended March 31, 2024 and 2023, total stock-based compensation expense included $1.3 million and nil related to warrants awarded to officers of the Company. As of March 31, 2024 and June 30, 2023, the equity compensation liability totaled $2.1 million and $0.8 million related to warrants awarded to officers of the Company. See Correction of Previously Issued Consolidated Financial Statements in Note 2. As of March 31, 2023 several grant performance targets for the fiscal year ended June 30, 2024 have been defined via employee and retention agreements. These performance targets have not yet been achieved by employees and officers thus, the Company has deferred any stock-based compensation recognition until such achievements are probable of achievement and approval by the board of directors has occurred.   As of March 31, 2024 and June 30, 2023, there were approximately $10.3 million and $8.7 million of unamortized expenses relating to outstanding share awards to be recognized over a remaining weighted-average period of 3.0 years and 3.2 years, respectively.   The table below presents the stock-based compensation expense per respective line item on the consolidated statements of operations for the nine months ended March 31:  Schedule of Stock-Based Compensation Expense     2024     2023                 General and administrative   $ 6,143,765     $ 3,588,076   Research and development     5,197,699       1,985,491   Exploration     952,592       505,322   Stock-based compensation expense   $ 12,294,056     $ 6,078,889     Executive officers and selected other key employees are eligible to receive common share performance-based awards, as determined by the board of directors. The payouts, in the form of share awards, vary based on the degree to which corporate operating objectives are met. These performance-based awards typically include a service-based requirement, which is generally four-years.     AMERICAN BATTERY TECHNOLOGY COMPANY Notes to the Condensed Consolidated Financial Statements For the period ended March 31, 2024 (unaudited)

v3.24.1.1.u2

Supplemental Statement of Cash Flow Disclosures	9 Months Ended
	Mar. 31, 2024
Supplemental Cash Flow Elements [Abstract]
Supplemental Statement of Cash Flow Disclosures	15. Supplemental Statement of Cash Flow Disclosures   For the nine months ended March 31:  Schedule of Statement of Cash Flow Disclosures     2024     2023                 Supplemental disclosures:                                   Interest paid   $ 16,017     $ -                     Non-cash investing and financing activities:                                   Current liabilities associated with investing activities     1,999,331       1,938,564                     Deposits capitalized as investing activities   27,103,351     150,000

v3.24.1.1.u2

Commitments and Contingencies	9 Months Ended
	Mar. 31, 2024
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	16. Commitments and Contingencies   From time to time, the Company may become involved in various lawsuits and legal proceedings, which arise in the ordinary course of business. Litigation is subject to inherent uncertainties, and an adverse result in these or other matters may arise from time to time that may harm business. Except as otherwise identified herein, management is currently not aware of any such legal proceedings or claims that could have, individually or in aggregate, a material adverse effect on our business, financial condition, or operating results.   Operating Leases   The Company leases its principal office location in Reno, Nevada. It also leases lab space at the University of Nevada, Reno on short term leases. The principal office location lease expires on November 30, 2024 and the Lab leases expire on November 30, 2024. Consistent with the guidance in ASC 842, The Company has recorded the principal office lease in its consolidated balance sheet as an operating lease. For further information on operating lease commitments, see Note 11 – Leases.   Financial Assurance:   Nevada and other states, as well as federal regulations governing mine operations on federal land, require financial assurance to be provided for the estimated costs of mine reclamation and closure, including groundwater quality protection programs. The Company has satisfied financial assurance requirements using a combination of cash bonds and surety bonds. The amount of financial assurance The Company is required to provide will vary with changes in laws, regulations, reclamation and closure requirements, and cost estimates. At March 31, 2024, The Company’s financial assurance obligations associated with U.S. mine closure and reclamation/restoration cost estimate totaled $59,646, for which the Company is legally required to satisfy its financial assurance obligations for its mining properties in Tonopah, Nevada. The Company was previously released of all of its liability in the Railroad Valley region of Nevada.

v3.24.1.1.u2

Subsequent Events	9 Months Ended
	Mar. 31, 2024
Subsequent Events [Abstract]
Subsequent Events	17. Subsequent Events   On April 3, 2024, the Company entered into an ATM Sales Agreement (the “Sales Agreement”) with Virtu Americas LLC (the “Sales Agent”), pursuant to which the Company may offer and sell, from time to time through the Sales Agent, shares (the “Shares”) of the Company’s common stock, par value $0.001 per share (the “Common Stock”), having an aggregate offering price of up to $50,000,000, subject to the terms and conditions of the Sales Agreement. The Company has filed a prospectus supplement to its registration statement on Form S-3 (File No. 333-252492) offering the Shares.   On April 24, 2024, the Company announced the completion of the “Amended Resource Estimate and Initial Assessment with Project Economics for the Tonopah Flats Lithium Project, Esmeralda and Nye Counties, Nevada, USA” (“Amended IA”) and the publication of the S-K 1300 Technical Report Summary (“TRS”) disclosing mineral resources, including an initial economic assessment, for the Tonopah Flats Lithium Project. The TRS was completed by RESPEC Company LLC, a qualified person, in compliance with Item 1300 of Regulation S-K and with an effective date of April 5, 2024.

v3.24.1.1.u2

Summary of Significant Accounting Policies (Policies)	9 Months Ended
	Mar. 31, 2024
Accounting Policies [Abstract]
Basis of Presentation and Principles of Consolidation	a) Basis of Presentation and Principles of Consolidation   The condensed consolidated financial statements of the Company have been prepared in accordance with accounting principles generally accepted in the United States (“US GAAP”) and are expressed in U.S. dollars. The Company’s fiscal year end is June 30.   These condensed consolidated financial statements include the accounts of the Company and its wholly owned subsidiaries, Oroplata Exploraciones E Ingenieria SRL (dissolved), LithiumOre Corporation (formerly Lithortech Resources Inc), ABMC AG, LLC (dissolved) and Aqua Metals Transfer LLC. All inter-company accounts and transactions have been eliminated upon consolidation.   On September 11, 2023, the Company effected a one-for-fifteen reverse-stock-split with respect to the authorized, issued, and outstanding shares of common stock and preferred stock. All share and per-share amounts included in this Form 10-Q are presented as if the stock split had been effective from the beginning of the earliest period presented.     AMERICAN BATTERY TECHNOLOGY COMPANY Notes to the Condensed Consolidated Financial Statements For the period ended March 31, 2024 (unaudited)   Immaterial Correction of Previously Issued Consolidated Financial Statements   Subsequent to the issuance of the Company’s December 31, 2023 condensed consolidated financial statements, the Company identified errors in the application of Accounting Standards Codification (“ASC”) 710, “Compensation-General,” and ASC 718, “Compensation-Stock Compensation,” related to expense recognition for cash and equity awards that are subject to both service and performance conditions. ASC 710 and ASC 718 require recognition of compensation cost once achievement of the performance condition becomes probable as the requisite service is provided. Historically, the Company did not recognize compensation cost for certain cash and equity awards until the performance conditions in the form of milestones were achieved, and for the Company’s common share warrant performance-based awards, no compensation cost had previously been recognized when the performance conditions either became probable of achievement or were achieved. As the common share warrant and RSU performance-based awards to executive officers and key employees are granted with a fixed dollar value and settled in a variable number of common share warrants or RSUs, these awards are liability-classified and the corresponding compensation cost should be recorded to current or long-term liabilities, depending on expected timing of settlement of the award, once the performance conditions become probable of achievement.   The correction of this error resulted in an increase in compensation cost of $0.9 million as of and for the fiscal year ended June 30, 2023, and an increase in compensation cost of $1.6 million and $0.6 million for the quarters ended September 30, 2023 and December 31, 2023, respectively. For the six-month period ended December 31, 2023, the errors resulted in an increase in compensation cost of $2.2 million. As certain of these awards are liability-classified, the correction of this error resulted in an increase of $0.3 million in accounts payable and accrued liabilities for the current portion of the awards and an increase of $0.8 million in equity compensation liability for the noncurrent portion of the awards as of June 30, 2023.   The Company also identified an error in application of ASC 815, “Derivatives and Hedging,” related to the initial and subsequent recognition of a conversion option in the Company’s convertible notes that does not qualify for equity classification. ASC 815 requires bifurcation of the conversion option with subsequent changes in the fair value of the bifurcated derivative to be recorded in earnings. At issuance of the convertible notes, the Company should have recognized a derivative liability and a corresponding discount on the convertible notes resulting from bifurcation of the derivative, with subsequent changes in the fair value of the derivative liability and accretion of the discount recorded in earnings.   The correction of this error resulted in an increase in interest and other expense of less than $0.1 million for the quarter ended September 30, 2023 and $0.3 million for the quarter ended December 31, 2023. For the six-month period ended December 31, 2023, the error resulted in an increase in interest and other expenses of $0.4 million.   The Company has evaluated the effects of the corrections detailed in the tables below on the previously issued consolidated financial statements, individually and in the aggregate, in accordance with the guidance in ASC 250, “Accounting Changes and Error Corrections.” The Company has concluded such corrections to be immaterial to its previously issued consolidated financial statements. While management believes the effect of the errors is immaterial to the Company’s previously issued consolidated financial statements as of and for the year ended June 30, 2023, and the condensed consolidated financial statements as of and for the three months ended September 30, 2023 and as of and for the three and six months ended December 31, 2023, the financial statement line items impacted by these errors have been corrected. In addition, the immaterial error is being corrected prospectively in the Company’s subsequent quarterly and annual filings.   The tables below reflect the sections of the Company’s condensed consolidated financial statements that were impacted by the error.  Schedule of Consolidated Financial Statements CONSOLIDATED BALANCE SHEET       As Reported     Adjustments     As Corrected       June 30, 2023       As Reported     Adjustments     As Corrected   Liabilities and Stockholders’ Equity                           Current liabilities:                         Accounts payable and accrued liabilities   $ 7,389,864     $ 345,000     $ 7,734,864   Total current liabilities     13,389,864       345,000       13,734,864   Equity compensation liability     -       833,427       833,427   Total liabilities     13,444,168       1,178,427       14,622,595                             Stockholders’ equity                         Additional paid in capital   $ 222,626,865     $ (325,494 )   $ 222,301,371   Accumulated deficit     (159,973,575 )     (852,933 )     (160,826,508 ) Total stockholders’ equity     61,214,484       (1,178,427 )     60,036,057       AMERICAN BATTERY TECHNOLOGY COMPANY Notes to the Condensed Consolidated Financial Statements For the period ended March 31, 2024 (unaudited)   CONSOLIDATED STATEMENT OF OPERATIONS                           Fiscal year ended June 30, 2023       As Reported     Adjustments     As Corrected                       Operating expenses                         General and administrative   $ 11,960,831     $ 887,300     $ 12,848,131   Research and development     7,703,895       (138,160 )     7,565,735   Exploration     1,910,548       103,793       2,014,341   Total operating expenses     21,575,274       852,933       22,428,207                             Net loss before other income (expense)   $ (21,575,274 )   $ (852,933 )   $ (22,428,207 )                           Net loss attributable to common stockholders   $ (21,338,207 )   $ (852,933 )   $ (22,191,140 ) Net loss per share, basic and diluted   $ (0.49 )   $ (0.02 )   $ (0.51 )   CONSOLIDATED STATEMENT OF STOCKHOLDERS’ EQUITY                                 Fiscal year ended June 30, 2023       As Reported     Adjustments     As Corrected   Stockholders’ Equity                                                   Additional Paid-In Capital:                         Stock-based compensation expense   $ 9,249,462     $ (325,494 )   $ 8,923,968   Balance, June 30, 2023   $ 222,626,865     $ (325,494 )   $ 222,301,371                             Accumulated Deficit                         Net loss for period   $ (21,338,207 )   $ (852,933 )   $ (22,191,140 ) Balance, June 30, 2023     (159,973,575 )   $ (852,933 )   $ (160,826,508 )   CONSOLIDATED STATEMENTS OF CASH FLOWS       As Reported     Adjustments     As Corrected       Fiscal year ended June 30, 2023       As Reported     Adjustments     As Corrected                       Operating Activities                         Net loss attributable to stockholders   $ (21,338,207 )   $ (852,933 )   $ (22,191,140 )                           Adjustments to reconcile net loss to net cash used in operating activities:                         Stock-based compensation     9,249,462       507,933       9,757,395   Changes in operating assets and liabilities:                         Accounts payable and accrued liabilities   $ (187,796 )   $ 345,000     $ 157,204                             Net Cash Used in Operating Activities   $ (13,367,980 )   $ -     $ (13,367,980 )     CONDENSED CONSOLIDATED STATEMENT OF OPERATIONS       As Reported     Adjustments     As Corrected       Three months ended September 30, 2023       As Reported     Adjustments     As Corrected                       Operating expenses                         General and administrative   $ 2,948,846     $ 105,152     $ 3,053,998   Research and development     2,155,314       1,458,538       3,613,852   Exploration     1,279,782       70,138       1,349,920   Total operating expenses     6,383,942       1,633,827       8,017,769                             Net loss before other income (expense)   $ (6,383,942 )   $ (1,633,827 )   $ (8,017,769 )                           Other income (expense)                         Amortization of financing costs   $ (706,731 )   $ (26,165 )   $ (732,896 ) Total other income (expense)     (848,043 )     (26,165 )     (874,208 )                           Net loss attributable to common stockholders   $ (7,231,985 )   $ (1,659,992 )   $ (8,891,977 ) Net loss per share, basic and diluted   $ (0.16 )   $ (0.03 )   $ (0.19 )   CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY       As Reported     Adjustments     As Corrected       Three months ended September 30, 2023       As Reported     Adjustments     As Corrected                       Stockholders’ Equity                                                   Additional Paid-In Capital:                         Balance, June 30, 2023   $ 222,626,865     $ (325,494 )   $ 222,301,371   Stock-based compensation expense     1,921,442       981,396       2,902,838   Balance, September 30, 2023   $ 226,317,285     $ 655,903     $ 226,973,188                             Accumulated Deficit                         Balance, June 30, 2023   $ (159,973,575 )   $ (852,933 )   $ (160,826,508 ) Net loss for period   (7,231,985 )   (1,659,992 )   (8,891,977 ) Balance, September 30, 2023   $ (167,205,560 )   $ (2,512,926 )   $ (169,718,486 )   CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS         As Reported       Adjustments       As Corrected         Three months ended September 30, 2023         As Reported       Adjustments       As Corrected   Operating Activities                         Net loss attributable to stockholders   $ (7,231,985 )   $ (1,659,992 )   $ (8,891,977 ) Adjustments to reconcile net loss to net cash used in operating activities:                         Accretion expense   $ 256,459     $ 26,165     $ 282,624   Stock-based compensation     1,921,442       1,447,827       3,369,269   Changes in operating assets and liabilities:                         Accounts payable and accrued liabilities   $ 228,071     $ 186,000     $ 414,071                             Net Cash Used in Operating Activities   $ (4,758,984 )   $ -     $ (4,758,984 )     AMERICAN BATTERY TECHNOLOGY COMPANY Notes to the Condensed Consolidated Financial Statements For the period ended March 31, 2024 (unaudited)   CONDENSED CONSOLIDATED STATEMENT OF OPERATIONS       As Reported     Adjustments     As Corrected       Three months ended December 31, 2023       As Reported     Adjustments     As Corrected                       Operating expenses                         General and administrative   $ 4,310,452     $ 106,264     $ 4,416,716   Research and development     3,148,873       420,294       3,569,167   Exploration costs     771,523       51,902       823,425   Total operating expenses     8,230,848       578,459       8,809,307                           Net loss before other income (expense)   $ (8,230,848 )   $ (578,459 )   $ (8,809,307 )                           Other income (expense)                         Amortization and accretion of financing costs   $ (1,053,766 )   $ (78,492 )   $ (1,132,258 ) Change in fair value of derivative liability     -       (229,473 )     (229,473 ) Total other income (expense)     (1,060,587 )     (307,965 )     (1,368,552 )                           Net loss   $ (9,291,435 )   $ (886,424 )   $ (10,177,859 ) Net loss per share, basic and diluted   $ (0.19 )   $ (0.02 )   $ (0.21 )   CONDENSED CONSOLIDATED STATEMENT OF OPERATIONS       As Reported     Adjustments     As Corrected       Six months ended December 31, 2023       As Reported     Adjustments     As Corrected                       Operating expenses                         General and administrative   $ 7,259,298     $ 211,415     $ 7,470,713   Research and development     5,304,187       1,878,831       7,183,018   Exploration costs     2,051,305       122,040       2,173,345   Total operating expenses     14,614,790       2,212,286       16,827,076                             Net loss before other income (expense)   $ (14,614,790 )   $ (2,212,286 )   $ (16,827,076 )                           Other income (expense)                         Amortization and accretion of financing costs   $ (1,760,497 )   $ (104,657 )   $ (1,865,154 ) Change in fair value of derivative liability     -       (229,473 )     (229,473 ) Total other income (expense)     (1,908,630 )     (334,130 )     (2,242,760 )                           Net loss   $ (16,523,420 )   $ (2,546,416 )   $ (19,069,836 ) Net loss per share, basic and diluted   $ (0.35 )   $ (0.05 ) $ (0.40 )     AMERICAN BATTERY TECHNOLOGY COMPANY Notes to the Condensed Consolidated Financial Statements For the period ended March 31, 2024 (unaudited)   CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY         As Reported       Adjustments       As Corrected       Three months ended December 31, 2023         As Reported       Adjustments       As Corrected   Stockholders’ Equity                                                   Additional Paid-In Capital:                         Balance, September 30, 2023   $ 226,317,285     $ 655,903     $ 226,973,188   Stock-based compensation expense     3,836,466       146,877       3,983,343   Balance, December 31, 2023   $ 243,020,935     $ 802,779     $ 243,823,714                             Accumulated Deficit                         Balance, September 30, 2023   $ (167,205,560 )   $ (2,512,926 )   $ (169,718,486   Net loss for period     (9,291,435 )     (886,424 )     (10,177,859 ) Balance, December 31, 2023   $ (176,496,995 )   $ (3,399,350 )   $ (179,896,345 )   CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY       As Reported     Adjustments     As Corrected       Six months ended December 31, 2023       As Reported     Adjustments     As Corrected                       Stockholders’ Equity                         Additional Paid-In Capital:                         Balance, June 30, 2023   $ 222,626,865     $ (325,494 )   $ 222,301,371   Stock-based compensation expense     5,757,908     1,128,273       6,886,181   Balance, December 31, 2023   $ 243,020,935     $ 802,779     $ 243,823,714   Accumulated Deficit                         Balance, June 30, 2023   $ (159,973,575 )   $ (852,933 )   $ (160,826,508 ) Net loss for period   (16,523,420 )   (2,546,416 )   (19,069,836 ) Balance, December 31, 2023   $ (176,496,995 )   $ (3,399,350 )   $ (179,896,345 )   CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS                           Six months ended December 31, 2023       As Reported     Adjustments     As Corrected                       Operating Activities                       Net loss attributable to stockholders   $ (16,523,420 )   $ (2,546,416 )   $ (19,069,836 ) Adjustments to reconcile net loss to net cash used in operating activities:                         Accretion of financing costs   $ 1,760,497     $ 104,657   $ 1,865,154   Stock-based compensation     5,757,908       1,933,603       7,691,511   Shares issued for professional services     (132)       (316 )     (448 ) Change in fair value of derivative liability     -       229,473       229,473   Changes in operating assets and liabilities:                         Accounts payable and accrued liabilities   $ 2,223,865     $ 279,000     $ 2,502,865                             Net Cash Used in Operating Activities   $ (7,418,700 )   $ -   $ (7,418,700 )
Use of Estimates	b) Use of Estimates   The preparation of these consolidated financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting periods. The Company regularly evaluates estimates and assumptions related to the fair value of stock-based compensation, valuation and recoverability of long-lived assets and intangible assets subject to impairment testing, and deferred income tax asset valuation allowances.   The Company bases its estimates and assumptions on current facts, historical experience, and various other factors that it believes to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities and the accrual of costs and expenses that are not readily apparent from other sources. The actual results experienced by the Company may differ materially and adversely from the Company’s estimates. To the extent there are material differences between the estimates and the actual results, future results of operations may be affected.     AMERICAN BATTERY TECHNOLOGY COMPANY Notes to the Condensed Consolidated Financial Statements For the period ended March 31, 2024 (unaudited)   2. Summary of Significant Accounting Policies (continued)
Long-Lived Assets	c) Long-Lived Assets   Long-lived assets, such as property and equipment, mineral properties, and purchased intangibles, are evaluated for impairment whenever events or changes in circumstances indicate that the carrying amount of the asset may not be recoverable in accordance with ASC 360, “Property, Plant, and Equipment.” Circumstances which could trigger a review include, but are not limited to: significant decreases in the market price of the asset; significant adverse changes in the business climate or legal factors; accumulation of costs significantly in excess of the amount originally expected for the acquisition or construction of the asset; current period cash flow or operating losses combined with a history of losses or a forecast of continuing losses associated with the use of the asset; and current expectation that the asset will more likely than not be sold or disposed significantly before the end of its estimated useful life. The Company’s long-lived assets consist of buildings, vehicles, equipment, and land. Buildings, vehicles, and equipment are depreciated on a straight-line basis over their estimated value lives ranging between three and thirty years.   The recoverability of assets is measured by a comparison of the carrying amount of an asset to estimated undiscounted future cash flows expected to be generated by an asset. If the carrying amount of an asset exceeds its estimated future cash flows, an impairment charge is recognized as the amount by which the carrying amount exceeds the estimated fair value of the asset. Any impairment in value is recognized as an expense in the period when the impairment occurs. No impairment charges were recorded in the three or nine months ended March 31, 2024.   Expenses for major repairs and maintenance which extend the useful lives of property and equipment are capitalized. All other maintenance expenses, including planned major maintenance activities, are expensed as incurred. Gains or losses from property disposals are included in income or loss from operations.
Mining Properties	d) Mining Properties   Costs of lease, exploration, carrying and retaining unproven mineral properties are expensed as incurred. The Company expenses all mineral exploration costs as incurred as it is still in the exploration stage. If the Company identifies proven and probable reserves in its investigation of its properties and upon development of a plan for operating a mine, it will enter the development stage and capitalize future costs until production is established. When a property reaches the production stage, the related capitalized costs are amortized on a units-of-production basis over the proven and probable reserves following the commencement of production. Interest expense allocable to the cost of developing mining properties and to construct new facilities is capitalized until assets are ready for their intended use.   To date, the Company has not established the commercial feasibility of any exploration prospects; therefore, all exploration costs are being expensed.   ASC 930-805, “Extractive Activities-Mining: Business Combinations,” states that mineral rights consist of the legal right to explore, extract, and retain at least a portion of the benefits from mineral deposits. Mining assets include mineral rights which are considered tangible assets under ASC 930-805. ASC 930-805 requires that mineral rights be recognized at fair value as of the acquisition date. As a result, the direct costs to acquire mineral rights are initially capitalized as tangible assets. Mineral rights include costs associated with acquiring patented and unpatented mining claims.
Intangible Assets	e) Intangible Assets   Intangible assets consist of water rights that have indefinite useful lives are tested annually for impairment, or more frequently if events and circumstances indicate that the asset might be impaired. An impairment loss is recognized to the extent that the carrying amount of the asset group exceeds its fair value. Annually, or when there is a triggering event, the Company first performs a qualitative assessment by evaluating all relevant events and circumstances to determine if it is more likely than not that the indefinite-lived intangible assets are impaired; this includes considering any potential effect on significant inputs to determining the fair value of the indefinite-lived intangible assets. When it is more likely than not that an indefinite-lived intangible asset is impaired, then the Company calculates the fair value of the intangible asset and performs a quantitative impairment test. No impairment charges were recorded in the three or nine months ended March 31, 2024.     AMERICAN BATTERY TECHNOLOGY COMPANY Notes to the Condensed Consolidated Financial Statements For the period ended March 31, 2024 (unaudited)   2. Summary of Significant Accounting Policies (continued)
Loss per Share	f) Loss per Share   The Company computes net income (loss) per share in accordance with ASC 260, “Earnings per Share.” ASC 260 requires presentation of both basic and diluted earnings per share (“EPS”) on the face of the income statement. Basic EPS is computed by dividing net income (loss) attributable to common stockholders (numerator) by the weighted average number of shares outstanding (denominator) during the period. Diluted EPS gives effect to all dilutive potential common shares outstanding during the period using the treasury stock method and convertible preferred stock using the if-converted method. In computing diluted EPS, the average stock price for the period is used in determining the number of shares assumed to be purchased from the exercise of stock options, warrants and awards. At March 31, 2024, the Company had 10,581,138 potentially dilutive shares outstanding, consisting of 1,355,853 from convertible notes, 5,757,894 from warrants and 3,467,391 from share awards outstanding. As the Company has reported losses for all periods presented, all potentially dilutive securities are anti-dilutive, and accordingly, basic net loss per share equaled diluted net loss per share.
Stock-based Compensation	g) Stock-based Compensation   The Company records stock-based compensation in accordance with ASC 718, “Stock Compensation,” using the fair value method. All transactions in which goods or services are the consideration received for the issuance of equity instruments are accounted for based on the fair value of the consideration received or the fair value of the equity instrument issued, whichever is more reliably measurable. Equity instruments issued to employees and the cost of the services received as consideration are measured and recognized based on the fair value of the equity instruments issued. The Company utilizes the Black Scholes method when calculating stock-based compensation expense relating to stock option awards and warrants.   The Company records the stock-based compensation expense attributed to share awards in accordance with US GAAP using the graded-vesting method. The Company amortizes the grant date fair value over the respective vesting period, beginning with recognition on the date of grant. Compensation in the form of warrants is limited to executives, and recorded as a liability until the warrant is exercised or expires. Executives may also receive compensation in the form of RSUs that are recorded as a liability until the award is settled in shares of common stock. The liability classification of these awards is based on the total value of the award granted at a fixed value but settled in a variable number of warrants or RSUs until the milestones are achieved and the warrants or RSUs are issued.
Exploration Costs	h) Exploration Costs   Mineral property acquisition costs are capitalized as incurred. Exploration and evaluation costs are expensed as incurred until proven and probable reserves are established. The Company assesses the carrying costs for impairment under ASC 360, “Property, Plant, and Equipment,” at each period end. When it has been determined that a mineral property can be economically developed as a result of establishing proven and probable reserves, the costs then incurred to develop such property are capitalized on a prospective basis. Such costs will be amortized using the units-of-production method over the estimated life of the probable reserve. If mineral properties are subsequently abandoned or impaired, any capitalized costs will be charged to operations. As of March 31, 2024 and 2023, the Company has not capitalized any such mineral property costs.
Research and Development Costs	i) Research and Development Costs   Research and development (“R&D”) costs are accounted for in accordance with ASC 730, “Research and Development.” ASC 730-10-25 requires that all R&D costs be recognized as an expense as incurred. However, some costs associated with R&D activities that have an alternative future use (e.g., materials, equipment, facilities) may be capitalizable.   The Company has been awarded federal grant awards for specific R&D programs. Under Accounting Standards Update (“ASU”) No. 2021-10 “Government Assistance,” the Company recognizes invoiced government funds as an offset to R&D costs in the period the qualifying costs are incurred. As the federal grants receivable are not deemed to have any significant realization risk, the Company believes this best reflects the expected net expenditures associated with these programs.     AMERICAN BATTERY TECHNOLOGY COMPANY Notes to the Condensed Consolidated Financial Statements For the period ended March 31, 2024 (unaudited)   2. Summary of Significant Accounting Policies (continued)
Leases	j) Leases   The Company follows the guidance of ASC 842, “Leases,” which requires an entity to recognize a right-of-use (“ROU”) asset and a lease liability for virtually all leases. Operating lease ROU assets and liabilities are recognized at commencement date based on the present value of lease payments over the lease term. ROU assets represent the Company’s right to use an underlying asset for the lease term and lease liabilities represent the Company’s obligation to make lease payments arising from the lease. The Company determines the present value of lease payments utilizing its incremental borrowing rate, as the implicit rate of interest in the respective leases is not readily determinable. The Company’s incremental borrowing rate is a hypothetical rate based on its understanding of what its credit rating would be.   The Company has elected not to recognize ROU assets and lease liabilities for short-term leases that have a lease term of 12 months or less. The Company recognizes the lease payments associated with its short-term office space leases as an expense on a straight-line basis over the lease term. Variable lease payments associated with these leases are recognized and presented in the same manner as for all other Company leases.
Income Taxes	k) Income Taxes   The Company accounts for income taxes using the asset and liability method in accordance with ASC 740, “Income Taxes.” The asset and liability method provides that deferred tax assets and liabilities are recognized for the expected future tax consequences of temporary differences between the financial reporting and tax bases of assets and liabilities, and for operating loss and tax credit carry-forwards.   Deferred tax assets and liabilities are measured using the currently enacted tax rates and laws that will be in effect when the differences are expected to reverse. The Company records a valuation allowance to reduce deferred tax assets to the amount that is believed more likely than not to be realized.   Any uncertain tax position liabilities have been applied against the deferred tax balance given that there is a sufficient net operating loss to cover any penalties and fees associated with the uncertain tax position. The Company assesses each of its identified uncertain positions and determines whether any potential penalties and interest liability should be accrued at the balance sheet dates.   Due to the Company’s cumulative loss position since inception, the likelihood of deferred tax assets being realized does not meet the more likely than not assessment guidelines. Accordingly, a valuation allowance equal to the deferred tax asset has been recorded at March 31, 2024 and June 30, 2023.
Accounting Pronouncements	l) Accounting Pronouncements   In November 2023, the FASB issued ASU 2023-07, “Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures.” The amendment in this update expands segment disclosures by requiring disclosures about significant segment expenses that are regularly provided to the chief operating decision maker and included within each reported measure of segment profit or loss, an amount and description of its composition for other segment items, and interim disclosures of a reportable segment’s profit or loss and assets. This update is effective for our annual report for fiscal year 2025, for interim period reporting beginning in fiscal year 2026, with early adoption permitted, and will be applied retrospectively to all prior periods presented in the financial statements. We are currently evaluating the timing of adoption and the impact of this ASU on our Consolidated Financial Statements and related disclosures.     AMERICAN BATTERY TECHNOLOGY COMPANY Notes to the Condensed Consolidated Financial Statements For the period ended March 31, 2024 (unaudited)   In December 2023, the FASB issued ASU 2023-09, “Income Taxes (Topic 740): Improvement to Income Tax Disclosures.” The amendments further enhance income tax disclosures, primarily through standardization and disaggregation of rate reconciliation categories and income taxes paid by jurisdiction. This ASU is effective for our annual report for fiscal year 2026, with early adoption permitted, and should be applied either prospectively or retrospectively. We are currently evaluating the timing of adoption and impact of this ASU on our Consolidated Financial Statements and related disclosures.
Derivative Financial Instruments	m) Derivative Financial Instruments   The Company evaluates its financial instruments to determine if such instruments are derivatives or contain features that qualify as embedded derivatives in accordance with ASC 815, “Derivatives and Hedging”. For derivative financial instruments that are accounted for as liabilities, the derivative instrument is initially recorded at its fair value on the issuance date and is then re-valued at each reporting date, with changes in the fair value reported in earnings in the condensed consolidated statements of operations.
Convertible Notes	n) Convertible Notes   The Company evaluates all conversion, repurchase and redemption features contained in a debt instrument to determine if there are any embedded features that require bifurcation as a derivative. The Company accounts for its convertible notes as a long-term liability, with the current portion reclassified to a short-term liability, equal to the proceeds received from issuance, including any embedded conversion features, net of the unamortized debt discount and offering costs in the accompanying unaudited condensed consolidated balance sheets. The debt discount, debt issuance and offering costs are amortized over the term of the convertible notes, using the effective interest method, as interest expense in the accompanying unaudited condensed consolidated statements of operations.
Inventory	o) Inventory   Inventory is stated at the lower of cost or market (net realizable value). The Company performs an assessment of the recoverability of capitalized inventory during each reporting period and writes down any excess and obsolete inventories to their net realizable value in the period in which the impairment is first identified.
Cash and Cash Equivalents	p) Cash and Cash Equivalents   The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company did not have any cash equivalents as of March 31, 2024 and June 30, 2023.
Fair Value of Financial Instruments	q) Fair Value of Financial Instruments   The fair value of the Company’s assets and liabilities, which qualify as financial instruments under the ASC 820, “Fair Value Measurements,” equals or approximates the carrying amounts represented in the condensed consolidated balance sheets.
Other Current Assets	r) Other Current Assets   Other Current Assets are comprised of payroll tax credits related to research and development activities per IRS form 6765.
Accrued Claims and Contingencies	s) Accrued Claims and Contingencies   The Company is subject to various claims and contingencies related to lawsuits. A liability is recorded for claims, legal costs or other contingencies when the risk of loss is probable and reasonable estimable. The required reserves may change due to new developments in each period.

v3.24.1.1.u2

Summary of Significant Accounting Policies (Tables)	9 Months Ended
	Mar. 31, 2024
Accounting Policies [Abstract]
Schedule of Consolidated Financial Statements	The tables below reflect the sections of the Company’s condensed consolidated financial statements that were impacted by the error.  Schedule of Consolidated Financial Statements CONSOLIDATED BALANCE SHEET       As Reported     Adjustments     As Corrected       June 30, 2023       As Reported     Adjustments     As Corrected   Liabilities and Stockholders’ Equity                           Current liabilities:                         Accounts payable and accrued liabilities   $ 7,389,864     $ 345,000     $ 7,734,864   Total current liabilities     13,389,864       345,000       13,734,864   Equity compensation liability     -       833,427       833,427   Total liabilities     13,444,168       1,178,427       14,622,595                             Stockholders’ equity                         Additional paid in capital   $ 222,626,865     $ (325,494 )   $ 222,301,371   Accumulated deficit     (159,973,575 )     (852,933 )     (160,826,508 ) Total stockholders’ equity     61,214,484       (1,178,427 )     60,036,057       AMERICAN BATTERY TECHNOLOGY COMPANY Notes to the Condensed Consolidated Financial Statements For the period ended March 31, 2024 (unaudited)   CONSOLIDATED STATEMENT OF OPERATIONS                           Fiscal year ended June 30, 2023       As Reported     Adjustments     As Corrected                       Operating expenses                         General and administrative   $ 11,960,831     $ 887,300     $ 12,848,131   Research and development     7,703,895       (138,160 )     7,565,735   Exploration     1,910,548       103,793       2,014,341   Total operating expenses     21,575,274       852,933       22,428,207                             Net loss before other income (expense)   $ (21,575,274 )   $ (852,933 )   $ (22,428,207 )                           Net loss attributable to common stockholders   $ (21,338,207 )   $ (852,933 )   $ (22,191,140 ) Net loss per share, basic and diluted   $ (0.49 )   $ (0.02 )   $ (0.51 )   CONSOLIDATED STATEMENT OF STOCKHOLDERS’ EQUITY                                 Fiscal year ended June 30, 2023       As Reported     Adjustments     As Corrected   Stockholders’ Equity                                                   Additional Paid-In Capital:                         Stock-based compensation expense   $ 9,249,462     $ (325,494 )   $ 8,923,968   Balance, June 30, 2023   $ 222,626,865     $ (325,494 )   $ 222,301,371                             Accumulated Deficit                         Net loss for period   $ (21,338,207 )   $ (852,933 )   $ (22,191,140 ) Balance, June 30, 2023     (159,973,575 )   $ (852,933 )   $ (160,826,508 )   CONSOLIDATED STATEMENTS OF CASH FLOWS       As Reported     Adjustments     As Corrected       Fiscal year ended June 30, 2023       As Reported     Adjustments     As Corrected                       Operating Activities                         Net loss attributable to stockholders   $ (21,338,207 )   $ (852,933 )   $ (22,191,140 )                           Adjustments to reconcile net loss to net cash used in operating activities:                         Stock-based compensation     9,249,462       507,933       9,757,395   Changes in operating assets and liabilities:                         Accounts payable and accrued liabilities   $ (187,796 )   $ 345,000     $ 157,204                             Net Cash Used in Operating Activities   $ (13,367,980 )   $ -     $ (13,367,980 )     CONDENSED CONSOLIDATED STATEMENT OF OPERATIONS       As Reported     Adjustments     As Corrected       Three months ended September 30, 2023       As Reported     Adjustments     As Corrected                       Operating expenses                         General and administrative   $ 2,948,846     $ 105,152     $ 3,053,998   Research and development     2,155,314       1,458,538       3,613,852   Exploration     1,279,782       70,138       1,349,920   Total operating expenses     6,383,942       1,633,827       8,017,769                             Net loss before other income (expense)   $ (6,383,942 )   $ (1,633,827 )   $ (8,017,769 )                           Other income (expense)                         Amortization of financing costs   $ (706,731 )   $ (26,165 )   $ (732,896 ) Total other income (expense)     (848,043 )     (26,165 )     (874,208 )                           Net loss attributable to common stockholders   $ (7,231,985 )   $ (1,659,992 )   $ (8,891,977 ) Net loss per share, basic and diluted   $ (0.16 )   $ (0.03 )   $ (0.19 )   CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY       As Reported     Adjustments     As Corrected       Three months ended September 30, 2023       As Reported     Adjustments     As Corrected                       Stockholders’ Equity                                                   Additional Paid-In Capital:                         Balance, June 30, 2023   $ 222,626,865     $ (325,494 )   $ 222,301,371   Stock-based compensation expense     1,921,442       981,396       2,902,838   Balance, September 30, 2023   $ 226,317,285     $ 655,903     $ 226,973,188                             Accumulated Deficit                         Balance, June 30, 2023   $ (159,973,575 )   $ (852,933 )   $ (160,826,508 ) Net loss for period   (7,231,985 )   (1,659,992 )   (8,891,977 ) Balance, September 30, 2023   $ (167,205,560 )   $ (2,512,926 )   $ (169,718,486 )   CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS         As Reported       Adjustments       As Corrected         Three months ended September 30, 2023         As Reported       Adjustments       As Corrected   Operating Activities                         Net loss attributable to stockholders   $ (7,231,985 )   $ (1,659,992 )   $ (8,891,977 ) Adjustments to reconcile net loss to net cash used in operating activities:                         Accretion expense   $ 256,459     $ 26,165     $ 282,624   Stock-based compensation     1,921,442       1,447,827       3,369,269   Changes in operating assets and liabilities:                         Accounts payable and accrued liabilities   $ 228,071     $ 186,000     $ 414,071                             Net Cash Used in Operating Activities   $ (4,758,984 )   $ -     $ (4,758,984 )     AMERICAN BATTERY TECHNOLOGY COMPANY Notes to the Condensed Consolidated Financial Statements For the period ended March 31, 2024 (unaudited)   CONDENSED CONSOLIDATED STATEMENT OF OPERATIONS       As Reported     Adjustments     As Corrected       Three months ended December 31, 2023       As Reported     Adjustments     As Corrected                       Operating expenses                         General and administrative   $ 4,310,452     $ 106,264     $ 4,416,716   Research and development     3,148,873       420,294       3,569,167   Exploration costs     771,523       51,902       823,425   Total operating expenses     8,230,848       578,459       8,809,307                           Net loss before other income (expense)   $ (8,230,848 )   $ (578,459 )   $ (8,809,307 )                           Other income (expense)                         Amortization and accretion of financing costs   $ (1,053,766 )   $ (78,492 )   $ (1,132,258 ) Change in fair value of derivative liability     -       (229,473 )     (229,473 ) Total other income (expense)     (1,060,587 )     (307,965 )     (1,368,552 )                           Net loss   $ (9,291,435 )   $ (886,424 )   $ (10,177,859 ) Net loss per share, basic and diluted   $ (0.19 )   $ (0.02 )   $ (0.21 )   CONDENSED CONSOLIDATED STATEMENT OF OPERATIONS       As Reported     Adjustments     As Corrected       Six months ended December 31, 2023       As Reported     Adjustments     As Corrected                       Operating expenses                         General and administrative   $ 7,259,298     $ 211,415     $ 7,470,713   Research and development     5,304,187       1,878,831       7,183,018   Exploration costs     2,051,305       122,040       2,173,345   Total operating expenses     14,614,790       2,212,286       16,827,076                             Net loss before other income (expense)   $ (14,614,790 )   $ (2,212,286 )   $ (16,827,076 )                           Other income (expense)                         Amortization and accretion of financing costs   $ (1,760,497 )   $ (104,657 )   $ (1,865,154 ) Change in fair value of derivative liability     -       (229,473 )     (229,473 ) Total other income (expense)     (1,908,630 )     (334,130 )     (2,242,760 )                           Net loss   $ (16,523,420 )   $ (2,546,416 )   $ (19,069,836 ) Net loss per share, basic and diluted   $ (0.35 )   $ (0.05 ) $ (0.40 )     AMERICAN BATTERY TECHNOLOGY COMPANY Notes to the Condensed Consolidated Financial Statements For the period ended March 31, 2024 (unaudited)   CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY         As Reported       Adjustments       As Corrected       Three months ended December 31, 2023         As Reported       Adjustments       As Corrected   Stockholders’ Equity                                                   Additional Paid-In Capital:                         Balance, September 30, 2023   $ 226,317,285     $ 655,903     $ 226,973,188   Stock-based compensation expense     3,836,466       146,877       3,983,343   Balance, December 31, 2023   $ 243,020,935     $ 802,779     $ 243,823,714                             Accumulated Deficit                         Balance, September 30, 2023   $ (167,205,560 )   $ (2,512,926 )   $ (169,718,486   Net loss for period     (9,291,435 )     (886,424 )     (10,177,859 ) Balance, December 31, 2023   $ (176,496,995 )   $ (3,399,350 )   $ (179,896,345 )   CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY       As Reported     Adjustments     As Corrected       Six months ended December 31, 2023       As Reported     Adjustments     As Corrected                       Stockholders’ Equity                         Additional Paid-In Capital:                         Balance, June 30, 2023   $ 222,626,865     $ (325,494 )   $ 222,301,371   Stock-based compensation expense     5,757,908     1,128,273       6,886,181   Balance, December 31, 2023   $ 243,020,935     $ 802,779     $ 243,823,714   Accumulated Deficit                         Balance, June 30, 2023   $ (159,973,575 )   $ (852,933 )   $ (160,826,508 ) Net loss for period   (16,523,420 )   (2,546,416 )   (19,069,836 ) Balance, December 31, 2023   $ (176,496,995 )   $ (3,399,350 )   $ (179,896,345 )   CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS                           Six months ended December 31, 2023       As Reported     Adjustments     As Corrected                       Operating Activities                       Net loss attributable to stockholders   $ (16,523,420 )   $ (2,546,416 )   $ (19,069,836 ) Adjustments to reconcile net loss to net cash used in operating activities:                         Accretion of financing costs   $ 1,760,497     $ 104,657   $ 1,865,154   Stock-based compensation     5,757,908       1,933,603       7,691,511   Shares issued for professional services     (132)       (316 )     (448 ) Change in fair value of derivative liability     -       229,473       229,473   Changes in operating assets and liabilities:                         Accounts payable and accrued liabilities   $ 2,223,865     $ 279,000     $ 2,502,865                             Net Cash Used in Operating Activities   $ (7,418,700 )   $ -   $ (7,418,700 )

v3.24.1.1.u2

Inventories (Tables)	9 Months Ended
	Mar. 31, 2024
Inventory Disclosure [Abstract]
Schedule of Inventories	Schedule of Inventories     March 31, 2024     June 30, 2023   Raw materials   $ 436,968     $ 125,204   Finished goods     185,577       -   Total   $ 622,545     $ 125,204

v3.24.1.1.u2

Property, Plant and Equipment (Tables)	9 Months Ended
	Mar. 31, 2024
Property, Plant and Equipment [Abstract]
Schedule of Property and Equipment	The table below presents the property, plant and equipment as of March 31, 2024 and June 30, 2023:  Schedule of Property and Equipment     Land     Building     Equipment     Total   Cost:                                                                   Balance, June 30, 2023   $ 6,728,838     $ 17,508,486     $ 5,870,496     $ 30,107,820   Additions     4,126,833       22,406,792       9,213,570       35,747,196                                     Balance, March 31, 2024   $ 10,855,671     $ 39,915,278     $ 15,084,066     $ 65,855,016                                     Accumulated Depreciation:                                                                   Balance, June 30, 2023   $ -     $ -     $ 161,721     $ 161,721   Additions                     106,644       106,644                                     Balance, March 31, 2024   $ -     $ -     $ 268,365     $ 268,365                                     Carrying Amounts:                                 Balance, June 30, 2023   $ 6,728,838     $ 17,508,486     $ 5,708,775     $ 29,946,099   Balance, March 31, 2024   $ 10,855,671     $ 39,915,278     $ 14,815,702     $ 65,586,651

v3.24.1.1.u2

Intangible Assets (Tables)	9 Months Ended
	Mar. 31, 2024
Goodwill and Intangible Assets Disclosure [Abstract]
Schedule of Intangible Assets	The table below presents total intangible assets at:  Schedule of Intangible Assets     March 31, 2024     June 30, 2023   Water rights   $ 4,584,831     $ 3,851,899

v3.24.1.1.u2

Accounts Payable and Accrued Liabilities (Tables)	9 Months Ended
	Mar. 31, 2024
Payables and Accruals [Abstract]
Schedule of Accounts Payable and Accrued Liabilities	The table below presents total accounts payable and accrued liabilities at:  Schedule of Accounts Payable and Accrued Liabilities     March 31, 2024     June 30, 2023   Trade payables   $ 2,949,290     $ 1,831,686   Accrued fixed assets     1,999,331       4,404,034   Accrued expenses     1,226,040       1,377,660   Right-of-use liability, current     86,030       121,484   Total accounts payable and accrued liabilities   $ 6,260,691     $ 7,734,864

v3.24.1.1.u2

Notes Payable (Tables)	9 Months Ended
	Mar. 31, 2024
Debt Disclosure [Abstract]
Schedule of Net Carrying Amounts of the Notes	The table below presents the net carrying amounts of the Notes as of:  Schedule of Net Carrying Amounts of the Notes     March 31, 2024     June 30, 2023   Principal outstanding   $ 12,483,333     $ -   Unamortized debt discount and issuance costs     (2,520,864 )     -   Derivative liability associated with convertible notes     366,298       -   Changes in fair market value of derivative liability     419,739       -   Net carrying value   $ 10,748,506     $ -
Schedule of Maturities of Notes Payable	The table below presents the maturities of notes payable as of March 31, 2024:  Schedule of Maturities of Notes Payable         March 31, 2025   $ 12,483,333   March 31, 2026     -   Total note payments     12,483,333   Less: unamortized debt discount and issuance costs     (2,520,864 ) Derivative liability, at fair value, less amortization     786,037   Total notes payable   $ 10,748,506             Notes payable, current   $ 10,748,506   Notes payable, non-current   $ -

v3.24.1.1.u2

Leases (Tables)	9 Months Ended
	Mar. 31, 2024
Leases
Schedule of Operating Lease ROU Assets and Lease Liabilities	Schedule of Operating Lease ROU Assets and Lease Liabilities     March 31, 2024     June 30, 2023   Operating lease right-of-use asset   $ 67,366     $ 143,154   Operating lease liabilities   $ 86,030     $ 175,788
Schedule of Maturity of Operating Lease Liabilities	The table below presents the maturities of operating lease liabilities as of March 31, 2024:  Schedule of Maturity of Operating Lease Liabilities            March 31, 2025   $ 88,632   March 31, 2026     -   Total lease payments     88,632   Less: discount     (2,601 )           Total operating lease liabilities   $ 86,030             Operating lease liabilities, current   $ 86,030   Operating lease liabilities, non-current   $ -
Schedule of Weighted Average Remaining Lease Term for Operating Leases and Weighted Average Discount Rate	The table below presents the weighted average remaining lease term for operating leases and weighted average discount rate used in calculating operating lease right-of-use asset as of March 31, 2024.  Schedule of Weighted Average Remaining Lease Term for Operating Leases and Weighted Average Discount Rate Weighted average lease term (years)     0.67   Weighted average discount rate     8.00 %

v3.24.1.1.u2

Share Purchase Warrants (Tables)	9 Months Ended
	Mar. 31, 2024
Share Purchase Warrants
Schedule of Share Purchase Warrants Activity	Schedule of Share Purchase Warrants Activity     Number of Warrants     Weighted Average Exercise Price                 Balance, June 30, 2023     5,729,360     $ 14.53   Granted     236,271       3.59   Exercised     (100,002 )     (1.13 ) Expired     (107,735 )     (3.75 ) Balance, March 31, 2024     5,757,894     $ 14.55
Schedule of Additional Information Regarding Share Purchase Warrants	Additional information regarding share purchase warrants as of March 31, 2024, is as follows:  Schedule of Additional Information Regarding Share Purchase Warrants     Outstanding and Exercisable   Range of Exercise Prices   Number of Warrants     Weighted Average Remaining Contractual Life (years)                     $1.13 - $4.33     919,214       0.33   $6.53 - $13.13     3,015,705       1.24   $23.10 - $26.25     1,822,975       0.74         5,757,894       2.31

v3.24.1.1.u2

Equity Compensation Awards (Tables)	9 Months Ended
	Mar. 31, 2024
Share-Based Payment Arrangement [Abstract]
Schedule of Restricted Shares and Restricted Share Units Non-vested	The table below reflects the share award activity for the period ended March 31, 2024:  Schedule of Restricted Shares and Restricted Share Units Non-vested     Units     Weighted- Average Grant Date Fair Value per Unit                 Unvested share awards at June 30, 2023     1,736,376     $ 8.35   Granted     2,634,678       4.03   Vested     (1,092,155 )     5.54   Other     –       –   Forfeitures     –     $ –   Unvested awards at March 31, 2024     3,278,899     $ 5.71
Schedule of Stock-Based Compensation Expense	The table below presents the stock-based compensation expense per respective line item on the consolidated statements of operations for the nine months ended March 31:  Schedule of Stock-Based Compensation Expense     2024     2023                 General and administrative   $ 6,143,765     $ 3,588,076   Research and development     5,197,699       1,985,491   Exploration     952,592       505,322   Stock-based compensation expense   $ 12,294,056     $ 6,078,889

v3.24.1.1.u2

Supplemental Statement of Cash Flow Disclosures (Tables)	9 Months Ended
	Mar. 31, 2024
Supplemental Cash Flow Elements [Abstract]
Schedule of Statement of Cash Flow Disclosures	For the nine months ended March 31:  Schedule of Statement of Cash Flow Disclosures     2024     2023                 Supplemental disclosures:                                   Interest paid   $ 16,017     $ -                     Non-cash investing and financing activities:                                   Current liabilities associated with investing activities     1,999,331       1,938,564                     Deposits capitalized as investing activities   27,103,351     150,000

v3.24.1.1.u2

Organization and Nature of Operations (Details Narrative) - USD ($)	3 Months Ended				6 Months Ended	9 Months Ended		12 Months Ended
	Mar. 31, 2024	Dec. 31, 2023	Sep. 30, 2023	Mar. 31, 2023	Dec. 31, 2023	Mar. 31, 2024	Mar. 31, 2023	Jun. 30, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Net loss	$ 9,995,137	$ 10,177,859		$ 5,608,021	$ 19,069,836	$ 29,064,973	$ 14,239,445
Net cash used in operating activities			$ 4,758,984		$ 7,418,700	12,430,522	$ 10,816,060	$ 13,367,980
Cash balance	5,995,134					5,995,134		2,320,149
Accumulated deficit	$ 189,891,481					$ 189,891,481		$ 160,826,508

v3.24.1.1.u2

Condensed Consolidated Balance Sheet (Details) - USD ($)	Mar. 31, 2024	Dec. 31, 2023	Jun. 30, 2023	Mar. 31, 2023	Dec. 31, 2022	Jun. 30, 2022
Current liabilities:
Accounts payable and accrued liabilities	$ 6,260,691		$ 7,734,864
Total current liabilities	17,009,197		13,734,864
Equity compensation liability	2,179,498		833,427
Total liabilities	19,188,695		14,622,595
Stockholders’ equity
Additional paid in capital	259,405,304		222,301,371
Accumulated deficit	(189,891,481)		(160,826,508)
Total stockholders’ equity	$ 70,068,563	$ 63,976,714	60,036,057	$ 53,936,502	$ 45,916,326	$ 49,634,059
Previously Reported [Member]
Current liabilities:
Accounts payable and accrued liabilities			7,389,864
Total current liabilities			13,389,864
Equity compensation liability
Total liabilities			13,444,168
Stockholders’ equity
Additional paid in capital			222,626,865
Accumulated deficit			(159,973,575)
Total stockholders’ equity			61,214,484
Revision of Prior Period, Error Correction, Adjustment [Member]
Current liabilities:
Accounts payable and accrued liabilities			345,000
Total current liabilities			345,000
Equity compensation liability			833,427
Total liabilities			1,178,427
Stockholders’ equity
Additional paid in capital			(325,494)
Accumulated deficit			(852,933)
Total stockholders’ equity			$ (1,178,427)

v3.24.1.1.u2

Condensed Consolidated Statement of Operations (Details) - USD ($)	3 Months Ended				6 Months Ended	9 Months Ended		12 Months Ended
	Mar. 31, 2024	Dec. 31, 2023	Sep. 30, 2023	Mar. 31, 2023	Dec. 31, 2023	Mar. 31, 2024	Mar. 31, 2023	Jun. 30, 2023
Operating expenses
General and administrative	$ 3,229,202	$ 4,416,716	$ 3,053,998	$ 3,538,541	$ 7,470,713	$ 10,699,915	$ 9,445,776	$ 12,848,131
Research and development	3,954,744	3,569,167	3,613,852	1,509,085	7,183,018	11,137,762	3,464,372	7,565,735
Exploration costs	1,422,758	823,425	1,349,920	584,344	2,173,345	3,596,103	1,479,507	2,014,341
Total operating expenses	8,606,704	8,809,307	8,017,769	5,631,970	16,827,076	25,433,780	14,389,655	22,428,207
Net loss before other income (expense)	$ (8,606,704)	$ (8,809,307)	(8,017,769)	$ (5,631,970)	(16,827,076)	$ (25,433,780)	$ (14,389,655)	(22,428,207)
Net loss attributable to common stockholders			$ (8,891,977)		$ (19,069,836)			$ (22,191,140)
Net loss per share, basic	$ (0.19)	$ (0.21)	$ (0.19)	$ (0.13)	$ (0.40)	$ (0.59)	$ (0.33)	$ (0.51)
Net loss per share, diluted	$ (0.19)	$ (0.21)	$ (0.19)	$ (0.13)	$ (0.40)	$ (0.59)	$ (0.33)	$ (0.51)
Other income (expense)
Amortization of financing costs			$ (732,896)
Total other income (expense)	$ (1,388,433)	$ (1,368,552)	(874,208)	$ 23,949	$ (2,242,760)	$ (3,631,193)	$ 150,210
Amortization and accretion of financing costs	(1,150,127)	(1,132,258)			(1,865,154)	(3,015,280)
Change in fair value of derivative liability	(216,765)	(229,473)			(229,473)	(446,238)
Net loss	$ (9,995,137)	(10,177,859)		$ (5,608,021)	(19,069,836)	$ (29,064,973)	$ (14,239,445)
Previously Reported [Member]
Operating expenses
General and administrative		4,310,452	2,948,846		7,259,298			$ 11,960,831
Research and development		3,148,873	2,155,314		5,304,187			7,703,895
Exploration costs		771,523	1,279,782		2,051,305			1,910,548
Total operating expenses		8,230,848	6,383,942		14,614,790			21,575,274
Net loss before other income (expense)		$ (8,230,848)	(6,383,942)		(14,614,790)			(21,575,274)
Net loss attributable to common stockholders			$ (7,231,985)		$ (16,523,420)			$ (21,338,207)
Net loss per share, basic		$ (0.19)	$ (0.16)		$ (0.35)			$ (0.49)
Net loss per share, diluted		$ (0.19)	$ (0.16)		$ (0.35)			$ (0.49)
Other income (expense)
Amortization of financing costs			$ (706,731)
Total other income (expense)		$ (1,060,587)	(848,043)		$ (1,908,630)
Amortization and accretion of financing costs		(1,053,766)			(1,760,497)
Change in fair value of derivative liability
Net loss		(9,291,435)			(16,523,420)
Revision of Prior Period, Error Correction, Adjustment [Member]
Operating expenses
General and administrative		106,264	105,152		211,415			$ 887,300
Research and development		420,294	1,458,538		1,878,831			(138,160)
Exploration costs		51,902	70,138		122,040			103,793
Total operating expenses		578,459	1,633,827		2,212,286			852,933
Net loss before other income (expense)		$ (578,459)	(1,633,827)		(2,212,286)			(852,933)
Net loss attributable to common stockholders			$ (1,659,992)		$ (2,546,416)			$ (852,933)
Net loss per share, basic		$ (0.02)	$ (0.03)		$ (0.05)			$ (0.02)
Net loss per share, diluted		$ (0.02)	$ (0.03)		$ (0.05)			$ (0.02)
Other income (expense)
Amortization of financing costs			$ (26,165)
Total other income (expense)		$ (307,965)	$ (26,165)		$ (334,130)
Amortization and accretion of financing costs		(78,492)			(104,657)
Change in fair value of derivative liability		(229,473)			(229,473)
Net loss		$ (886,424)			$ (2,546,416)

v3.24.1.1.u2

Condensed Consolidated Statement of Stockholders' Equity (Details) - USD ($)	3 Months Ended				6 Months Ended	9 Months Ended		12 Months Ended
	Mar. 31, 2024	Dec. 31, 2023	Sep. 30, 2023	Mar. 31, 2023	Dec. 31, 2023	Mar. 31, 2024	Mar. 31, 2023	Jun. 30, 2023
Balance	$ 70,068,563	$ 63,976,714		$ 53,936,502	$ 63,976,714	$ 70,068,563	$ 53,936,502	$ 60,036,057
Net loss for the period	(9,995,137)	(10,177,859)		(5,608,021)	(19,069,836)	(29,064,973)	(14,239,445)
Balance	63,976,714		$ 60,036,057	45,916,326	60,036,057	60,036,057	49,634,059	49,634,059
Previously Reported [Member]
Balance								61,214,484
Net loss for the period		(9,291,435)			(16,523,420)
Balance			61,214,484		61,214,484	61,214,484
Revision of Prior Period, Error Correction, Adjustment [Member]
Balance								(1,178,427)
Net loss for the period		(886,424)			(2,546,416)
Balance			(1,178,427)		(1,178,427)	(1,178,427)
Additional Paid-in Capital [Member]
Stock-based compensation expense		3,983,343	2,902,838		6,886,181			8,923,968
Balance	259,405,304	243,823,714	226,973,188	206,748,030	243,823,714	259,405,304	206,748,030	222,301,371
Net loss for the period
Balance	243,823,714	226,973,188	222,301,371	193,785,953	222,301,371	222,301,371	188,151,484	188,151,484
Additional Paid-in Capital [Member] | Previously Reported [Member]
Stock-based compensation expense		3,836,466	1,921,442		5,757,908			9,249,462
Balance		243,020,935	226,317,285		243,020,935			222,626,865
Balance	243,020,935	226,317,285	222,626,865		222,626,865	222,626,865
Additional Paid-in Capital [Member] | Revision of Prior Period, Error Correction, Adjustment [Member]
Stock-based compensation expense		146,877	981,396		1,128,273			(325,494)
Balance		802,779	655,903		802,779			(325,494)
Balance	802,779	655,903	(325,494)		(325,494)	(325,494)
Retained Earnings [Member]
Balance	(189,891,481)	(179,896,345)	(169,718,486)	(152,874,813)	(179,896,345)	(189,891,481)	(152,874,813)	(160,826,508)
Net loss for the period	(9,995,137)	(10,177,859)	(8,891,977)	(5,608,021)	(19,069,836)	(29,064,973)	(14,239,445)	(22,191,140)
Balance	(179,896,345)	(169,718,486)	(160,826,508)	$ (147,266,792)	(160,826,508)	(160,826,508)	$ (138,635,368)	(138,635,368)
Retained Earnings [Member] | Previously Reported [Member]
Balance		(176,496,995)	(167,205,560)		(176,496,995)			(159,973,575)
Net loss for the period		(9,291,435)	(7,231,985)		(16,523,420)			(21,338,207)
Balance	(176,496,995)	(167,205,560)	(159,973,575)		(159,973,575)	(159,973,575)
Retained Earnings [Member] | Revision of Prior Period, Error Correction, Adjustment [Member]
Balance		(3,399,350)	(2,512,926)		(3,399,350)			(852,933)
Net loss for the period		(886,424)	(1,659,992)		(2,546,416)			$ (852,933)
Balance	$ (3,399,350)	$ (2,512,926)	$ (852,933)		$ (852,933)	$ (852,933)

v3.24.1.1.u2

Condensed Consolidated Statements of Cash Flows (Details) - USD ($)	3 Months Ended	6 Months Ended	9 Months Ended		12 Months Ended
	Sep. 30, 2023	Dec. 31, 2023	Mar. 31, 2024	Mar. 31, 2023	Jun. 30, 2023
Operating Activities
Net loss attributable to stockholders	$ (8,891,977)	$ (19,069,836)			$ (22,191,140)
Adjustments to reconcile net loss to net cash used in operating activities:
Stock-based compensation	3,369,269	7,691,511	$ 12,322,198	$ 6,078,889	9,757,395
Changes in operating assets and liabilities:
Accounts payable and accrued liabilities	414,071	2,502,865	969,487	(1,653,541)	157,204
Net Cash Used in Operating Activities	(4,758,984)	(7,418,700)	(12,430,522)	(10,816,060)	(13,367,980)
Accretion of financing costs	282,624	1,865,154	3,014,414
Shares issued for professional services		(448)	$ (1,047)	$ 47,275
Change in fair value of derivative liability		229,473
Previously Reported [Member]
Operating Activities
Net loss attributable to stockholders	(7,231,985)	(16,523,420)			(21,338,207)
Adjustments to reconcile net loss to net cash used in operating activities:
Stock-based compensation	1,921,442	5,757,908			9,249,462
Changes in operating assets and liabilities:
Accounts payable and accrued liabilities	228,071	2,223,865			(187,796)
Net Cash Used in Operating Activities	(4,758,984)	(7,418,700)			(13,367,980)
Accretion of financing costs	256,459	1,760,497
Shares issued for professional services		(132)
Change in fair value of derivative liability
Revision of Prior Period, Error Correction, Adjustment [Member]
Operating Activities
Net loss attributable to stockholders	(1,659,992)	(2,546,416)			(852,933)
Adjustments to reconcile net loss to net cash used in operating activities:
Stock-based compensation	1,447,827	1,933,603			507,933
Changes in operating assets and liabilities:
Accounts payable and accrued liabilities	186,000	279,000			345,000
Net Cash Used in Operating Activities
Accretion of financing costs	$ 26,165	104,657
Shares issued for professional services		(316)
Change in fair value of derivative liability		$ 229,473

v3.24.1.1.u2

Summary of Significant Accounting Policies (Details Narrative) - USD ($)	3 Months Ended		6 Months Ended	9 Months Ended	12 Months Ended
	Dec. 31, 2023	Sep. 30, 2023	Dec. 31, 2023	Mar. 31, 2024	Jun. 30, 2023
Employee Stock Ownership Plan (ESOP), Compensation Expense	$ 600,000	$ 1,600,000
Accounts Payable and Accrued Liabilities, Current				$ 6,260,691	$ 7,734,864
Interest Expense, Other		$ 100,000	$ 300,000
Increase in interest and other expenses			400,000
Number of potentially dilutive shares				10,581,138
Lessee operating lease description				The Company has elected not to recognize ROU assets and lease liabilities for short-term leases that have a lease term of 12 months or less.
Convertible Notes [Member]
Number of potentially dilutive shares				1,355,853
Warrant [Member]
Number of potentially dilutive shares				5,757,894
Share Awards [Member]
Number of potentially dilutive shares				3,467,391
Revision of Prior Period, Error Correction, Adjustment [Member]
Employee Stock Ownership Plan (ESOP), Compensation Expense					900,000
Increase decrease in compensation cost			$ 2,200,000
Accounts Payable and Accrued Liabilities, Current					345,000
Accounts Payable and Accrued Liabilities, Noncurrent					$ 800,000

v3.24.1.1.u2

Schedule of Inventories (Details) - USD ($)	Mar. 31, 2024	Jun. 30, 2023
Inventory Disclosure [Abstract]
Raw materials	$ 436,968	$ 125,204
Finished goods	185,577
Total	$ 622,545	$ 125,204

v3.24.1.1.u2

Government Grant and Tax Credit Awards (Details Narrative) - USD ($)	Mar. 28, 2024	Nov. 17, 2022	Oct. 21, 2022	Aug. 16, 2021	Jan. 20, 2021	Mar. 31, 2024	Jun. 30, 2023
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Grants receivable						$ 527,723	$ 320,457
Project budget		$ 20,000,000.0	$ 115,500,000
Tax credit	$ 19,500,000
Additional tax credit	$ 40,500,000
September 1, 2023 [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Government grant cumulative funds invoiced						$ 1,457,877
Percentage of net eligible reimbursements						3.00%
October 1, 2023 [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Government grant cumulative funds invoiced						$ 421,735
Percentage of net eligible reimbursements						4.00%
Maximum [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Reimbursement percentage		50.00%	50.00%
Reimbursement of eligible expenditure		$ 10,000,000.0	$ 57,700,000
AMMTO Grant [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Project budget					$ 4,500,000
AMMTO Grant [Member] | October 1, 2021 [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Government grant cumulative funds invoiced						$ 1,560,962
Percentage of net eligible reimbursements						68.00%
AMMTO Grant [Member] | Maximum [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Reimbursement percentage					50.00%
Reimbursement of eligible expenditure					$ 2,300,000
USABC Grant [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Project budget				$ 2,000,000.0
Government grant cumulative funds invoiced						$ 479,939
Percentage of net eligible reimbursements						96.00%
USABC Grant [Member] | Maximum [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Reimbursement of eligible expenditure				$ 500,000

v3.24.1.1.u2

Other Deposits (Details Narrative) - USD ($) $ in Millions	Jun. 30, 2023	Mar. 01, 2023	Aug. 11, 2023
Amended Agreement [Member]
Restructuring Cost and Reserve [Line Items]
Aggregate purchase price	$ 1.5
Shares issued	128,206
Purchase price expected	$ 6.0
Linico Corporation [Member] | Asset Purchase Agreement [Member]
Restructuring Cost and Reserve [Line Items]
Aggregate purchase price		$ 6.0
Aqua Metals Transfer LLC [Member] | Asset Purchase Agreement [Member]
Restructuring Cost and Reserve [Line Items]
Aggregate purchase price		$ 21.6
Deposits			$ 27.6
Aqua Metals Transfer LLC [Member] | Membership Interest Purchase Agreement [Member]
Restructuring Cost and Reserve [Line Items]
Membership interests		100.00%

v3.24.1.1.u2

Schedule of Property and Equipment (Details)	9 Months Ended
	Mar. 31, 2024 USD ($)
Property, Plant and Equipment [Line Items]
Cost, beginning	$ 30,107,820
Cost additions	35,747,196
Cost, ending	65,855,016
Accumulated Depreciation, beginning	161,721
Accumulated Depreciation, additions	106,644
Accumulated Depreciation, ending	268,365
Carrying Amounts, beginning	29,946,099
Carrying Amounts, ending	65,586,651
Land [Member]
Property, Plant and Equipment [Line Items]
Cost, beginning	6,728,838
Cost additions	4,126,833
Cost, ending	10,855,671
Accumulated Depreciation, beginning
Accumulated Depreciation, ending
Carrying Amounts, beginning	6,728,838
Carrying Amounts, ending	10,855,671
Building [Member]
Property, Plant and Equipment [Line Items]
Cost, beginning	17,508,486
Cost additions	22,406,792
Cost, ending	39,915,278
Accumulated Depreciation, beginning
Accumulated Depreciation, ending
Carrying Amounts, beginning	17,508,486
Carrying Amounts, ending	39,915,278
Equipment [Member]
Property, Plant and Equipment [Line Items]
Cost, beginning	5,870,496
Cost additions	9,213,570
Cost, ending	15,084,066
Accumulated Depreciation, beginning	161,721
Accumulated Depreciation, additions	106,644
Accumulated Depreciation, ending	268,365
Carrying Amounts, beginning	5,708,775
Carrying Amounts, ending	$ 14,815,702

v3.24.1.1.u2

Property, Plant and Equipment (Details Narrative) $ in Millions	Aug. 11, 2023 USD ($)
Aqua Metals Transfer LLC [Member] | Asset Purchase Agreement [Member]
Restructuring Cost and Reserve [Line Items]
Deposits	$ 27.6

v3.24.1.1.u2

Schedule of Intangible Assets (Details) - USD ($)	Mar. 31, 2024	Jun. 30, 2023
Water Rights [Member]
Finite-Lived Intangible Assets [Line Items]
Water rights	$ 4,584,831	$ 3,851,899

v3.24.1.1.u2

Intangible Assets (Details Narrative) $ in Millions	Sep. 12, 2023 USD ($) a	Aug. 21, 2023 USD ($) a
Goodwill and Intangible Assets Disclosure [Abstract]
Area of land | a	40.52	18.45
Payments to acquire intangible assets | $	$ 0.1	$ 0.6

v3.24.1.1.u2

Schedule of Accounts Payable and Accrued Liabilities (Details) - USD ($)	Mar. 31, 2024	Jun. 30, 2023
Payables and Accruals [Abstract]
Trade payables	$ 2,949,290	$ 1,831,686
Accrued fixed assets	1,999,331	4,404,034
Accrued expenses	1,226,040	1,377,660
Right-of-use liability, current	86,030	121,484
Total accounts payable and accrued liabilities	$ 6,260,691	$ 7,734,864

v3.24.1.1.u2

Schedule of Net Carrying Amounts of the Notes (Details) - USD ($)	Mar. 31, 2024	Jun. 30, 2023
Debt Disclosure [Abstract]
Principal outstanding	$ 12,483,333
Unamortized debt discount and issuance costs	(2,520,864)
Derivative liability associated with convertible notes	366,298
Changes in fair market value of derivative liability	419,739
Net carrying value	$ 10,748,506

v3.24.1.1.u2

Schedule of Maturities of Notes Payable (Details) - USD ($)	Mar. 31, 2024	Jun. 30, 2023
Debt Disclosure [Abstract]
March 31, 2025	$ 12,483,333
March 31, 2026
Total note payments	12,483,333
Less: unamortized debt discount and issuance costs	(2,520,864)
Derivative liability, at fair value, less amortization	786,037
Net carrying value	10,748,506
Notes payable, current	10,748,506
Notes payable, non-current

v3.24.1.1.u2

Notes Payable (Details Narrative)			3 Months Ended			6 Months Ended	9 Months Ended
	Aug. 29, 2023 USD ($)	May 17, 2023 USD ($)	Mar. 31, 2024 USD ($)	Dec. 31, 2023 USD ($)	Mar. 31, 2023 USD ($)	Dec. 31, 2023 USD ($)	Mar. 31, 2024 USD ($)	Mar. 31, 2023 USD ($)	Jun. 30, 2023 USD ($)
Debt Instrument [Line Items]
Aggregrate loan amount			$ 12,483,333				$ 12,483,333
Repayments of notes payable							18,600,000
Sale of stock								8,857,351
Cash and cash equivalents at carrying value			5,995,134				5,995,134		$ 2,320,149
Fair value of derivative liability			400,000				400,000
Change in fair value of derivative liability			216,765	$ 229,473		$ 229,473	446,238
Derivative liability			$ 800,000				$ 800,000
Measurement Input, Price Volatility [Member] | Fair Value, Inputs, Level 3 [Member]
Debt Instrument [Line Items]
Derivative liability measurement input			81.1				81.1
Measurement Input, Risk Free Interest Rate [Member] | Fair Value, Inputs, Level 3 [Member]
Debt Instrument [Line Items]
Derivative liability measurement input			4.79				4.79
Credit Agreement [Member]
Debt Instrument [Line Items]
Aggregrate loan amount		$ 20,000,000
Principal amount		6,000,000
Loan commitment		$ 14,000,000
Description of notes payable interest rate		Borrowings under the Credit Agreement carry interest calculated as the secured overnight financing rate published on the Federal Reserve Bank of New York’s website, plus the applicable credit spread adjustment, based on the elected interest period, plus an applicable margin rate of 6%.
Purchase Agreement [Member]
Debt Instrument [Line Items]
Proceeds from secured notes payable	$ 25,000,000.0
Repayments of notes payable	12,600,000
Line of credit	$ 12,500,000
Debt instrument convertible conversion percent	1.10
Debt instrument maturity date	Sep. 01, 2025
Cash and cash equivalents at carrying value	$ 5,000,000.0
Amortization of financing costs and discounts	4,700,000						$ 2,800,000
Purchase Agreement [Member] | Common Stock [Member]
Debt Instrument [Line Items]
Aggregate partial redemptions of convertible notes	1,800,000
Purchase Agreement [Member] | Senior Secured Convertible Notes [Member]
Debt Instrument [Line Items]
Proceeds from secured notes payable	26,000,000
Line of credit	13,500,000
Sale of stock	250,000
Purchase Agreement [Member] | Maximum [Member]
Debt Instrument [Line Items]
Proceeds from secured notes payable	$ 51,000,000.0

v3.24.1.1.u2

Schedule of Operating Lease ROU Assets and Lease Liabilities (Details) - USD ($)	Mar. 31, 2024	Jun. 30, 2023
Leases
Operating lease right-of-use asset	$ 67,366	$ 143,154
Operating lease liabilities	$ 86,030	$ 175,788

v3.24.1.1.u2

Schedule of Maturity of Operating Lease Liabilities (Details) - USD ($)	Mar. 31, 2024	Jun. 30, 2023
Leases
March 31, 2025	$ 88,632
March 31, 2026
Total lease payments	88,632
Less: discount	(2,601)
Total operating lease liabilities	86,030	$ 175,788
Operating lease liabilities, current	86,030
Operating lease liabilities, non-current

v3.24.1.1.u2

Schedule of Weighted Average Remaining Lease Term for Operating Leases and Weighted Average Discount Rate (Details)	Mar. 31, 2024
Leases
Weighted average lease term (years)	8 months 1 day
Weighted average discount rate	8.00%

v3.24.1.1.u2

Leases (Details Narrative) - USD ($)	9 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Leases
Percentage of discount rate	8.00%	8.00%
Operating lease costs	$ 100,000	$ 100,000
Current lease liabilities	$ 86,030

v3.24.1.1.u2

Stockholders’ Equity (Details Narrative) - USD ($)		3 Months Ended		6 Months Ended	9 Months Ended		12 Months Ended
	Jul. 28, 2023	Sep. 30, 2023	Mar. 31, 2023	Dec. 31, 2023	Mar. 31, 2024	Mar. 31, 2023	Jun. 30, 2024	Jun. 30, 2023	Sep. 11, 2023
Accumulated Other Comprehensive Income (Loss) [Line Items]
Common stock, shares authorized					80,000,000			80,000,000
Common stock par value					$ 0.001			$ 0.001
Common stock, shares issued					55,058,411			45,888,131
Common stock, shares outstanding					55,058,411			45,888,131
Common shares issued for services, value			$ 10,596		$ (134)	$ 47,275
Stock issued during period, shares, restricted stock award, gross					171,500
Proceeds from issuance of warrants					$ 37,498
Stock-based compensation expense		$ 3,369,269		$ 7,691,511	12,322,198	6,078,889		$ 9,757,395
Stock-based compensation expense					$ 12,294,056	6,078,889
Number of shares vested					1,092,155
Proceeds from issuance of common stock						$ 8,857,351
Building Purchase Agreement [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Increase in stockholders equity	$ 200,000
Value of indemnification requirement as per agreement	$ 1,500,000
Number of shares reclaim	128,205
Tysadco Agreement [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Number of shares issued					8,209,262
Sale of stock, description					Pursuant to the Tysadco Agreement, the Company may offer and sell up to 8,666,667 common shares of the Company at a purchase price of 95% of the weighted-average price, with a minimum request of 33,333 shares.
Proceeds due from issuance of common stock					$ 27,800,000
Receivables net current					$ 2,400,000
Tysadco Agreement [Member] | Maximum [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Number of shares issued					8,666,667
Share Purchase Agreement [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Number of shares issued						8,209,262
Proceeds from issuance of common stock						$ 3,600,000
Professional Service [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Common shares issued for services, shares						10,009
Common shares issued for services, value						$ 104,000
Professional Service Providers [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Common shares issued for services, shares					1,326
Officers [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Stock issued during period, shares, restricted stock award, gross					171,500
Officer and Director [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Stock-based compensation expense					$ 4,400,000	2,700,000
Officer [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Stock-based compensation expense					$ 5,000,000.0	$ 5,000,000.0
Series A Preferred Stock [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Preferred stock, shares authorized					33,334			33,334
Preferred stock, par value					$ 0.001			$ 0.001
Preferred stock, shares issued
Preferred stock, shares outstanding
Series B Preferred Stock [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Preferred stock, shares authorized					133,334			133,334
Preferred stock, par value					$ 10.00			$ 10.00
Preferred stock, shares issued
Preferred stock, shares outstanding
Series C Preferred Stock [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Preferred stock, shares authorized					66,667			66,667
Preferred stock, par value					$ 10.00			$ 10.00
Preferred stock, shares issued
Preferred stock, shares outstanding
Preferred Stock [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Preferred stock, shares authorized					1,666,667
Preferred stock shares designated					233,334
Preferred Stock [Member] | Series A Preferred Stock [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Preferred stock, shares authorized					33,334			33,334
Preferred stock, par value					$ 0.001			$ 0.001
Preferred stock, shares issued
Preferred stock, shares outstanding
Preferred Stock [Member] | Series B Preferred Stock [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Preferred stock, shares authorized					133,334			133,334
Preferred stock, par value					$ 10.00			$ 10.00
Preferred stock, shares issued
Preferred stock, shares outstanding
Preferred Stock [Member] | Series C Preferred Stock [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Preferred stock, shares authorized					66,667			66,667
Preferred stock, par value					$ 10.00			$ 10.00
Preferred stock, shares issued
Preferred stock, shares outstanding
Prior Reverse Stock [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Common stock, shares issued									692,068,218
Common stock, shares outstanding									692,068,218
Post Reverse Stock [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Common stock, shares issued									46,137,882
Common stock, shares outstanding									46,137,882
Common Stock [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Common shares issued for services, shares					1,326	10,009
Common shares issued for services, value					$ 1	$ 10
Number of shares issued			133,333		39,883	400,000
Common Stock [Member] | Executives, Directors and Employees [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Common shares issued for services, shares					909,972
Common shares issued for services, value					$ 4,600,000
Common Stock [Member] | Employees and Directors [Member] | Restricted Stock [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Number of shares issued						293,908
Common Stock [Member] | Officer [Member] | Restricted Stock [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Number of shares vested						166,574
Number of shares vested, value						$ 1,700,000
Warrant [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Number of shares issued					39,883		45,545
Stock issued during period shares exercise of warrants					66,667		50,000
Proceeds from issuance of warrants					$ 37,500
Pursuant to share purchase warrants					33,334
Warrant [Member] | Officer [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Stock-based compensation expense					$ 1,300,000

v3.24.1.1.u2

Schedule of Share Purchase Warrants Activity (Details)	9 Months Ended
	Mar. 31, 2024 $ / shares shares
Share Purchase Warrants
Number of warrants, Beginning Balance | shares	5,729,360
Weighted average exercise price, Beginning Balance | $ / shares	$ 14.53
Number of warrants, Granted | shares	236,271
Weighted average exercise price, Granted | $ / shares	$ 3.59
Number of warrants, Exercised | shares	(100,002)
Weighted average exercise price, Exercised | $ / shares	$ (1.13)
Number of warrants, Expired | shares	(107,735)
Weighted average exercise price, Expired | $ / shares	$ (3.75)
Number of warrants, Ending Balance | shares	5,757,894
Weighted average exercise price, Ending Balance | $ / shares	$ 14.55

v3.24.1.1.u2

Schedule of Additional Information Regarding Share Purchase Warrants (Details) - $ / shares	Mar. 31, 2024	Jun. 30, 2023
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]
Outstanding and Exercisable, Number of Warrants	5,757,894	5,729,360
Weighted Average Remaining Contractual Life (years)	2 years 3 months 21 days
Exercise Price Range One [Member]
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]
Outstanding and Exercisable, Number of Warrants	919,214
Weighted Average Remaining Contractual Life (years)	3 months 29 days
Exercise Price Range One [Member] | Minimum [Member]
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]
Range of Exercise Prices	$ 1.13
Exercise Price Range One [Member] | Maximum [Member]
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]
Range of Exercise Prices	$ 4.33
Exercise Price Range Two [Member]
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]
Outstanding and Exercisable, Number of Warrants	3,015,705
Weighted Average Remaining Contractual Life (years)	1 year 2 months 26 days
Exercise Price Range Two [Member] | Minimum [Member]
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]
Range of Exercise Prices	$ 6.53
Exercise Price Range Two [Member] | Maximum [Member]
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]
Range of Exercise Prices	$ 13.13
Exercise Price Range Three [Member]
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]
Outstanding and Exercisable, Number of Warrants	1,822,975
Weighted Average Remaining Contractual Life (years)	8 months 26 days
Exercise Price Range Three [Member] | Minimum [Member]
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]
Range of Exercise Prices	$ 23.10
Exercise Price Range Three [Member] | Maximum [Member]
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]
Range of Exercise Prices	$ 26.25

v3.24.1.1.u2

Share Purchase Warrants (Details Narrative) - shares	9 Months Ended	12 Months Ended
	Mar. 31, 2024	Jun. 30, 2024
Number of warrants, granted	236,271
Stock issued during period, shares, restricted stock award, gross	171,500
Warrant [Member]
Common shares issued related to warrants exercised	73,217
Number of common shares issued, shares	39,883	45,545
Stock issued during period shares cashless exercise of warrants	66,667	50,000
Number of warrants, granted	249,119

v3.24.1.1.u2

Schedule of Restricted Shares and Restricted Share Units Non-vested (Details)	9 Months Ended
	Mar. 31, 2024 $ / shares shares
Share-Based Payment Arrangement [Abstract]
Units, Unvested share awards, Beginning | shares	1,736,376
Weighted average grant date fair value, Unvested share awards, Beginning | $ / shares	$ 8.35
Units, Granted | shares	2,634,678
Weighted average grant date fair value, Granted | $ / shares	$ 4.03
Units, Vested | shares	(1,092,155)
Weighted average grant date fair value, Vested | $ / shares	$ 5.54
Units, Other | shares
Weighted average grant date fair value, Other | $ / shares
Units, Forfeitures | shares
Weighted average grant date fair value, Forfeitures | $ / shares
Units, Unvested share awards, Ending | shares	3,278,899
Weighted average grant date fair value, Unvested share awards, Ending | $ / shares	$ 5.71

v3.24.1.1.u2

Schedule of Stock-Based Compensation Expense (Details) - USD ($)	9 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Stock-based compensation expense	$ 12,294,056	$ 6,078,889
General and Administrative Expense [Member]
Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Stock-based compensation expense	6,143,765	3,588,076
Research and Development Expense [Member]
Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Stock-based compensation expense	5,197,699	1,985,491
Exploration [Member]
Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Stock-based compensation expense	$ 952,592	$ 505,322

v3.24.1.1.u2

Equity Compensation Awards (Details Narrative) - USD ($)	3 Months Ended	6 Months Ended	9 Months Ended		12 Months Ended
	Sep. 30, 2023	Dec. 31, 2023	Mar. 31, 2024	Mar. 31, 2023	Jun. 30, 2023	Dec. 31, 2022
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Award vest rate			25.00%
Outstanding percentage						10.00%
Number of restricted shares issued, shares			2,634,678
Stock-based compensation expense	$ 3,369,269	$ 7,691,511	$ 12,322,198	$ 6,078,889	$ 9,757,395
Stock-based compensation expense			12,294,056	6,078,889
Unamortized expenses			$ 10,300,000		$ 8,700,000
Remaining weighted average period			3 years		3 years 2 months 12 days
Officer [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Stock-based compensation expense			$ 5,000,000.0	5,000,000.0
Officer [Member] | Warrant [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Stock-based compensation expense			1,300,000
Equity compensation liability			2,100,000	800,000
Director [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Stock-based compensation expense			$ 2,700,000	$ 2,700,000
2021 Equity Retention Plan [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Number of restricted shares issued, shares			1,800,000	2,600,000

v3.24.1.1.u2

Schedule of Statement of Cash Flow Disclosures (Details) - USD ($)	9 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Supplemental disclosures:
Interest paid	$ 16,017
Non-cash investing and financing activities:
Current liabilities associated with investing activities	1,999,331	1,938,564
Deposits capitalized as investing activities	$ 27,103,351	$ 150,000

v3.24.1.1.u2

Commitments and Contingencies (Details Narrative)	Mar. 31, 2024 USD ($)
Commitments and Contingencies Disclosure [Abstract]
Financial assurance reclamation or restoration cost	$ 59,646

v3.24.1.1.u2

Subsequent Events (Details Narrative) - $ / shares	Apr. 03, 2024	Mar. 31, 2024	Jun. 30, 2023
Subsequent Event [Line Items]
Common stock, par value		$ 0.001	$ 0.001
Subsequent Event [Member] | Sales Agreement [Member]
Subsequent Event [Line Items]
Sale of stock, number of shares issued in transaction	50,000,000
Subsequent Event [Member] | Sales Agreement [Member] | Common Stock [Member]
Subsequent Event [Line Items]
Common stock, par value	$ 0.001

---